,para,label,document,predictions
94,"<img> id-US20180072767A1-20180315-C00013.TIF </img>
",0,data/dev/US20180072767A1.txt,1
99,"<img> id-US20180072767A1-20180315-C00014.TIF </img>
",0,data/dev/US20180072767A1.txt,1
114,"<img> id-US20180072767A1-20180315-C00015.TIF </img>
",0,data/dev/US20180072767A1.txt,1
121,"<img> id-US20180072767A1-20180315-C00016.TIF </img>
",0,data/dev/US20180072767A1.txt,1
159,"<img> id-US20180072767A1-20180315-C00017.TIF </img>
",0,data/dev/US20180072767A1.txt,1
172,"<img> id-US20180072767A1-20180315-C00024.TIF </img>
",0,data/dev/US20180072767A1.txt,1
173,"(A) Syntheses of alkyne- and azide-modified TMM reporters 1-4. a) TMSCl, Et3N; b) K2CO3, CH3OH (92% over two steps, ref. 31); c) carboxylic acid, DCC, DMAP, CH2Cl2; d) Dowex H+ resin, CH3OH (yields over two steps are given). (B) Syntheses of TCO- and fluorescein-modified TMM reporters 5 and 6. e) Pd/C, H2, CH3OH; f) NHS-TCO, Et3N, N,N'-dimethylformamide (DMF); g) FITC, Et3N, DMF; h) reaction of 8 with any commercially available amine-reactive reagent will provide access to custom TMM reporters.
",0,data/dev/US20180072767A1.txt,1
175,"6-O-(6-heptynoyl)-α,α-D-trehalose (O-AlkTMM or O-AlkTMM-CT)
",1,data/dev/US20180072767A1.txt,0
184,"Unlabeled probes for competition experiments: 6-O-(6-heptanoyl)-α,α-D-trehalose and N-(6-heptanoyl)-6-amino-6-deoxy-α,α-D-trehalose
",1,data/dev/US20180072767A1.txt,0
193,"6-O-(10-undecynoyl)-α,α-D-trehalose (O-AlkTMM-C11)
",1,data/dev/US20180072767A1.txt,0
197,"6-O-(5-azidopentanoyl)-α,α-D-trehalose
",1,data/dev/US20180072767A1.txt,0
220,"General Procedures for Bacterial Labeling.
",0,data/dev/US20180072767A1.txt,1
250,"General Procedures for Bacterial Labeling.
",0,data/dev/US20180072767A1.txt,1
267,"FRET-TDM (5) was synthesized from diol 1 as shown in Scheme 4 and described below. (Compound numbering in this Example refers to Scheme 4)
",0,data/dev/US20180072767A1.txt,1
270,"<img> id-US20180072767A1-20180315-C00032.TIF </img>
",0,data/dev/US20180072767A1.txt,1
603,"Method 1
",0,data/dev/US20200121691A1.txt,1
623,"Method 2
",0,data/dev/US20200121691A1.txt,1
644,"Method 3
",0,data/dev/US20200121691A1.txt,1
705,"<img> id-US20200121691A1_00010.PNG </img>
",1,data/dev/US20200121691A1.txt,0
711,"<img> id-US20200121691A1_00011.PNG </img>
",1,data/dev/US20200121691A1.txt,0
713,"Example 1b
",0,data/dev/US20200121691A1.txt,1
717,"<img> id-US20200121691A1_00012.PNG </img>
",1,data/dev/US20200121691A1.txt,0
719,"Example 2a
",0,data/dev/US20200121691A1.txt,1
722,"<img> id-US20200121691A1_00013.PNG </img>
",1,data/dev/US20200121691A1.txt,0
725,"Example 2b
",0,data/dev/US20200121691A1.txt,1
728,"<img> id-US20200121691A1_00014.PNG </img>
",1,data/dev/US20200121691A1.txt,0
731,"Example 2c
",0,data/dev/US20200121691A1.txt,1
734,"<img> id-US20200121691A1_00015.PNG </img>
",1,data/dev/US20200121691A1.txt,0
737,"Example 2d
",0,data/dev/US20200121691A1.txt,1
740,"<img> id-US20200121691A1_00016.PNG </img>
",1,data/dev/US20200121691A1.txt,0
743,"Example 2e
",0,data/dev/US20200121691A1.txt,1
750,"Example 2f
",0,data/dev/US20200121691A1.txt,1
756,"Example 2g
",0,data/dev/US20200121691A1.txt,1
763,"Example 2h
",0,data/dev/US20200121691A1.txt,1
766,"<img> id-US20200121691A1_00020.PNG </img>
",1,data/dev/US20200121691A1.txt,0
769,"Example 2i
",0,data/dev/US20200121691A1.txt,1
772,"<img> id-US20200121691A1_00021.PNG </img>
",1,data/dev/US20200121691A1.txt,0
775,"Example 2k
",0,data/dev/US20200121691A1.txt,1
779,"<img> id-US20200121691A1_00022.PNG </img>
",1,data/dev/US20200121691A1.txt,0
782,"Example 2j
",0,data/dev/US20200121691A1.txt,1
788,"Example 2l
",0,data/dev/US20200121691A1.txt,1
794,"Example 2m
",0,data/dev/US20200121691A1.txt,1
799,"Example 3a
",0,data/dev/US20200121691A1.txt,1
804,"Example 3b
",0,data/dev/US20200121691A1.txt,1
809,"Example 3c
",0,data/dev/US20200121691A1.txt,1
814,"Example 3d
",0,data/dev/US20200121691A1.txt,1
819,"Example 3e
",0,data/dev/US20200121691A1.txt,1
825,"Example 3f
",0,data/dev/US20200121691A1.txt,1
830,"Example 3g
",0,data/dev/US20200121691A1.txt,1
836,"Example 3h
",0,data/dev/US20200121691A1.txt,1
841,"Example 3i
",0,data/dev/US20200121691A1.txt,1
846,"Example 3k
",0,data/dev/US20200121691A1.txt,1
852,"Example 3j
",0,data/dev/US20200121691A1.txt,1
857,"Example 3l
",0,data/dev/US20200121691A1.txt,1
862,"Example 3m
",0,data/dev/US20200121691A1.txt,1
867,"Example 4a
",0,data/dev/US20200121691A1.txt,1
872,"Example 4b
",0,data/dev/US20200121691A1.txt,1
877,"Example 4c
",0,data/dev/US20200121691A1.txt,1
882,"Example 4d
",0,data/dev/US20200121691A1.txt,1
887,"Example 4e
",0,data/dev/US20200121691A1.txt,1
892,"Example 4f
",0,data/dev/US20200121691A1.txt,1
897,"Example 4g
",0,data/dev/US20200121691A1.txt,1
902,"Example 4h
",0,data/dev/US20200121691A1.txt,1
907,"Example 4i
",0,data/dev/US20200121691A1.txt,1
912,"Example 4k
",0,data/dev/US20200121691A1.txt,1
918,"Example 4j
",0,data/dev/US20200121691A1.txt,1
923,"Example 4l
",0,data/dev/US20200121691A1.txt,1
928,"Example 4m
",0,data/dev/US20200121691A1.txt,1
931,"Example 1
",1,data/dev/US20200121691A1.txt,0
938,"Example 2
",1,data/dev/US20200121691A1.txt,0
946,"Example 3
",1,data/dev/US20200121691A1.txt,0
954,"Example 4
",1,data/dev/US20200121691A1.txt,0
962,"Example 5
",1,data/dev/US20200121691A1.txt,0
970,"Example 6
",1,data/dev/US20200121691A1.txt,0
982,"Example 7
",0,data/dev/US20200121691A1.txt,1
990,"Example 8
",0,data/dev/US20200121691A1.txt,1
998,"Example 9
",0,data/dev/US20200121691A1.txt,1
1006,"Example 18
",0,data/dev/US20200121691A1.txt,1
1013,"Example 30
",0,data/dev/US20200121691A1.txt,1
1021,"Example 3l
",0,data/dev/US20200121691A1.txt,1
1029,"Example 33
",0,data/dev/US20200121691A1.txt,1
1037,"Example 34
",0,data/dev/US20200121691A1.txt,1
1045,"Example 35
",0,data/dev/US20200121691A1.txt,1
1053,"Example 36
",0,data/dev/US20200121691A1.txt,1
1134,"Example 1: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)pyrimidin-2-ylamino)phenyl)acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1135,"<img> id-imgb0020.tif </img>
",0,data/dev/EP3323817A1.txt,1
1157,"Example 2: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(2-oxo -2,3-dihydrobenzo[d]imidazol-1-yl)pyrimidin-2-ylamino)phenyl)acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1158,"<img> id-imgb0028.tif </img>
",0,data/dev/EP3323817A1.txt,1
1168,"Example 3: N-(5-(5-chloro-4-(3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1 -yl)pyrimidin-2-ylamino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl) acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1169,"<img> id-imgb0032.tif </img>
",0,data/dev/EP3323817A1.txt,1
1191,"Example 4: N-(5-(5-chloro-4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1 -yl)pyrimidin-2-ylamino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl) acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1192,"<img> id-imgb0040.tif </img>
",0,data/dev/EP3323817A1.txt,1
1198,"The title compound was prepared from 1-(5-chloro-2-(4-fluoro-2-methoxy-5 -nitrophenylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one by a method similar to that described in Step 5 of Example 1.
",0,data/dev/EP3323817A1.txt,1
1202,"Example 5: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(2 -oxobenzo[d]oxazol-3(2H)-yl)pyrimidin-2-ylamino)phenyl) acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1203,"<img> id-imgb0044.tif </img>
",0,data/dev/EP3323817A1.txt,1
1222,"Example 6: N-(2-((2-hydroxyethyl)(methyl)amino)-4-methoxy-5-(4-(3-methyl-2 -oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)pyrimidin-2-ylamino)phenyl)acrylamide
",0,data/dev/EP3323817A1.txt,1
1223,"<img> id-imgb0051.tif </img>
",0,data/dev/EP3323817A1.txt,1
1230,"Example 7: (E)-N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4 -(3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)pyrimidin-2-ylamino)phenyl)-4 -methoxybut-2-enamide
",1,data/dev/EP3323817A1.txt,0
1233,"Example 8: N-(4-methoxy-5-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]midazol-1-yl) pyrimidin-2-ylamino)-2-morpholinophenyl)acrylamide
",0,data/dev/EP3323817A1.txt,1
1234,"<img> id-imgb0055.tif </img>
",0,data/dev/EP3323817A1.txt,1
1241,"Example 9: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(5-methyl-2-oxo-2,3-dihydrobenzo [d]imidazol-1-yl)pyrimidin-2-ylamino)phenyl)acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1242,"<img> id-imgb0058.tif </img>
",0,data/dev/EP3323817A1.txt,1
1258,"Example 10: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-5-(4-(5-fluoro-3 -methyl-2-oxo-2,3-dihydrobenzo[d]imidazol-1-yl)pyrimidin-2-ylamino)-4-methoxyphenyl) acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1259,"<img> id-imgb0064.tif </img>
",0,data/dev/EP3323817A1.txt,1
1278,"Example 11: N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-5-(4-(5-fluoro-2-oxo -2,3-dihydrobenzo[d]imidazol-1-yl)pyrimidin-2-ylamino)-4-methoxyphenyl)acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1279,"<img> id-imgb0071.tif </img>
",0,data/dev/EP3323817A1.txt,1
1289,"Example 12: N-(4-methoxy-2-(methyl(2-(methylamino)ethyl)amino)-5-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d|imidazol-1-yl)pyrimidin-2-ylamino)phenyl)acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1290,"<img> id-imgb0075.tif </img>
",0,data/dev/EP3323817A1.txt,1
1303,"Example 14: N-(5-(4-(5-chloro-3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole -1-yl)pyrimidin-2-ylamino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl) acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1304,"<img> id-imgb0080.tif </img>
",0,data/dev/EP3323817A1.txt,1
1326,"Example 15: N-(5-(4-(5-bromo-3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole -1-yl)pyrimidin-2-ylamino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl) acrylamide hydrochloride
",0,data/dev/EP3323817A1.txt,1
1327,"<img> id-imgb0088.tif </img>
",0,data/dev/EP3323817A1.txt,1
1467,"ZD005 & (3-((2-methylthiazol-4-yl)ethynyl)phenyl) (3-trifluoromethyl-5,6-dihydro-[1,2,4]tria zolo[4,3-a]pyrazin-7(8H)-yl)methanone & <img> id-imgb0023.tif </img>
",0,data/dev/EP3284738A1.txt,1
1485,"ZD041 & N-(4-fluorophenyl)-2-methyl-5-((2-methyl thiazol-4-yl)ethynyl)benzamide & <img> id-imgb0041.tif </img>
",0,data/dev/EP3284738A1.txt,1
1496,"ZD052 & (3,4-dihydro-isoquinolin-2(1H)-yl)(2-fluo ro-5-((2-methyl-thiazol-4-yl)ethynyl)pyrid in-3-yl)methanone & <img> id-imgb0052.tif </img>
",0,data/dev/EP3284738A1.txt,1
1498,"ZD054 & 2-chloro-N-(4-fluorophenyl)-5-((2-methyl thiazol-4-yl)ethynyl)nicotinamide & <img> id-imgb0054.tif </img>
",0,data/dev/EP3284738A1.txt,1
1504,"ZD060 & N-(4-fluorophenyl)-5-((2-methylthiazol-4-yl)ethynyl)-2-(trifluoromethyl)benzamide & <img> id-imgb0060.tif </img>
",0,data/dev/EP3284738A1.txt,1
1507,"ZD063 & (3,4-dihydro-isoquinolin-2(1H)-yl)(5-((2-methyl-thiazol-4-yl)ethynyl)-2-(trifluorom ethyl)phenyl)methanone & <img> id-imgb0063.tif </img>
",0,data/dev/EP3284738A1.txt,1
1567,"Example 2 The preparation of (2-chloro-5- (pyridin-2-ethynyl) phenyl) (7-oxa-2-aza-spiro [3.5] nonan-2-yl) methanone (ZD002)
",1,data/dev/EP3284738A1.txt,0
1569,"Example 3 The preparation of (2-chloro-5- (pyridin-2-ethynyl) phenyl) (8-oxa-2-aza-spiro [4.5] dec-2-yl) methanone (ZD003)
",1,data/dev/EP3284738A1.txt,0
1571,"Example 4 The preparation of 2-fluoro-N- (4-fluorophenyl) -5 - ((2-methylthiazol-4-yl) ethynyl) benzamide (ZD004)
",1,data/dev/EP3284738A1.txt,0
1700,"2-fluoro-5-iodobenzoic acid was replaced by 3-iodobenzoic acid, 4-fluoroaniline was replaced by 3-trifluoromethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine, 2-ethynylpyridine was replaced by 4-ethynyl-2-methylthiazole, while the remaining raw materials, reagents and the preparation method were the same as those in Example 1 to give the product ZD005, yield 80%. 1H NMR (400 MHz, CDCl3) δ 7.68 (s, 1H), 7.65 (s, 1H), 7.47 (d, J = 5.6 Hz,2H), 7.41 (s, 1H), 5.06 (s, 2H), 4.26 (s, 2H), 4.12 (s,2H), 2.74 (s, 3H).LRMS (EI) m/z 418(M+).
",1,data/dev/EP3284738A1.txt,0
2050,"<img> id-US20180002276A1-20180104-C00084.TIF </img>
",0,data/dev/US20180002276A1.txt,1
2076,"<img> id-US20180002276A1-20180104-C00087.TIF </img>
",0,data/dev/US20180002276A1.txt,1
2079,"<img> id-US20180002276A1-20180104-C00088.TIF </img>
",0,data/dev/US20180002276A1.txt,1
2104,"(Example 2) Production of the Compound Represented by Formula (I-61)
",1,data/dev/US20180002276A1.txt,0
2105,"<img> id-US20180002276A1-20180104-C00100.TIF </img>
",1,data/dev/US20180002276A1.txt,0
2106,"The compounds represented by Formula (I-61-1) to (I-61) were prepared as in Example 1.
",1,data/dev/US20180002276A1.txt,0
2108,"(Example 3) Production of the Compound Represented by Formula (I-67)
",1,data/dev/US20180002276A1.txt,0
2110,"The compounds represented by Formula (I-67-1) to (I-67) were prepared as in Example 1. MS (m/z): 1167 [M++1]
",1,data/dev/US20180002276A1.txt,0
2112,"<img> id-US20180002276A1-20180104-C00102.TIF </img>
",0,data/dev/US20180002276A1.txt,1
2183,"<img> id-US20180002276A1-20180104-C00119.TIF </img>
",0,data/dev/US20180002276A1.txt,1
2259,"<img> id-US20200048291A1_00025.PNG </img>
",0,data/dev/US20200048291A1.txt,1
2261,"<img> id-US20200048291A1_00026.PNG </img>
",0,data/dev/US20200048291A1.txt,1
2264,"<img> id-US20200048291A1_00027.PNG </img>
",0,data/dev/US20200048291A1.txt,1
2279,"<img> id-US20200048291A1_00028.PNG </img>
",0,data/dev/US20200048291A1.txt,1
2281,"<img> id-US20200048291A1_00029.PNG </img>
",0,data/dev/US20200048291A1.txt,1
2292,"<img> id-US20200048291A1_00030.PNG </img>
",0,data/dev/US20200048291A1.txt,1
2373,"[Pt(BPI)(NHC)](OTf) with different alkyl chains and aromatic groups on the NHC ligands were prepared by refluxing [Pt(BPI)Cl][25] with corresponding imidazolium salt in the presence of base (FIG. 1; See Supporting Information for experimental details and characterization data). The structure of 1a was further examined by X-ray crystallography (FIG. 2 and Table 1) and the NHC ligand was found to be perpendicular to the plane of BPI ligand with bond angle (C19-Pt1-N5) of 90.6°.
",0,data/dev/US20200048291A1.txt,1
2523,"The BPI (1,3-Bis(2-pyridylimino)isoindoline), benz(f)BPI (3-Bis(2-pyridylimino)benz(f)isoindoline) and Pt(BPI)Cl were synthesized according to reported procedures. [47]
",0,data/dev/US20200048291A1.txt,1
2749,"Example 1-1
",1,data/dev/US20200270285A1.txt,0
2750,"Synthesis of Organic Silicon Compound 1
",1,data/dev/US20200270285A1.txt,0
2753,"<img> id-US20200270285A1_00024.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2754,"Example 1-2
",1,data/dev/US20200270285A1.txt,0
2758,"<img> id-US20200270285A1_00025.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2759,"Example 1-3
",1,data/dev/US20200270285A1.txt,0
2763,"<img> id-US20200270285A1_00026.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2764,"Example 1-4
",1,data/dev/US20200270285A1.txt,0
2768,"<img> id-US20200270285A1_00027.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2769,"Example 1-5
",1,data/dev/US20200270285A1.txt,0
2773,"<img> id-US20200270285A1_00028.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2774,"Example 1-6
",1,data/dev/US20200270285A1.txt,0
2778,"<img> id-US20200270285A1_00029.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2779,"Example 1-7
",1,data/dev/US20200270285A1.txt,0
2783,"<img> id-US20200270285A1_00030.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2784,"Example 1-8
",1,data/dev/US20200270285A1.txt,0
2788,"<img> id-US20200270285A1_00031.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2789,"Example 1-9
",1,data/dev/US20200270285A1.txt,0
2793,"<img> id-US20200270285A1_00032.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2794,"Example 1-10
",1,data/dev/US20200270285A1.txt,0
2798,"<img> id-US20200270285A1_00033.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2799,"Example 1-11
",1,data/dev/US20200270285A1.txt,0
2803,"<img> id-US20200270285A1_00034.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2804,"Example 1-12
",1,data/dev/US20200270285A1.txt,0
2808,"<img> id-US20200270285A1_00035.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2809,"Example 1-13
",1,data/dev/US20200270285A1.txt,0
2813,"<img> id-US20200270285A1_00036.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2814,"Example 1-14
",1,data/dev/US20200270285A1.txt,0
2818,"<img> id-US20200270285A1_00037.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2819,"Example 1-15
",1,data/dev/US20200270285A1.txt,0
2823,"<img> id-US20200270285A1_00038.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2824,"Example 1-16
",1,data/dev/US20200270285A1.txt,0
2828,"<img> id-US20200270285A1_00039.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2830,"<img> id-US20200270285A1_00040.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2832,"Example 1-17
",1,data/dev/US20200270285A1.txt,0
2836,"<img> id-US20200270285A1_00041.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2838,"<img> id-US20200270285A1_00042.PNG </img>
",0,data/dev/US20200270285A1.txt,1
2852,"<img> id-US20200270285A1_00043.PNG </img>
",0,data/dev/US20200270285A1.txt,1
3238," & c-Pr & Et
",0,data/dev/US20200165244A1.txt,1
3549,"Preparation Example 1
",1,data/dev/US20200165244A1.txt,0
3551,"<img> id-US20200165244A1_00020.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3555,"Preparation Example 2
",1,data/dev/US20200165244A1.txt,0
3557,"<img> id-US20200165244A1_00022.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3559,"Preparation Example 3
",1,data/dev/US20200165244A1.txt,0
3561,"<img> id-US20200165244A1_00023.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3563,"Preparation Example 4
",1,data/dev/US20200165244A1.txt,0
3565,"<img> id-US20200165244A1_00024.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3567,"Preparation Example 5
",1,data/dev/US20200165244A1.txt,0
3569,"<img> id-US20200165244A1_00025.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3571,"Preparation Example 6
",1,data/dev/US20200165244A1.txt,0
3573,"<img> id-US20200165244A1_00026.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3593," & A2 & NBoc2
",1,data/dev/US20200165244A1.txt,0
3594," & A4 & NHC(O)OMe
",1,data/dev/US20200165244A1.txt,0
3596," & A8 & <img> id-US20200165244A1_00028.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3598," & A9 & <img> id-US20200165244A1_00029.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3605,"Preparation Example 8
",1,data/dev/US20200165244A1.txt,0
3607,"<img> id-US20200165244A1_00030.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3627," & A4 & C(O)OMe & H
",1,data/dev/US20200165244A1.txt,0
3628," & A6 & C(O)OPr & H
",1,data/dev/US20200165244A1.txt,0
3634,"<img> id-US20200165244A1_00032.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3637,"The compound A5 which was prepared according to the method described in Preparation Example 10 and physical property value thereof is shown below.
",1,data/dev/US20200165244A1.txt,0
3638,"<img> id-US20200165244A1_00033.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3642,"<img> id-US20200165244A1_00034.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3645,"<img> id-US20200165244A1_00035.PNG </img>
",1,data/dev/US20200165244A1.txt,0
3647,"Preparation Example 14
",0,data/dev/US20200165244A1.txt,1
3665," & C2 & H & C(O)Ot-Bu
",1,data/dev/US20200165244A1.txt,0
3666," & C3 & H & C(O)OMe
",1,data/dev/US20200165244A1.txt,0
3710,"Formulation Example 19
",0,data/dev/US20200165244A1.txt,1
3718,"Formulation Example 23
",0,data/dev/US20200165244A1.txt,1
3924,"<Preparative Example 1> Synthesis of B-BTM-C9
",0,data/dev/US20200123187A1.txt,1
3933,"<Preparative Example 2> Synthesis of B-BTM-C10
",0,data/dev/US20200123187A1.txt,1
3942,"<Preparative Example 3> Synthesis of B-BTM-C11
",0,data/dev/US20200123187A1.txt,1
3951,"<Preparative Example 4> Synthesis of A-BTM-C9
",0,data/dev/US20200123187A1.txt,1
3960,"<Preparative Example 5> Synthesis of A-BTM-C10
",0,data/dev/US20200123187A1.txt,1
3969,"<Preparative Example 6> Synthesis of A-BTM-C11
",0,data/dev/US20200123187A1.txt,1
3978,"<Preparative Example 7> Synthesis of M-BTM-C9
",0,data/dev/US20200123187A1.txt,1
3987,"<Preparative Example 8> Synthesis of M-BTM-C10
",0,data/dev/US20200123187A1.txt,1
3996,"<Preparative Example 9> Synthesis of M-BTM-C11
",0,data/dev/US20200123187A1.txt,1
4136,"Example 1: Preparation of 1-(trans-3-((2-((1-ethyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-4-fluoropiperidin-1-yl)prop-2-en-1-one
",0,data/dev/US20200308177A1.txt,1
4153,"<img> id-US20200308177A1_00006.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4157,"<img> id-US20200308177A1_00007.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4161,"<img> id-US20200308177A1_00008.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4164,"<img> id-US20200308177A1_00009.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4168,"<img> id-US20200308177A1_00010.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4172,"<img> id-US20200308177A1_00011.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4176,"<img> id-US20200308177A1_00012.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4180,"<img> id-US20200308177A1_00013.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4184,"<img> id-US20200308177A1_00014.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4188,"<img> id-US20200308177A1_00015.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4192,"<img> id-US20200308177A1_00016.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4196,"<img> id-US20200308177A1_00017.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4200,"<img> id-US20200308177A1_00018.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4204,"<img> id-US20200308177A1_00019.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4208,"<img> id-US20200308177A1_00020.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4212,"<img> id-US20200308177A1_00021.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4216,"<img> id-US20200308177A1_00022.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4219,"Example 19: Preparation of 1-((3S,4R)-3-((2-((1-ethyl-1H-pyrazol-4-yl)amino)-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-4-fluoropiperidin-1-yl)prop-2-en-1-one
",0,data/dev/US20200308177A1.txt,1
4233,"<img> id-US20200308177A1_00024.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4237,"<img> id-US20200308177A1_00025.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4244,"Example 23: Preparation of 1-(trans-4-fluoro-3-((2-(isoxazol-4-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)piperidin-1-yl)prop-2-en-1-one
",0,data/dev/US20200308177A1.txt,1
4261,"<img> id-US20200308177A1_00028.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4265,"<img> id-US20200308177A1_00029.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4269,"<img> id-US20200308177A1_00030.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4276,"Example 28: Preparation of 1-((3R,4S)-3-((2-((1-ethyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-4-fluoropiperidin-1-yl)prop-2-en-1-one
",0,data/dev/US20200308177A1.txt,1
4277,"<img> id-US20200308177A1_00032.PNG </img>
",0,data/dev/US20200308177A1.txt,1
4298,"<img> id-US20200308177A1_00034.PNG </img>
",1,data/dev/US20200308177A1.txt,0
4321,"Example 36: Preparation of 1-((3S,4R)-4-fluoro-3-((2-((1-(piperidin-4-yl)-1H-pyrazol-4-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)piperidin-1-yl)prop-2-en-1-one
",0,data/dev/US20200308177A1.txt,1
4766,"<img> id-US20200148885A1_00032.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4770,"<img> id-US20200148885A1_00033.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4789,"The compound thus obtained was confirmed to be a target compound from the following analysis results:
",0,data/dev/US20200148885A1.txt,1
4796,"<img> id-US20200148885A1_00039.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4812,"<img> id-US20200148885A1_00043.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4816,"<img> id-US20200148885A1_00044.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4817,"Comparative Synthesis Example 1: Synthesis of Compound 1-X
",1,data/dev/US20200148885A1.txt,0
4820,"<img> id-US20200148885A1_00045.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4823,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1270 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (35.01%, 2.88%, 2.59%); theoretical values (34.29%, 2.91%, 2.64%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4824,"<img> id-US20200148885A1_00046.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4827,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1326 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (35.28%, 3.15%, 2.63%); theoretical values (35.18%, 3.11%, 2.59%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4828,"<img> id-US20200148885A1_00047.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4831,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1355 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (35.55%, 3.24%, 2.61%); theoretical values (35.61%, 3.20%, 2.57%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4832,"<img> id-US20200148885A1_00048.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4835,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1078 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (30.20%, 3.14%, 2.86%); theoretical values (30.070, 3.10%, 2.81%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4839,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1106 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (30.63%, 3.18%, 2.75%); theoretical values (30.59%, 3.20%, 2.78%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4843,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1383 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (36.25%, 3.33%, 2.54%); theoretical values (36.04%, 3.30%, 2.55%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4844,"<img> id-US20200148885A1_00051.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4847,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1383 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (36.25%, 3.33%, 2.54%); theoretical values (36.04%, 3.30%, 2.55%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4851,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1440 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (36.88%, 3.49%, 2.51%); theoretical values (36.87%, 3.48%, 2.50%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4852,"<img> id-US20200148885A1_00053.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4855,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1352 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (34.88%, 3.79%, 2.58%); theoretical values (34.92%, 3.83%, 2.57%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4856,"<img> id-US20200148885A1_00054.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4859,"The compound thus obtained was confirmed to be a target compound from the following analysis results: 31P NMR (d-dmso, ppm) δ-15.15 MS (MALDI) (m/z): 1122 (M+), 2879 (MH2 −) Elemental analysis values: CHN measurement values (29.04%, 2.90%, 2.81%); theoretical values (29.01%, 2.88%, 2.85%) Fluorescent X-ray analysis: Mo/W measurement values (0%, 100%); theoretical values (0%, 100%)
",0,data/dev/US20200148885A1.txt,1
4862,"In a reactor, 60.74 parts by mass of PGMEA and 35.64 parts by mass (effective solid content 21.38 parts by mass) of a block copolymer containing tertiary amino groups (product name: BYK-LPN 6919, manufactured by: BYK-Chemie GmbH) (amine value 120 mgKOH/g, solid content 60% by weight) were dissolved. Then, 3.62 parts by mass (0.5 molar equivalent with respect to the tertiary amino groups of the block copolymer) of PPA was added to the mixture. The mixture was stirred at 40° C. for 30 minutes, thereby preparing a salt-type block polymer dispersant A solution (solid content 25%).
",0,data/dev/US20200148885A1.txt,1
4864,"(1) Synthesis of Binder Resin A)
",0,data/dev/US20200148885A1.txt,1
4866,"Then, with maintaining the synthesis temperature, the reaction was continued. Two hours after the completion of the addition of the mixture in a dropwise manner, 0.05 part by mass of p-methoxyphenol, which is a polymerization inhibitor, was added thereto.
",0,data/dev/US20200148885A1.txt,1
4871,"(1) Synthesis of Block Copolymer B
",0,data/dev/US20200148885A1.txt,1
4877,"(1) Synthesis of Phosphate Triester Compound A
",0,data/dev/US20200148885A1.txt,1
4879,"<img> id-US20200148885A1_00056.PNG </img>
",0,data/dev/US20200148885A1.txt,1
4883,"(1) First, 13.0 parts by mass of the color material 2-1 of Synthesis Example 18, 20.80 parts by mass (effective solid content 5.20 parts by mass) of the salt-type block polymer dispersant A solution prepared in Preparation Example 1, 11.82 parts by mass (effective solid content 5.20 parts by mass) of the binder resin A of Preparation Example 2, and 54.38 parts by mass of PGMEA were mixed. Using a paint shaker (manufactured by Asada Iron Works Co., Ltd.), the mixture was subjected to a pre-dispersion for 1 hour with 2 mm zirconia beads and then a main dispersion for 6 hours with 0.1 mm zirconia beads, thereby obtaining a color material dispersion liquid A.
",0,data/dev/US20200148885A1.txt,1
5332,"<img> id-US20200031833A1_00071.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5334,"Tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-indazole, used in the General Procedures 1-3, was synthesized by the below 2-step procedure illustrated in the following reaction scheme:
",0,data/dev/US20200031833A1.txt,1
5335,"<img> id-US20200031833A1_00072.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5340,"General Procedure 1: Synthesis of Imidazopyridazine Derivatives (Scheme 1)
",0,data/dev/US20200031833A1.txt,1
5341,"<img> id-US20200031833A1_00073.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5366,"1 & 1H-NMR (CDCl3, 400 MHz): δ 8.61 (d, 2H), 7.91 (s, 1H), 7.69 (d, 1H), 7.45 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5369,"2 & 1H-NMR (CDCl3, 400 MHz): δ 8.56 (d, 1H), 8.32 (s, 1H), 8.16 (d, 1H), 7.86 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5373,"3 & 1H-NMR (CDCl3, 400 MHz): δ 7.90 (s, 1H), 7.70 (d, 1H), 7.45 (d, 1H), 7.32 (m, 4 H),
",1,data/dev/US20200031833A1.txt,0
5376,"4 & 1H-NMR (CDCl3, 400 MHz): δ 8.20 (d, 1H), 7.89 (s, 1H), 7.67 (d, 1H), 7.62 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5380,"5 & 1H-NMR (CDCl3, 400 MHz): δ 7.89 (s, 1H), 7.68 (d, 1H), 7.46 (d, 1H), 7.27 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5383,"6 & 1H-NMR (CDCl3, 400 MHz): δ 7.90 (s, 1H), 7.68 (d, 1H), 7.44 (d, 1H), 7.32 (d, 2H),
",1,data/dev/US20200031833A1.txt,0
5386,"7 & 1H-NMR (CDCl3, 400 MHz): δ 8.02 (m, 2H), 7.90 (s, 1H), 7.82 (d, 1H), 7.75 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5390,"General Procedure 2: Synthesis of Pyrazolopyrimidine Derivatives (Scheme 2)
",0,data/dev/US20200031833A1.txt,1
5391,"<img> id-US20200031833A1_00074.PNG </img>
",0,data/dev/US20200031833A1.txt,1
5417,"8 & 1H-NMR (DMSO, 400 MHz): δ 8.52 (m, 3H), 7.85 (s, 1H), 7.75 (d, 1H), 7.59 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5420,"9 & 1H-NMR (DMSO, 400 MHz): δ 8.53 (s, 1H), 8.41 (s, 1H), 7.84 (s, 1H), 7.73 (dd, 2H),
",1,data/dev/US20200031833A1.txt,0
5423,"10 & 1H-NMR (DMSO, 400 MHz): δ 8.38 (t, 1H), 7.84 (s, 1H), 7.75 (d, 1H), 7.58 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5426,"11 & 1H-NMR (DMSO, 400 MHz): δ 8.48 (t, 1H), 7.85 (s, 1H), 7.75 (d, 1H), 7.58 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5429,"12 & 1H-NMR (CDCl3, 400 MHz): δ 8.00 (s, 1H), 7.94 (d, 1H), 7.87 (d, 1H), 7.70 (dd, 2H),
",1,data/dev/US20200031833A1.txt,0
5432,"13 & 1H-NMR (CDCl3, 400 MHz): δ 7.85 (m, 3H), 7.69 (d, 1H), 7.51 (d, 2H), 7.41 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5435,"14 & 1H-NMR (CDCl3, 400 MHz): δ 8.21 (d, 1H), 7.87 (s, 1H), 7.73 (d, 1H), 7.63 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5438,"15 & 1H-NMR (CDCl3, 400 MHz): δ 7.87 (s, 1H), 7.72 (d, 1H), 7.40 (d, 1H), 7.30 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5441,"16 & 1H-NMR (DMSO, 400 MHz): δ 9.71 (s, 1H), 8.41 (t, 1H), 7.85 (s, 1H), 7.75 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5444,"17 & 1H-NMR (DMSO, 400 MHz): δ 8.86 (s, 1H), 8.58 (t, 1H), 8.08 (d, 1H), 7.89 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5447,"18 & 1H-NMR (DMSO, 400 MHz): δ 8.44 (t, 1H), 7.85 (s, 1H), 7.77 (d, 1H), 7.58 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5450,"19 & 1H-NMR (DMSO, 400 MHz): δ 8.44 (t, 1H), 7.82 (s, 1H), 7.71 (d, 1H), 7.54 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5454,"General Procedure 3: Synthesis of Pyrazolo Triazine Derivatives (Scheme 3)
",0,data/dev/US20200031833A1.txt,1
5482,"20 & 1H-NMR (DMSO, 400 MHz): δ 9.28 (s, 1H), 8.52 (d, 2H), 7.84 (s, 1H), 7.71 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5485,"21 & 1H-NMR (DMSO, 400 MHz): δ 9.14 (s, 1H), 8.41 (s, 1H), 7.82 (s, 1H), 7.70 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5488,"22 & 1H-NMR (DMSO, 400 MHz): δ 9.26 (s, 1H), 8.49 (d, 1H), 7.82 (d, 1H), 7.58 (m, 2H),
",1,data/dev/US20200031833A1.txt,0
5491,"23 & 1H-NMR (DMSO, 400 MHz): δ 9.32 (s, 1H), 7.84 (s, 1H), 7.78 (d, 2H), 7.71 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5494,"24 & 1H-NMR (DMSO, 400 MHz): δ 9.26 (t, 1H) 7.83 (s, 1H), 7.69 (d, 1H), 7.61 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5497,"25 & 1H-NMR (DMSO, 400 MHz): δ 9.34 (t, 1H) 8.02 (s, 1H), 7.84 (d, 2H), 7.75 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5500,"26 & 1H-NMR (DMSO, 400 MHz): δ 9.68 (bs, 1H) 9.18 (s, 1H), 7.83 (s, 1H), 7.69 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5503,"27 & 1H-NMR (CDCl3, 400 MHz): δ 7.81 (s, 1H), 7.68 (d, 1H), 7.40 (d, 1H), 7.21 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5506,"28 & 1H-NMR (DMSO, 400 MHz): δ 9.19 (s, 1H), 8.18 (t, 1H), 7.82 (s, 1H), 7.78 (d, 1H),
",1,data/dev/US20200031833A1.txt,0
5524," & 1, 8, 20 & pyridin-4-ylmethanamine
",0,data/dev/US20200031833A1.txt,1
5525," & 2, 9, 22 & (6-methylpyridin-3-yl)methanamine
",0,data/dev/US20200031833A1.txt,1
5526," & 3, 11, 24 & (4-chlorophenyl)methanamine
",0,data/dev/US20200031833A1.txt,1
5528," & 5, 15, 27 & thiophen-2-ylmethanamine
",0,data/dev/US20200031833A1.txt,1
5529," & 6, 10, 21 & (4-methoxyphenyl)methanamine
",0,data/dev/US20200031833A1.txt,1
5532," & 16, 26 & N-(4-(aminomethyl)phenyl)methanesulfonamide
",0,data/dev/US20200031833A1.txt,1
5534," & 18 & benzylamine
",0,data/dev/US20200031833A1.txt,1
5535," & 19 & (4-fluorophenyl)methanamine
",0,data/dev/US20200031833A1.txt,1
5757,"Nuclear magnetic resonance (1HNMR) spectra were obtained on 600 MHz Bruker Advance DPX600 spectrometer at Faculty of Science, King Abdulaziz University using Me4Si as the internal reference, and DMSO-d6 or CDCl3 were used as solvents. The chemical shifts were measured in δ ppm. General procedure for the synthesis of target compounds.
",1,data/dev/US10654800B1.txt,0
5762,"N.B. All compounds were confirmed with LC/MS and showed excellent purities (over 95%) 1H NMR of GLP-1: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.46 (brs, 6H, 2CH2, 2 CH), 1.50-1.51 (brs, 4H, 2CH2), 2.13 (brs, 2H, CH2), 2.33 (br, 1H, NH—CH2), 3.24 (brs, 2H, CH2), 4.45 (brs, 1H, OH), 7.04-7.07 (t, 1H, Arom-H), 7.29-7.33 (t, 2H, Arom-H) 7.60-7.63 (d, 2H, Arom-H), 9.88 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5763,"1H NMR of GLP-2: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.48 (brs, 6H, 2CH2, 2 CH), 1.51 (brs, 4H, 2CH2), 2.14 (brs, 2H, CH2), 2.26 (s, 3H, CH3), 2.75 (br, 1H, NH—CH2), 3.23 (brs, 2H, CH2), 4.46 (brs, 1H, OH), 6.99-7.03 (t, 1H, Arom-H), 7.16-7.18 (d, 1H, Arom-H) 7.20-7.23 (t, 1H, Arom-H), 8.01-8.03 (d, 1H, Arom-H), 9.86 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5764,"1H NMR of GLP-3: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.46-1.47 (brs, 6H, 2CH2+2 CH), 1.51-1.51 (brs, 4H, 2CH2), 2.13 (brs, 2H, CH2), 2.25 (s, 3H, CH3), 2.30 (br, 1H, NH—CH2), 3.22 (brs, 2H, CH2), 4.41 (brs, 1H, OH), 7.10-7.12 (d, 2H, Arom-H), 7.49-7.51 (d, 2H, Arom-H), 9.74 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5765,"1H NMR of GLP-5: DMSO-d6, δ 1.42 (brs, 2H, CH2), 1.46 (brs, 6H, 2CH2, 2 CH), 1.50 (brs, 4H, 2CH2), 2.13 (brs, 2H, CH2), 2.78 (br, t, 1H, NH—CH2), 3.33 (brs, 2H, CH2), 3.88 (s, 3H, OCH3), 4.45 (brs, 1H, OH), 6.90-6.93 (m, 1H, Arom-H), 7.00-7.07 (m, 1H, Arom-H) 8.24-8.25 (d, 1H, Arom-H), 10.27 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5766,"1H NMR of GLP-14: DMSO-d6, δ 1.44 (brs, 2H, CH2), 1.48 (brs, 6H, 2CH2, 2 CH), 1.52 (brs, 4H, 2CH2), 2.16 (brs, 2H, CH2), 2.56 (br, 1H, NH—CH2), 3.27 (brs, 2H, CH2), 4.54 (brs, 1H, OH), 7.31-7.33 (t, 1H, Arom-H), 7.70-7.72 (t, 1H, Arom-H) 7.75-7.76 (d, 1H, Arom-H), 8.51-8.53 (d, 1H, Arom-H), 10.5 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5767,"1H NMR of GLP-15: DMSO-d6, δ 1.45 (brs, 2H, CH2), 1.49 (brs, 6H, 2CH2, 2 CH), 1.53 (brs, 4H, 2CH2), 2.16 (brs, 2H, CH2), 2.57 (br, 1H, NH—CH2), 3.31 (brs, 2H, CH2), 4.51 (brs, 1H, OH), 7.44-7.45 (d, 1H, Arom-H), 7.59-7.61 (t, 1H, Arom-H) 7.89-7.91 (d, 1H, Arom-H), 8.20 (s, 1H, Arom-H), 10.2 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5768,"1H NMR of GLP-16: DMSO-d6, δ 1.44 (brs, 2H, CH2), 1.51 (brs, 6H, 2CH2, 2 CH), 1.54 (brs, 4H, 2CH2), 2.15 (brs, 2H, CH2), 2.69-2.71 (br, 1H, NH—CH2), 3.28 (brs, 2H, CH2), 3.45 (s, 3H, OCH3), 4.50 (brs, 1H, OH), 7.18-7.21 (d, 1H, Arom-H), 7.63-7.65 (t, 1H, Arom-H) 7.99-8.01 (d, 1H, Arom-H), 8.58-8.59 (d, 1H, Arom-H), 12.11 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5769,"1H NMR of GLP-17: DMSO-d6, δ 1.45 (brs, 2H, CH2), 1.48 (brs, 6H, 2CH2, 2 CH), 1.53 (brs, 4H, 2CH2), 2.15 (brs, 2H, CH2), 2.36 (br, 1H, NH—CH2), 3.24 (brs, 2H, CH2), 4.51 (brs, 1H, OH), 6.47-6.50 (dd, 1H, Arom-H), 6.96-6.97 (d, 1H, Arom-H) 7.09-7.12 (d, 1H, Arom-H), 7.25 (s, 1H, Arom-H), 9.46 (brs, 1H, OH), 9.76 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5770,"1H NMR of GLP-19: CDCl3, δ 1.52-1.53 (br, t, 2H, CH2), 1.62-1.63 (br, d, 6H, 2CH2, 2 CH), 1.67 (brs, 4H, 2CH2), 1.74 (brs, 1H, NH—CH2), 2.29 (brs, 2H, CH2), 3.42 (brs, 2H, CH2), 4.62 (brs, 1H, OH), 7.13-7.16 (m, 1H, Arom-H), 7.57-7.60 (m, 2H, Arom-H) 8.54-8.56 (br, d, 1H, Arom-H), 10.64 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5771,"1H NMR of GLP-26: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.48 (brs, 6H, 2CH2, 2 CH), 1.50 (brs, 4H, 2CH2), 2.13 (brs, 2H, CH2), 2.62 (br, 1H, NH—CH2), 3.30 (brs, 2H, CH2), 4.49 (brs, 1H, OH), 7.54-7.55 (m, 1H, Arom-H), 7.94-7.96 (dt, 1H, Arom-H) 8.17-8.18 (br, 1H, Arom-H), 10.18 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5772,"1H NMR of GLP-27: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.45-1.46 (br, d, 6H, 2CH2, 2 CH), 1.50 (brs, 4H, 2CH2), 2.14 (brs, 2H, CH2), 2.62-2.63 (br, t, 1H, NH—CH2), 3.26 (brs, 2H, CH2), 4.50 (brs, 1H, OH), 7.10-7.14 (m, 1H, Arom-H), 7.18-7.20 (t, 1H, Arom-H) 7.29-7.32 (m, 1H, Arom-H), 8.20-8.22 (t, 1H, Arom-H), 10.09 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5773,"1H NMR of GLP-30: DMSO-d6, δ 1.46 (brs, 2H, CH2), 1.52 (brs, 6H, 2CH2, 2 CH), 1.53 (brs, 4H, 2CH2), 2.17 (brs, 2H, CH2), 2.31 (s, 3H, CH3), 2.75 (br, 1H, NH—CH2), 3.23 (brs, 2H, CH2), 4.55 (brs, 1H, OH), 6.99-7.03 (t, 1H, Arom-H), 7.16-7.18 (d, 1H, Arom-H) 7.20-7.23 (t, 1H, Arom-H), 8.01-8.03 (d, 1H, Arom-H), 9.86 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5774,"1H NMR of GLP-31: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.46-1.47 (br, d, 6H, 2CH2, 2 CH), 1.50-1.51 (br, d, 4H, 2CH2), 2.13 (brs, 2H, CH2), 2.62-2.63 (br, t, 1H, NH—CH2), 3.26 (brs, 2H, CH2), 4.51 (brs, 1H, OH), 6.88-6.91 (m, 1H, Arom-H), 7.33-7.39 (m, 2H, Arom-H) 7.66-7.67 (m, 1H, Arom-H), 10.05 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5775,"1H NMR of GLP-43: CDCl3, δ 1.49 (brs, 2H, CH2), 1.55 (brs, 6H, 2CH2, 2 CH), 1.60 (brs, 4H, 2CH2), 2.22 (br, 1H, NH—CH2), 2.28 (brs, 2H, CH2), 3.36 (brs, 2H, CH2), 4.81 (brs, 1H, OH), 7.28-7.29 (d, 2H, Arom-H), 7.53-7.54 (d, 2H, Arom-H) 10.53 (brs, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5776,"1H NMR of GLP-53: CDCl3, δ 1.52 (br, t, 2H, CH2), 1.62-1.63 (br, d, 6H, 2CH2, 2 CH), 1.66 (brs, 4H, 2CH2), 2.23 (brs, 1H, NH—CH2), 2.27 (brs, 2H, CH2), 3.43 (brs, 2H, CH2), 4.42-4.46 (d, 2H, N—CH 2 -Ph), 7.26-7.29 (m, 3H, Arom-H), 7.32-7.35 (m, 2H, Arom-H) 7.79 (br, t, 1H, —CO—NH—CH2).
",1,data/dev/US10654800B1.txt,0
5777,"1H NMR of GLP-54: CDCl3, δ 1.49 (br, t, 2H, CH2), 1.54 (br, d, 6H, 2CH2, 2 CH), 1.67 (brs, 4H, 2CH2), 2.23 (brs, 1H, NH—CH2), 2.27 (brs, 2H, CH2), 3.41 (brs, 2H, CH2), 4.42-4.46 (d, 2H, N—CH 2 -Ph), 7.00-7.03 (d, 2H, Arom-H), 7.25-7.27 (d, 2H, Arom-H) 7.74 (br, t, 1H, —CO—NH—CH2).
",1,data/dev/US10654800B1.txt,0
5778,"1H NMR of GLP-59: CDCl3, δ 1.37 (brs, 2H, CH2), 1.43 (br, 3H, CH+CH2) 1.47-1.50 (br, m, 1H, CH2), 1.56-1.58 (br, m, 2H, CH2), 1.62-1.64 (br, m, 2H, CH2), 2.03 (brs, 1H, NH—CH2), 2.21 (brs, 2H, CH2), 2.83-2.85 (t, 2H, CH 2 Ph), 3.2 (d, 2H, N—CH 2—CH 2), 3.53-3.56, (q, 2H, N—CH 2 —CH2), 7.21-7.25 (m, 3H, Arom-H), 7.30-7.33 (m, 2H, Arom-H), 7.59 (br, t, 1H, CO—NH).
",1,data/dev/US10654800B1.txt,0
5779,"1H NMR of GLP-60: CDCl3, δ 1.45 (brs, 2H, CH2), 1.49 (brs, 6H, 2CH2, 2 CH), 1.56 (brs, 4H, 2CH2), 2.05 (brs, 2H, CH2), 2.29 (br, 1H, NH—CH2), 3.35 (s, 2H, CH2), 4.58 (brs, 1H, OH), 6.80-6.83 (m, 2H, Arom-H), 7.40-7.43 (d, 2H, Arom-H), 9.34 (brs, 1H, OH), 9.44 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5780,"1H NMR of GLP-73: DMSO-d6, δ 0.85-0.88 (t, 1H, NH—CH2), 1.25 (brs, 1H, CH2), 1.42 (brs, 2H, CH2), 1.48 (brs, 9H, 4CH2+CH), 2.14 (brs, 2H, CH2), 3.4 (brs, 1H, OH), 3.44 (s, 2H, CH2), 7.46 (s, 1H, Arom-H).
",1,data/dev/US10654800B1.txt,0
5781,"1H NMR of GLP-107: DMSO-d6, δ 1.43 (brs, 2H, CH2), 1.47 (brs, 6H, 2CH2, 2 CH), 1.52 (brs, 4H, 2CH2), 2.13 (brs, 2H, CH2), 2.34 (br, 1H, NH—CH2), 3.22 (brs, 2H, CH2), 4.50 (brs, 1H, OH), 6.46-6.49 (dd, 1H, Arom-H), 6.94-6.95 (d, 1H, Arom-H) 7.07-7.10 (d, 1H, Arom-H), 7.24 (s, 1H, Arom-H), 9.43 (brs, 1H, OH), 9.72 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5782,"1H NMR of GLP-110: DMSO-d6, δ 1.57-1.59 (br, d, 3H, 3CH), 1.66-1.68 (br, d, 3H, 3CH), 1.90 (brs, 6H, 3CH2), 2.13 (br, 1H, 3CH), 4.02-4.04 (t, 2H, CH2), 7.59-7.60 (m, 2H, Arom-H), 7.92-7.94 (m, 1H, Arom-H), 8.12-8.13 (d, 1H, Arom-H) 9.11 (br, s, 1H, NH), 11.62 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5783,"1H NMR of GLP-111: DMSO-d6, δ 1.56-1.57 (br, m, 9H, 3CH2), 1.61-1.63 (br, m, 2H, CH2), 2.01 (brs, 4H, CH2), 2.36 (br, 1H, NH—CH2), 3.22 (brs, 2H, CH2), 5.77 (s, 1H, OH), 6.44-6.46 (dd, 1H, Arom-H), 6.92-6.93 (dd, 1H, Arom-H) 7.06-7.09 (t, 1H, Arom-H), 7.21-7.22 (t, 1H, Arom-H), 9.40 (br, s, 1H, NH), 9.74 (br, s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5784,"1H NMR of GLP-112: DMSO-d6, δ 1.56-1.58 (br, d, 3H, 3CH), 1.65-1.67 (br, d, 3H, 3CH), 1.90 (brs, 6H, 3CH2), 2.12 (br, 1H, 3CH), 3.99 (br, 2H, CH2), 6.40-6.443 (dt, 1H, Arom-H), 7.70-7.72 (dt, 1H, Arom-H), 9.11 (br, s, 1H, NH), 11.37 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5785,"1H NMR of GLP-117: DMSO-d6, δ 1.59-1.80 (br, m, 12H, 6CH2), 2.01 (br, s, 3H, 3CH), 3.31 (br, s, 2H, CH2), 4.63 (br, s, 1H, NH), 7.47-7.48 (d, 1H, Arom-H), 8.15-8.20 (dd, 1H, Arom-H) 8.67-8.68 (d, 1H, Arom-H), 11.08 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5786,"1H NMR of GLP-118: DMSO-d6, δ 1.58-1.69 (m, 3H, 3CH2), 1.89 (br, s, 6H, 3 CH2), 2.01 (s, 3H, 3CH), 4.01-4.03 (t, 1H, NH), 4.64 (br, s, 1H, CH2), 7.66-7.68 (dd, 1H, Arom-H), 7.84-7.85 (d, 2H, Arom-H), 7.92-7.94 (dd, 1H, Arom-H) 9.04 (s, 1H, NH).
",1,data/dev/US10654800B1.txt,0
5787,"1H NMR of GLP-119: DMSO-d6, δ 1.53-1.62 (m, 12H, 6 CH2), 2.01 (br, s, 3H, 3CH), 3.28 (br, s, 2H, CH2), 3.39 (br, s, 1H, NH), 7.10-7.13 (m, 1H, Arom-H), 7.78-7.81 (m, 1H, Arom-H) 8.10-8.11 (d, 1H, Arom-H), 8.31-8.32 (m, 1H, Arom-H), 10.18 (s, 1H, NH—CO).
",1,data/dev/US10654800B1.txt,0
5788,"1H NMR of GLP-120: DMSO-d6, δ 1.55-1.64 (m, 12H, 6CH2), 2.03 (br, s, 3H, 3CH), 2.13 (s, 6H, 2CH3), 3.27 (br, s, 2H, CH2), 3.38 (br, s, 1H, NH), 7.10 (s, 3H, Arom-H), 9.31 (s, 1H, NH—CO).
",1,data/dev/US10654800B1.txt,0
6055,"I-3 & F & H & purine
",0,data/dev/US20180092937A1.txt,1
6057,"I-5 & F & H & xanthine
",0,data/dev/US20180092937A1.txt,1
6058,"I-6 & F & H & hypoxanthine
",0,data/dev/US20180092937A1.txt,1
6060,"I-8 & OH & H & purine
",0,data/dev/US20180092937A1.txt,1
6062,"I-10 & OH & H & xanthine
",0,data/dev/US20180092937A1.txt,1
6063,"I-11 & OH & H & hypoxanthine
",0,data/dev/US20180092937A1.txt,1
6441,"Intermediate 1.1
",1,data/dev/US20180092937A1.txt,0
6443,"<img> id-US20180092937A1-20180405-C00015.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6445,"Intermediate 1.2
",1,data/dev/US20180092937A1.txt,0
6447,"<img> id-US20180092937A1-20180405-C00016.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6451,"Intermediate 1.3-a and Intermediate 1.3-b
",1,data/dev/US20180092937A1.txt,0
6452,"5'-DMT-2'-TBS-imidazopyridazinon-β-D-ribofuranoside (Intermediate 1.3-a) and 5'-DMT-3'-TBS-imidazopyridazinon-β-D-ribofuranoside (Intermediate 1.3-b)
",1,data/dev/US20180092937A1.txt,0
6453,"<img> id-US20180092937A1-20180405-C00017.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6458,"Intermediate 1.4
",1,data/dev/US20180092937A1.txt,0
6460,"<img> id-US20180092937A1-20180405-C00018.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6465,"Intermediate 1.5
",1,data/dev/US20180092937A1.txt,0
6467,"<img> id-US20180092937A1-20180405-C00019.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6472,"The flask was stoppered, carefully sealed and stored at +2° C. for 16 hours. The solvents were evaporated under reduced pressure and the residue was azeotroped with anhydrous acetonitrile (4×15 mL). During the last evaporation procedure the solution was concentrated to approximately 5 mL of final azeotrope. The resulting anhydrous solution of intermediate 1.5 was immediately used in the next sequence of reactions.
",0,data/dev/US20180092937A1.txt,1
6473,"Intermediate 1.6
",1,data/dev/US20180092937A1.txt,0
6474,"Linear Dimer 5'-OH-3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphorothioate-2'-TBS-3'-H-phosphonate-N6-Bz-adenosine
",1,data/dev/US20180092937A1.txt,0
6475,"<img> id-US20180092937A1-20180405-C00020.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6480,"The flask was stoppered, carefully sealed and stored at +2° C. for 16 hours. The mixture was evaporated under reduced pressure and the residue was co-evaporated with anhydrous pyridine (2×20 mL) under reduced pressure. A further portion of 40 mL anhydrous pyridine was added and the residue was concentrated under reduced pressure to approximately 20 mL total volume. The resulting anhydrous solution of INTERMEDIATE 1.6 was immediately used in the next sequence of reactions.
",0,data/dev/US20180092937A1.txt,1
6481,"Intermediate 1.7
",1,data/dev/US20180092937A1.txt,0
6482,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphorothioate-2'-TBS-N6-Bz-adenosine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6483,"<img> id-US20180092937A1-20180405-C00021.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6489,"Intermediate 1.8
",1,data/dev/US20180092937A1.txt,0
6490,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-2'-TBS-adenosine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6491,"<img> id-US20180092937A1-20180405-C00022.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6497,"Intermediate 2.1
",1,data/dev/US20180092937A1.txt,0
6499,"<img> id-US20180092937A1-20180405-C00023.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6501,"LC-MS analytics of the raw material confirmed the presence of INTERMEDIATE 2.1.
",1,data/dev/US20180092937A1.txt,0
6504,"Intermediate 2.2
",1,data/dev/US20180092937A1.txt,0
6505,"Linear Dimer 5'-OH-3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphorothioate-2'-F-3'-H-phosphonate-N6-Bz-2'-deoxyadenosine
",1,data/dev/US20180092937A1.txt,0
6506,"<img> id-US20180092937A1-20180405-C00024.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6508,"Intermediate 2.3
",1,data/dev/US20180092937A1.txt,0
6509,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphorothioate-2'-F-N6-Bz-2'-deoxyadenosine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6510,"<img> id-US20180092937A1-20180405-C00025.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6517,"Intermediate 2.4
",1,data/dev/US20180092937A1.txt,0
6518,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-2'-F-2'-deoxyadenosine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6519,"<img> id-US20180092937A1-20180405-C00026.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6521,"LC-MS analytics of the material confirmed the presence of INTERMEDIATEs 2.4-a/b/c/d.
",1,data/dev/US20180092937A1.txt,0
6526,"Intermediate 3.1
",1,data/dev/US20180092937A1.txt,0
6528,"<img> id-US20180092937A1-20180405-C00027.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6530,"LC-MS analytics of the raw material confirmed the presence of INTERMEDIATE 3.1.
",1,data/dev/US20180092937A1.txt,0
6533,"Intermediate 3.2
",1,data/dev/US20180092937A1.txt,0
6534,"Linear Dimer 5'-OH-3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphorothioate-3'-H-phosphonate-N6-Bz-LNA-adenine
",1,data/dev/US20180092937A1.txt,0
6535,"<img> id-US20180092937A1-20180405-C00028.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6537,"Intermediate 3.3
",1,data/dev/US20180092937A1.txt,0
6538,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphoro-thioate-N6-Bz-LNA-adenine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6539,"<img> id-US20180092937A1-20180405-C00029.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6541,"LC-MS analytics of the material confirmed the presence of INTERMEDIATEs 3.3-a/b/c/d.
",1,data/dev/US20180092937A1.txt,0
6546,"Intermediate 3.4
",1,data/dev/US20180092937A1.txt,0
6547,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-LNA-adenine-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6548,"<img> id-US20180092937A1-20180405-C00030.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6550,"LC-MS analytics of the material confirmed the presence of INTERMEDIATEs 3.4-a/b/c/d.
",1,data/dev/US20180092937A1.txt,0
6555,"Intermediate 4.1
",1,data/dev/US20180092937A1.txt,0
6557,"<img> id-US20180092937A1-20180405-C00031.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6559,"LC-MS analytics of the raw material confirmed the presence of INTERMEDIATE 4.1.
",1,data/dev/US20180092937A1.txt,0
6562,"Intermediate 4.2
",1,data/dev/US20180092937A1.txt,0
6563,"Linear Dimer 5'-OH-3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphorothioate-2'-TBS-3'-H-phosphonate-purine-β-D-ribofuranoside
",1,data/dev/US20180092937A1.txt,0
6564,"<img> id-US20180092937A1-20180405-C00032.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6566,"LC-MS analytics of the raw material confirmed the presence of INTERMEDIATE 4.2 as a mixture of diastereoisomers.
",1,data/dev/US20180092937A1.txt,0
6570,"Intermediate 4.3
",1,data/dev/US20180092937A1.txt,0
6571,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-cyanoethyl-phosphoro-thioate-2'-TBS-purine-β-D-ribofuranoside-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6572,"<img> id-US20180092937A1-20180405-C00033.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6578,"Intermediate 4.4
",1,data/dev/US20180092937A1.txt,0
6579,"Cyclic Dimer 3'-TBS-imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-2'-TBS-purine-β-D-ribofuranoside-(3'→5')-phosphorothioate
",1,data/dev/US20180092937A1.txt,0
6580,"<img> id-US20180092937A1-20180405-C00034.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6592,"Example 1.1 and Example 1.2
",1,data/dev/US20180092937A1.txt,0
6593,"Cyclic (imidazopyridazinon-β-D-ribofuranoside-(2'→5')-phosphorothioate-adenosine-(3'→5')-phosphorothioate)
",1,data/dev/US20180092937A1.txt,0
6594,"<img> id-US20180092937A1-20180405-C00035.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6598,"Preparation of Example 1.1, Sodium Salt (“Fourth Eluting Diastereomer”)
",1,data/dev/US20180092937A1.txt,0
6604,"Preparation of Example 1.2, Sodium Salt (“Third Eluting Diastereomer”)
",1,data/dev/US20180092937A1.txt,0
6605,"Desalting and salt change from TEA to sodium of EXAMPLE 1.2, TEA salt was performed in similar fashion as described for EXAMPLE 1.1, TEA salt.
",1,data/dev/US20180092937A1.txt,0
6610,"Example 2.1 and Example 2.2
",1,data/dev/US20180092937A1.txt,0
6612,"<img> id-US20180092937A1-20180405-C00036.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6619,"Example 2.2
",1,data/dev/US20180092937A1.txt,0
6625,"Example 3.1 and Example 3.2
",1,data/dev/US20180092937A1.txt,0
6627,"<img> id-US20180092937A1-20180405-C00037.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6637,"Example 4.1 and Example 4.2
",1,data/dev/US20180092937A1.txt,0
6639,"<img> id-US20180092937A1-20180405-C00038.TIF </img>
",1,data/dev/US20180092937A1.txt,0
6716,"Compound 1
",1,data/dev/EP3674305A1.txt,0
6717,"<img> id-EP3674305A1_00022.PNG </img>
",1,data/dev/EP3674305A1.txt,0
6720,"<img> id-EP3674305A1_00023.PNG </img>
",1,data/dev/EP3674305A1.txt,0
6723,"<img> id-EP3674305A1_00024.PNG </img>
",1,data/dev/EP3674305A1.txt,0
6725,"1H NMR (400 MHz, CDCl3): a (ppm) = 9.66 (br s, 1H), 9.17 (br s, 1H), 9.00 (br s, 2H), 7.73-7.85 (m, 15H), 3.74-3.79 (m, 2H), 3.63-3.67 (m, 2H), 3.38 (br s, 2H), 2.96 (br s, 2H), 2.49 (br s, 1H), 2.28 (br s, 2H), 2.06 (br s, 2H).
",1,data/dev/EP3674305A1.txt,0
6733,"<img> id-EP3674305A1_00027.PNG </img>
",1,data/dev/EP3674305A1.txt,0
6736,"<img> id-EP3674305A1_00028.PNG </img>
",1,data/dev/EP3674305A1.txt,0
6739,"<img> id-EP3674305A1_00029.PNG </img>
",1,data/dev/EP3674305A1.txt,0
6741,"MitoFreSH-Piperazine (Formula IV)
",1,data/dev/EP3674305A1.txt,0
6742,"<img> id-EP3674305A1_00030.PNG </img>
",1,data/dev/EP3674305A1.txt,0
6745,"<img> id-EP3674305A1_00031.PNG </img>
",0,data/dev/EP3674305A1.txt,1
6756,"MitoFreSH-Cl (Formula V)
",1,data/dev/EP3674305A1.txt,0
6771,"<img> id-EP3674305A1_00033.PNG </img>
",0,data/dev/EP3674305A1.txt,1
6777,"<img> id-EP3674305A1_00036.PNG </img>
",1,data/dev/EP3674305A1.txt,0
6779,"Compound 2A 1H NMR (500 MHz, CDCl3): a (ppm) = 6.73 (br, 1H), 4.96 (br, 1H), 3.57-3.69 (m, 8H), 3.51 (m, 2H), 3.41 (s, 2H), 3.34 (m, 2H), 1.45 (s, 9H).
",1,data/dev/EP3674305A1.txt,0
6780,"Compound 2B 1H NMR (500 MHz, DMSO-d6): a (ppm) = 8.19 (t, J = 5.2 Hz, 1H), 6.79 (t, J = 5.6 Hz, 1H), 3.59 (s, 2H), 3.04 (m, 2H), 2.88 (m, 2H), 1.37 (s, 9H), 1.33-1.39 (m, 4H), 1.22-1.24 (m, 4H).
",1,data/dev/EP3674305A1.txt,0
6783,"<img> id-EP3674305A1_00037.PNG </img>
",1,data/dev/EP3674305A1.txt,0
6785,"Compound 3A 1H NMR (500 MHz, CDCl3): a (ppm) = 8.62 (s, 1H), 8.55 (s, 1H), 7.00 (s, 1H), 6.67 (br, 1H), 5.08 (br, 1H), 3.62-3.65 (m, 5H), 3.57 (t, J = 5.2 Hz, 2H), 3.34-3.39 (m, 6H), 2.87 (t, J = 6.5 Hz, 2H), 2.76 (t, J = 6.2 Hz, 2H), 1.96-2.00 (m, 4H), 1.44 (s, 9H).
",1,data/dev/EP3674305A1.txt,0
6786,"Compound 3B 1H NMR (500 MHz, CDCl3): a (ppm) = 8.60 (s, 1H), 8.56 (s, 1H), 7.00 (s, 1H), 6.22 (br, 1H), 4.53 (br, 1H), 3.35-3.40 (m, 6H), 3.11 (m, 2H), 2.87 (t, J = 6.2 Hz, 2H), 2.76 (t, J = 6.1 Hz, 2H), 1.96-2.00 (m, 4H), 1.44 (s, 9H), 1.44-1.50 (m, 4H), 1.35-1.38 (m, 4H).
",1,data/dev/EP3674305A1.txt,0
6788,"GogiFreSH
",1,data/dev/EP3674305A1.txt,0
6789,"<img> id-EP3674305A1_00038.PNG </img>
",1,data/dev/EP3674305A1.txt,0
6791,"GolgiFreSH-A (formula VII) 1H NMR (500 MHz, CDCl3): a (ppm) = 8.52 (s, 1H), 8.49 (s, 1H), 7.64 (d, J = 8.6 Hz, 2H), 7.46 (d, J = 8.6 Hz, 2H), 6.93 (d, J = 2.3 Hz, 1H), 6.89 (s, 1H), 6.80 (d, J = 9.1 Hz, 1H), 6.61-6.63 (m, 2H), 6.39 (t, J = 5.6 Hz, 1H), 3.80 (s, 3H), 3.65 (s, 2H), 3.48-3.55 (m, 10H), 3.44 (m, 2H), 3.35-3.39 (m, 4H), 2.86 (t, J = 6.2 Hz, 2H), 2.72 (t, J = 6.5 Hz, 2H), 2.40 (s, 3H), 1.95-1.99 (m, 4H).
",1,data/dev/EP3674305A1.txt,0
6792,"GolgiFreSH-B (formula VIII) 1H NMR (500 MHz, CDCl3): a (ppm) = 8.57 (s, 1H), 8.50 (s, 1H), 7.66 (m, 2H), 7.48 (m, 2H), 6.98 (s, 1H), 6.90 (d, J = 2.4 Hz, 1H), 6.87 (d, J = 9.1 Hz, 1H), 6.69 (dd, 3J = 9.1 Hz, 4J = 2.4 Hz, 1 H), 6.23 (t, J = 5.7 Hz, 1H), 5.78 (t, J = 5.8 Hz, 1H), 3.82 (s, 3H), 3.65 (s, 2H), 3.28-3.39 (m, 6H), 3.20 (m, 2H), 2.86 (t, J = 6.4 Hz, 2H), 2.76 (t, J = 6.2 Hz, 2H), 2.39 (s, 3H), 1.95-2.00 (m, 4H), 1.50 (m, 2H), 1.42 (m, 2H), 1.22-1.31 (m, 4H); HRMS (m/z): [M+Na]+ 769.2772.
",1,data/dev/EP3674305A1.txt,0
6793,"GolgiFreSH-C (formula IX) 1H NMR (500 MHz, CDCl3): a (ppm) = 8.55 (s, 1H), 8.48 (s, 1H), 7.67 (d, J = 8.0 Hz, 2H), 7.47 (d, J = 8.0 Hz, 2H), 6.98 (t, J = 4.9 Hz, 1H), 6.96 (s, 1H), 6.92 (s, 1H), 6.87 (d, J = 9.0 Hz, 1H), 6.66 (d, J = 9.0 Hz, 1H), 6.34 (t, J = 4.9 Hz, 1H), 3.81 (s, 3H), 3.57-3.63 (m, 8H), 3.42-3.51 (m, 8H), 3.31-3.38 (m, 6H), 2.85 (t, J = 6.2 Hz, 2H), 2.75 (t,J = 5.9 Hz, 2H), 2.37 (s, 3H), 1.95-1.99 (m, 4H), 1.84 (m, 2H), 1.71 (m, 2H); HRMS (m/z): [M+Na]+ 900.3390.
",1,data/dev/EP3674305A1.txt,0
6898,"<img> id-US20180083209A1-20180322-C00012.TIF </img>
",0,data/dev/US20180083209A1.txt,1
6904,"<img> id-US20180083209A1-20180322-C00013.TIF </img>
",0,data/dev/US20180083209A1.txt,1
6912,"<img> id-US20180083209A1-20180322-C00014.TIF </img>
",0,data/dev/US20180083209A1.txt,1
6919,"<img> id-US20180083209A1-20180322-C00015.TIF </img>
",0,data/dev/US20180083209A1.txt,1
6935,"<img> id-US20180083209A1-20180322-C00020.TIF </img>
",0,data/dev/US20180083209A1.txt,1
6949,"<img> id-US20180083209A1-20180322-C00021.TIF </img>
",0,data/dev/US20180083209A1.txt,1
6974,"(Synthesis of Compound B)
",1,data/dev/US20180083209A1.txt,0
6978,"(Synthesis of Compound 1)
",1,data/dev/US20180083209A1.txt,0
6984,"3. Synthesis of Compound 4
",0,data/dev/US20180083209A1.txt,1
6985,"(Synthesis of Compound E)
",1,data/dev/US20180083209A1.txt,0
6989,"(Synthesis of Compound F)
",1,data/dev/US20180083209A1.txt,0
6991,"Compound F was synthesized according to the same method of synthesizing Compound B except for using Compound E instead of Compound A in the synthetic method of Compound B. The molecular weight of Compound F measured by FAB-MS was 485.
",1,data/dev/US20180083209A1.txt,0
6992,"(Synthesis of Compound 4)
",1,data/dev/US20180083209A1.txt,0
6995,"4. Synthesis of Compound 6
",0,data/dev/US20180083209A1.txt,1
6996,"(Synthesis of Compound H)
",1,data/dev/US20180083209A1.txt,0
7001,"(Synthesis of Compound 6)
",1,data/dev/US20180083209A1.txt,0
7008,"<img> id-US20180083209A1-20180322-C00032.TIF </img>
",0,data/dev/US20180083209A1.txt,1
7127,"Example 1: Preparation of 2,2′-(1,4-phenylene)bis(1-((1-((1-methoxypropan-2-yl)oxy)propan-2-yl)oxy)propan-2-ol) [1]
",1,data/dev/US10815179B1.txt,0
7128,"<img> id-US10815179B1_00011.PNG </img>
",1,data/dev/US10815179B1.txt,0
7130,"Example 2: Preparation of 13,13′-(1,4-phenylene)bis(4,7,10-trimethyl-2,5,8,11-tetraoxatetradecan-13-ol) [2]
",1,data/dev/US10815179B1.txt,0
7131,"<img> id-US10815179B1_00012.PNG </img>
",1,data/dev/US10815179B1.txt,0
7133,"Example 3: Preparation of 2,2′-(1,4-phenylene)bis(1-(2-(2-methoxyethoxy)ethoxy)propan-2-ol) [3]
",1,data/dev/US10815179B1.txt,0
7134,"<img> id-US10815179B1_00013.PNG </img>
",1,data/dev/US10815179B1.txt,0
7136,"Example 4: Preparation of 2,2′-(1,4-phenylene)bis(1-(2-(2-ethoxyethoxy)ethoxy)propan-2-ol) [4]
",1,data/dev/US10815179B1.txt,0
7137,"<img> id-US10815179B1_00014.PNG </img>
",1,data/dev/US10815179B1.txt,0
7139,"Example 5: Preparation of 2,2′-(1,4-phenylene)bis(1-(2-(2-propoxyethoxy)ethoxy)propan-2-ol) [5]
",1,data/dev/US10815179B1.txt,0
7140,"<img> id-US10815179B1_00015.PNG </img>
",1,data/dev/US10815179B1.txt,0
7142,"Example 6: Preparation of 2,2′-(1,4-phenylene)bis(1-(2-(2-butoxyethoxy)ethoxy)propan-2-ol) [6]
",1,data/dev/US10815179B1.txt,0
7143,"<img> id-US10815179B1_00016.PNG </img>
",1,data/dev/US10815179B1.txt,0
7145,"Example 7: Preparation of 13,13′-(1,4-phenylene)bis(2,5,8,11-tetraoxatetradecan-13-ol) [7]
",1,data/dev/US10815179B1.txt,0
7146,"<img> id-US10815179B1_00017.PNG </img>
",1,data/dev/US10815179B1.txt,0
7148,"Example 8: Preparation of 2,2′-(1,4-phenylene)bis(4,7,10,13-tetraoxaheptadecan-2-ol) [8]
",1,data/dev/US10815179B1.txt,0
7149,"<img> id-US10815179B1_00018.PNG </img>
",1,data/dev/US10815179B1.txt,0
7151,"Example 9: Preparation of 2,2′-(1,3-phenylene)bis(1-((1-((1-methoxypropan-2-yl)oxy)propan-2-yl)oxy)propan-2-ol) [9]
",1,data/dev/US10815179B1.txt,0
7152,"<img> id-US10815179B1_00019.PNG </img>
",1,data/dev/US10815179B1.txt,0
7155,"<img> id-US10815179B1_00020.PNG </img>
",1,data/dev/US10815179B1.txt,0
7158,"<img> id-US10815179B1_00021.PNG </img>
",1,data/dev/US10815179B1.txt,0
7161,"<img> id-US10815179B1_00022.PNG </img>
",1,data/dev/US10815179B1.txt,0
7163,"Example 13: Preparation of 2,2′-(1,3-phenylene)bis(1-(2-(2-propoxyethoxy)ethoxy)propan-2-ol) [13]
",1,data/dev/US10815179B1.txt,0
7164,"<img> id-US10815179B1_00023.PNG </img>
",1,data/dev/US10815179B1.txt,0
7167,"<img> id-US10815179B1_00024.PNG </img>
",1,data/dev/US10815179B1.txt,0
7169,"Example 15: Preparation of 13,13′-(1,3-phenylene)bis(2,5,8,11-tetraoxatetradecan-13-ol) [15}
",1,data/dev/US10815179B1.txt,0
7170,"<img> id-US10815179B1_00025.PNG </img>
",1,data/dev/US10815179B1.txt,0
7173,"<img> id-US10815179B1_00026.PNG </img>
",1,data/dev/US10815179B1.txt,0
7495,"A similar procedure to Reference Example 1 → Reference Example 8 → Reference Example 9 → Example 2 was carried out by using a corresponding amine compound instead of 1,3-dimethylpyrazol-4-amine hydrochloride and using a corresponding boronic acid instead of 1-(tert-butyldimethylsilyl)-1H-indol-5-ylboronic acid to give the compound of the present invention having the following physical properties. In Example 5-5, HPLC preparative purification was performed instead of silica gel column chromatography in Example 2.
",0,data/dev/EP3312182A1.txt,1
7509,"A similar procedure to Reference Example 1 → Reference Example 8 → Reference Example 9 → Example 1 was carried out by using a corresponding amine compound instead of 1,3-dimethylpyrazol-4-amine hydrochloride and using a corresponding boronic acid instead of 1-(tert-butyldimethylsilyl)-1H-indol-5-ylboronic acid to give the compound of the present invention having the following physical properties. In Examples 6-4 to 6-9, HPLC preparative purification was performed instead of silica gel column chromatography in Example 1.
",0,data/dev/EP3312182A1.txt,1
7532,"A similar procedure to Reference Example 9 was carried out by using the compound prepared in Reference Example 13 instead of the compound prepared in Reference Example 8 and using 6-amino-5-methoxypyridine-3-boronic acid pinacol ester instead of 1-(tert-butyldimethylsilyl)-1H-indol-5-ylboronic acid to give the compound of the present invention having the following physical properties.TLC: Rf 0.25 (hexane : ethyl acetate =1:2);1H-NMR (CDCl3): δ1.59-1.64, 3.06, 3.94, 4.86-4.94, 4.97-5.11, 5.36-5.42, 7.23-7.26, 7.39-7.43, 7.62-7.69, 7.72-7.80, 7.95-7.97, 8.98-9.05.
",1,data/dev/EP3312182A1.txt,0
7535,"A similar procedure to Reference Example 4 → Reference Example 5 → Reference Example 6 → Reference Example 7 → Reference Example 8 → Reference Example 9 was carried out by using 2,2,2-trifluoroethanol instead of isopropanol and using benzofuran-5-boronic acid instead of 1-(tert-butyldimethylsilyl)-1H-indol-5-ylboronic acid to give the compound of the present invention having the following physical properties. Meanwhile, HPLC preparative purification was performed instead of silica gel column chromatography in Reference Example 9.1H-NMR (DMSO-d6): δ2.13, 3.74, 5.02-5.13, 6.25-6.70, 7.07-7.08, 7.57-7.59, 7.74-7.76, 7.92, 7.99, 8.08-8.09, 8.45.Purity (LC-MS/ELSD): 99.7% (Retention time: 0.85 minutes);MASS (ESI, Pos.): 443 (M + H)+.
",1,data/dev/EP3312182A1.txt,0
7551,"A similar procedure to Reference Example 1 → Reference Example 2 → Reference Example 3 → Reference Example 4 → Reference Example 5 → Reference Example 6 → Reference Example 7 → Reference Example 8 → Reference Example 9 → Example 2 was carried out by using 1,3-dimethylpyrazol-4-amine hydrochloride or a corresponding amine compound instead of 1,3-dimethylpyrazol-4-amine hydrochloride, using 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine instead of 4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine, and using a corresponding boronic acid instead of 1-(tert-butyldimethylsilyl)-1H-indol-5-ylboronic acid to give the compound of the present invention having the following physical properties. Meanwhile, in Example 13-7, HPLC preparative purification was performed instead of silica gel column chromatography in Example 2.
",0,data/dev/EP3312182A1.txt,1
7585,"A similar procedure to Reference Example 1 → Reference Example 2 → Reference Example 3 → Reference Example 4 → Reference Example 5 → Reference Example 6 → Reference Example 7 → Reference Example 8 → Reference Example 9 was carried out by using 1,3-dimethylpyrazol-4-amine hydrochloride or a corresponding amine compound instead of 1,3-dimethylpyrazol-4-amine hydrochloride, using 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine instead of 4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine and using a corresponding boronic acid instead of 1-(tert-butyldimethylsilyl)-1H-indol-5-ylboronic acid to give the compound of the present invention having the following physical properties.
",0,data/dev/EP3312182A1.txt,1
7626,"A similar procedure to Reference Example 1 → Reference Example 2 → Reference Example 3 → Reference Example 4 → Reference Example 5 → Reference Example 6 → Reference Example 7 → Reference Example 8 → Reference Example 9 → Example 2 → Example 15 was carried out by using a corresponding amine compound instead of 1,3-dimethylpyrazol-4-amine hydrochloride, using 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine instead of 4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine, and using 1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-yl-4-boronic acid instead of 1-(tert-butyldimethylsilyl)-1H-indol-5-ylboronic acid to give the compound of the present invention having the following physical properties.
",0,data/dev/EP3312182A1.txt,1
7642,"Example 20: (4-{[4-Amino-5-(1H-indazol-4-yl)-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}-3-methyl-1H-pyrazol-1-yl)acetonitrile
",1,data/dev/EP3312182A1.txt,0
7681,"A similar procedure to Reference Example 23 → Reference Example 24 → Reference Example 25 → Reference Example 26 → Reference Example 27 → Reference Example 28 → Example 2 was carried out by using 4-amino-3-fluoro-N,N-dimethylbenzamide or a corresponding amine compound instead of 4-amino-3-fluoro-N,N-dimethylbenzamide, and using 1-(tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole instead of 4-benzyloxyphenylboronic acid to give the compound of the present invention having the following physical properties. Meanwhile, HPLC preparative purification was performed instead of silica gel column chromatography in Example 2.
",0,data/dev/EP3312182A1.txt,1
7854,"Example 1: N-cyclopropyl-2,2-difluoro-2-(4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl) ureido)phenyl)acetamide
",0,data/dev/EP3330263A1.txt,1
7856,"<img> id-imgb0045.tif </img>
",0,data/dev/EP3330263A1.txt,1
7906,"Example 14: N-cyclopropyl-2-(4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)ureido)phenyl) propanamide
",0,data/dev/EP3330263A1.txt,1
7908,"<img> id-imgb0059.tif </img>
",0,data/dev/EP3330263A1.txt,1
7930,"N-cyclopropyl-1-(4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)ureido)phenyl) cyclopropanecarboxamide was prepared referring to the synthetic method in Example 14. 1H-NMR (400 MHz, DMSO-d6): δ=9.39 (s, 1H), 8.00 (s, 1H), 7.89 (s, 1H), 7.85 (d, J=1.6 Hz, 1H), 7.71 (dd, J=5.0, 2.9 Hz, 1H), 7.67-7.64 (m, 1H), 7.50 (q, J=8.3 Hz, 2H), 7.28 (m, 3H), 7.06 (dd, J=7.9, 1.7 Hz, 1H), 6.97 (d, J=3.8 Hz, 1H), 2.60 (m, 1H), 1.33 (m, 2H), 0.97 (m, 2H), 0.55 (m, 2H), 0.42 (m, 2H).
",1,data/dev/EP3330263A1.txt,0
7936,"N-cyclopropyl-1-(4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)ureido)phenyl) cyclobutanecarboxamide was prepared referring to the synthetic method in Example 14. 1H-NMR (400 MHz, DMSO-d6): δ=9.39 (s, 1H), 8.00 (s, 1H), 7.88-7.76 (m, 2H), 7.68 (dd, J=4.9, 2.9 Hz, 1H), 7.63-7.57 (m, 2H), 7.53-7.40 (m, 2H), 7.26 (dd, J=9.2, 4.5 Hz, 3H), 7.09 (dd, J=8.0, 1.8 Hz, 1H), 2.76-2.61 (m, 2H), 2.58 (m, 1H), 2.39-2.23 (m, 2H), 1.81-1.68 (m, 2H), 0.60-0.47 (m, 2H), 0.47-0.35 (m, 2H).
",1,data/dev/EP3330263A1.txt,0
7946,"Example 23: N-cyclopropyl-4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)ureido)benzamide
",0,data/dev/EP3330263A1.txt,1
7947,"<img> id-imgb0069.tif </img>
",0,data/dev/EP3330263A1.txt,1
7959,"Example 24: 1-(5-(1-(cyclopropylamino)ethyl)-2-(thiophen-3-yl)phenyl)-3-(3-(trifluoromethyl) phenyl)urea
",0,data/dev/EP3330263A1.txt,1
7961,"<img> id-imgb0071.tif </img>
",0,data/dev/EP3330263A1.txt,1
7974,"Example 26: N-cyclopropyl-1-(4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)ureido)phenyl) methanesulfonamide
",0,data/dev/EP3330263A1.txt,1
7975,"<img> id-imgb0074.tif </img>
",0,data/dev/EP3330263A1.txt,1
7993,"Example 27: N-(1-(4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)uredio)phenyl)ethyl) cyclopropanecarboxamide
",0,data/dev/EP3330263A1.txt,1
7995,"<img> id-imgb0076.tif </img>
",0,data/dev/EP3330263A1.txt,1
8013,"N-(4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)ureido)benzyl)cyclopropanecarboxami de was prepared referring to the synthetic method in Example 27. 1H-NMR (400 MHz, DMSO-d6): δ=9.35 (s, 1H), 8.57 (t, J=5.9 Hz, 1H), 7.97 (s, 1H), 7.81 (s, 1H), 7.72 (d, J=1.4 Hz, 1H), 7.64 (dd, J=4.9, 2.9 Hz, 1H), 7.57 (dd, J=2.9, 1.3 Hz, 1H), 7.47-7.38 (m, 2H), 7.22 (m, 2H), 7.19 (dd, J=4.9, 1.3 Hz, 1H), 6.97 (dd, J=7.9, 1.6 Hz, 1H), 4.22 (s, 2H), 1.64-1.48 (m, 1H), 0.75-0.53 (m, 4H).
",1,data/dev/EP3330263A1.txt,0
8016,"N-(4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)ureido)benzyl)cyclopropylsulfonamid e was prepared referring to the synthetic method in Example 27. 1H-NMR (400 MHz, DMSO-d6): δ=9.40 (s, 1H), 8.01 (s, 1H), 7.87 (d, J=3.5 Hz, 2H), 7.73-7.60 (m, 3H), 7.51-7.46 (m, 2H), 7.33-7.22 (m, 3H), 7.16-7.08 (m, 1H), 4.20 (d, J=6.4 Hz, 2H), 2.61-2.49 (m, 1H), 0.91 (m, 4H).
",1,data/dev/EP3330263A1.txt,0
8247,"Embodiment 1
",1,data/dev/US20200055807A1.txt,0
8249,"The chemical reaction of the above alcoholysis process is as follows:
",1,data/dev/US20200055807A1.txt,0
8250,"<img> id-US20200055807A1_00017.PNG </img>
",1,data/dev/US20200055807A1.txt,0
8253,"Embodiment 2
",1,data/dev/US20200055807A1.txt,0
8255,"Embodiment 3
",1,data/dev/US20200055807A1.txt,0
8257,"Embodiment 4
",1,data/dev/US20200055807A1.txt,0
8259,"Embodiment 5
",1,data/dev/US20200055807A1.txt,0
8261,"Embodiment 6
",1,data/dev/US20200055807A1.txt,0
8263,"Embodiment 7
",1,data/dev/US20200055807A1.txt,0
8265,"Embodiment 8
",1,data/dev/US20200055807A1.txt,0
8267,"Embodiment 9
",1,data/dev/US20200055807A1.txt,0
8269,"Embodiment 10
",1,data/dev/US20200055807A1.txt,0
8271,"Embodiment 11
",1,data/dev/US20200055807A1.txt,0
8273,"Embodiment 12
",1,data/dev/US20200055807A1.txt,0
8274,"It differs from Embodiment 1 in that the pH adjuster used is KHCO3, and the product yield is 74%.
",1,data/dev/US20200055807A1.txt,0
8275,"Embodiment 13
",1,data/dev/US20200055807A1.txt,0
8276,"It differs from Embodiment 1 in that the pH adjuster used is K2HPO4, and the product yield is 51%.
",1,data/dev/US20200055807A1.txt,0
8277,"Embodiment 14
",1,data/dev/US20200055807A1.txt,0
8279,"Embodiment 15
",1,data/dev/US20200055807A1.txt,0
8281,"Embodiment 16
",1,data/dev/US20200055807A1.txt,0
8283,"Embodiment 17
",1,data/dev/US20200055807A1.txt,0
8285,"Embodiment 18
",1,data/dev/US20200055807A1.txt,0
8287,"Embodiment 19
",1,data/dev/US20200055807A1.txt,0
8289,"Embodiment 20
",1,data/dev/US20200055807A1.txt,0
8291,"Embodiment 21
",1,data/dev/US20200055807A1.txt,0
8293,"Embodiment 22
",1,data/dev/US20200055807A1.txt,0
8295,"Embodiment 23
",1,data/dev/US20200055807A1.txt,0
8297,"Embodiment 24
",1,data/dev/US20200055807A1.txt,0
8299,"Embodiment 25
",1,data/dev/US20200055807A1.txt,0
8303,"Embodiment 26
",1,data/dev/US20200055807A1.txt,0
8307,"Embodiment 27
",1,data/dev/US20200055807A1.txt,0
8311,"Embodiment 28
",1,data/dev/US20200055807A1.txt,0
8315,"Embodiment 29
",1,data/dev/US20200055807A1.txt,0
8317,"Embodiment 30
",1,data/dev/US20200055807A1.txt,0
8319,"Embodiment 31
",1,data/dev/US20200055807A1.txt,0
8321,"Embodiment 32
",1,data/dev/US20200055807A1.txt,0
8325,"Embodiment 33
",1,data/dev/US20200055807A1.txt,0
8327,"Embodiment 34
",1,data/dev/US20200055807A1.txt,0
8329,"Embodiment 35
",1,data/dev/US20200055807A1.txt,0
8331,"Embodiment 36
",1,data/dev/US20200055807A1.txt,0
8333,"Embodiment 37
",1,data/dev/US20200055807A1.txt,0
8335,"Embodiment 38
",1,data/dev/US20200055807A1.txt,0
8339,"Embodiment 39
",1,data/dev/US20200055807A1.txt,0
8343,"Embodiment 40
",1,data/dev/US20200055807A1.txt,0
8345,"Embodiment 41
",1,data/dev/US20200055807A1.txt,0
8349,"Embodiment 42
",1,data/dev/US20200055807A1.txt,0
8353,"Embodiment 43
",1,data/dev/US20200055807A1.txt,0
8358,"Embodiment 44
",1,data/dev/US20200055807A1.txt,0
8362,"Embodiment 45
",1,data/dev/US20200055807A1.txt,0
8366,"Embodiment 46
",1,data/dev/US20200055807A1.txt,0
8370,"Embodiment 47
",1,data/dev/US20200055807A1.txt,0
8374,"Embodiment 48
",1,data/dev/US20200055807A1.txt,0
8378,"Embodiment 49
",1,data/dev/US20200055807A1.txt,0
8382,"Embodiment 50
",1,data/dev/US20200055807A1.txt,0
8386,"Embodiment 51
",1,data/dev/US20200055807A1.txt,0
8390,"Embodiment 52
",1,data/dev/US20200055807A1.txt,0
8394,"Embodiment 53
",1,data/dev/US20200055807A1.txt,0
8398,"Embodiment 54
",1,data/dev/US20200055807A1.txt,0
8402,"Embodiment 55
",1,data/dev/US20200055807A1.txt,0
8406,"Embodiment 56
",1,data/dev/US20200055807A1.txt,0
8410,"Embodiment 57
",1,data/dev/US20200055807A1.txt,0
8414,"Embodiment 58
",1,data/dev/US20200055807A1.txt,0
8418,"Embodiment 59
",1,data/dev/US20200055807A1.txt,0
8422,"Embodiment 60
",1,data/dev/US20200055807A1.txt,0
8424,"Embodiment 61
",1,data/dev/US20200055807A1.txt,0
8426,"Embodiment 62
",1,data/dev/US20200055807A1.txt,0
8428,"Embodiment 63
",1,data/dev/US20200055807A1.txt,0
8430,"Embodiment 64
",1,data/dev/US20200055807A1.txt,0
8432,"Embodiment 65
",1,data/dev/US20200055807A1.txt,0
8434,"Embodiment 66
",1,data/dev/US20200055807A1.txt,0
8490,"Then, ethyl acetoacetate (Compound 4) in which the alpha position is substituted is synthesized by allowing Compound 3 to react with tributyltinhydride (n-Bu3SnH) in a toluene solvent. Then, an oxime (Compound 5) is synthesized by adding butyl nitrite (n-BuONO) to Compound 4 in the presence of an ethanolic ethoxide base. After Compound 6 was obtained by reacting Compound 5 with dihydropyran (DHP) in the presence of a p-toluenesulfonic acid (p-TsOH) catalyst, Compound 7 is synthesized by performing hydrolysis with an aqueous potassium hydroxide (1 N-KOH) solution in an ethanol solvent. Then, Compound 8 (a compound of Chemical Formula 3) is synthesized by a condensation reaction with N-hydroxysuccinimide and Compound 7 in a dioxane solvent (1,4-dioxane). Compound 9 (a compound of Chemical Formula 4) is produced by allowing 2,2'-diselanediyldiethanamine to react with synthesized Compound 8 (a compound of Chemical Formula 3) in the presence of a triethylamine (TEA) base, subsequently, a selenopsammaplin A derivative (Compound 1, a compound of Chemical Formula 1) is synthesized by performing a hydrolysis reaction using a hydrochloric acid (1 M-HCl) ether (Et2O) solution as an acid catalyst, phenyl disulfide, dithiothreitol, and a phosphoric acid buffer are dissolved in a dimethyl sulfoxide solvent, and then a selenopsammaplin A derivative (Compound 10, a compound of Chemical Formula 2) is synthesized by diluting the reaction product thereof with ethyl acetate and separating the reaction product thereof with column chromatography.
",0,data/dev/EP3708563A1.txt,1
8527,"Further, in the present Examples 1 to 28, a selenopsammaplin A monomer derivative as illustrated in FIG. 1B is prepared, and the compounds in Examples 1 to 28 are prepared according to the above-described Reaction Scheme 1 (FIG. 2). First, after synthesized selenopsammaplin A (1,133 mg) which is a substrate, phenyl disulfide (44.2 mg), and dithiothreitol (3.2 mg) were dissolved in a pH 8.3 phosphoric acid buffer (2 mL) and a dimethyl sulfoxide solvent (6 mL), the resulting solution was stirred at room temperature for 16 hours. After completion of the reaction, a selenopsammaplin A monomer (SSM-15, 35 mg) was obtained by separating the residue obtained by diluting the reaction solution with ethyl acetate (50 mL), washing the diluted reaction solution with water (10 mL x 10), and distilling the resulting product under reduced pressure.
",1,data/dev/EP3708563A1.txt,0
8529,"Example 1. Preparation of (2E,2'E)-N,N'-(diselanediylbis(ethane-2,1-diyl))bis(3-(3-bromo-4-hydroxyphenyl)-2-(hydroxyimino)propanamide) (SSM-1)
",1,data/dev/EP3708563A1.txt,0
8533,"Example 3. Preparation of (2E,2'E)-N,N'-(diselanediylbis(ethane-2,1-diyl))bis(3-(3-fluoro-4-hydroxyphenyl)-2-(hydroxyimino)propanamide) (SSM-3)
",1,data/dev/EP3708563A1.txt,0
8535,"Example 4. Preparation of (2E,2'E)-N,N'-(diselanediylbis(ethane-2,1-diyl))bis(2-(hydroxyimino)-3-phenylpropanamide) (SSM-4)
",1,data/dev/EP3708563A1.txt,0
8759,"<img> id-US20180105741A1-20180419-C00177.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8787,"<img> id-US20180105741A1-20180419-C00178.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8789,"<img> id-US20180105741A1-20180419-C00179.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8791,"<img> id-US20180105741A1-20180419-C00180.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8793,"<img> id-US20180105741A1-20180419-C00181.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8795,"<img> id-US20180105741A1-20180419-C00182.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8815,"<img> id-US20180105741A1-20180419-C00190.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8864,"<img> id-US20180105741A1-20180419-C00205.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8893,"<img> id-US20180105741A1-20180419-C00212.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8914,"<img> id-US20180105741A1-20180419-C00219.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8941,"<img> id-US20180105741A1-20180419-C00220.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8961,"<img> id-US20180105741A1-20180419-C00233.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8967,"<img> id-US20180105741A1-20180419-C00234.TIF </img>
",0,data/dev/US20180105741A1.txt,1
8995,"<img> id-US20180105741A1-20180419-C00235.TIF </img>
",0,data/dev/US20180105741A1.txt,1
9049,"Synthesis Example 2: Synthesis of Compound 41
",1,data/dev/US20180105741A1.txt,0
9055,"Synthesis Example 3: Synthesis of Compound 42
",1,data/dev/US20180105741A1.txt,0
9061,"Synthesis Example 4: Synthesis of Compound 43
",1,data/dev/US20180105741A1.txt,0
9067,"Synthesis Example 5: Synthesis of Compound 44
",1,data/dev/US20180105741A1.txt,0
9073,"Synthesis Example 6: Synthesis of Compound 45
",1,data/dev/US20180105741A1.txt,0
9079,"Synthesis Example 7: Synthesis of Compound 46
",1,data/dev/US20180105741A1.txt,0
9085,"Synthesis Example 8: Synthesis of Compound 47
",1,data/dev/US20180105741A1.txt,0
9091,"Synthesis Example 9: Synthesis of Compound 355
",1,data/dev/US20180105741A1.txt,0
9111,"Synthesis Example 10: Synthesis of Compound 356
",1,data/dev/US20180105741A1.txt,0
9162,"<img> id-US20180105741A1-20180419-C00239.TIF </img>
",0,data/dev/US20180105741A1.txt,1
9166,"Example 9
",0,data/dev/US20180105741A1.txt,1
9334,"In the dehydrogenative condensation steps, two equivalents of H2 are liberated per pyrrole motif, thus making the protocol completely environmentally benign. The reaction proceeded successfully with both aliphatic and aromatic unprotected β-aminoalcohols and gave the de-sired 1H-pyrroles in moderate to good yields (58%-86%).
",0,data/dev/US20200384451A1.txt,1
9343,"a) Bis(2-(ethylthio)ethyl)amine (EtSNS; L1)
",1,data/dev/US20200384451A1.txt,0
9347,"Example 2: Synthesis of Cobalt-Complexes
",0,data/dev/US20200384451A1.txt,1
9348,"a) Dimer of Co(II)chloride:bis(2-(diethyl-λ3-sulfanyl)ethyl)amine
",1,data/dev/US20200384451A1.txt,0
9349,"<img> id-US20200384451A1_00008.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9352,"b) Dimer of Co(II)chloride:bis(2-(isopropylthio)ethyl)amine
",1,data/dev/US20200384451A1.txt,0
9353,"<img> id-US20200384451A1_00009.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9356,"c) Dimer of Co(II)bromide:bis(2-(diethyl-λ3-sulfanyl)ethyl)amine
",1,data/dev/US20200384451A1.txt,0
9357,"<img> id-US20200384451A1_00010.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9359,"d) Dimer of Co(II)bromide:bis(2-(isopropylthio)ethyl)amine
",1,data/dev/US20200384451A1.txt,0
9360,"<img> id-US20200384451A1_00011.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9363,"a) Reaction with Different Solventa
",1,data/dev/US20200384451A1.txt,0
9364,"<img> id-US20200384451A1_00012.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9365,"<table>
",1,data/dev/US20200384451A1.txt,0
9366,"<header>
",1,data/dev/US20200384451A1.txt,0
9367,"TABLE 1
",1,data/dev/US20200384451A1.txt,0
9368,"</header>
",1,data/dev/US20200384451A1.txt,0
9369,"<header>
",1,data/dev/US20200384451A1.txt,0
9370,"
",1,data/dev/US20200384451A1.txt,0
9371,"</header>
",1,data/dev/US20200384451A1.txt,0
9372,"<header>
",1,data/dev/US20200384451A1.txt,0
9373,"Entry & Solvent & Yield (%)b
",1,data/dev/US20200384451A1.txt,0
9374,"</header>
",1,data/dev/US20200384451A1.txt,0
9375,"<header>
",1,data/dev/US20200384451A1.txt,0
9376,"
",1,data/dev/US20200384451A1.txt,0
9377,"</header>
",1,data/dev/US20200384451A1.txt,0
9378,"1 & Toluene & 47
",1,data/dev/US20200384451A1.txt,0
9379,"2 & m-xylene & 77
",1,data/dev/US20200384451A1.txt,0
9381,"4 & n-octane & 52
",1,data/dev/US20200384451A1.txt,0
9382,"5 & THF & 32
",1,data/dev/US20200384451A1.txt,0
9384,"bYield determined by GC using 1,4-dibromo butane as an internal standard.
",1,data/dev/US20200384451A1.txt,0
9385,"</table>
",1,data/dev/US20200384451A1.txt,0
9386,"b) Reaction with Different Catalysta
",1,data/dev/US20200384451A1.txt,0
9387,"<img> id-US20200384451A1_00013.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9388,"<table>
",1,data/dev/US20200384451A1.txt,0
9389,"<header>
",1,data/dev/US20200384451A1.txt,0
9390,"TABLE 2
",1,data/dev/US20200384451A1.txt,0
9391,"</header>
",1,data/dev/US20200384451A1.txt,0
9392,"<header>
",1,data/dev/US20200384451A1.txt,0
9393,"
",1,data/dev/US20200384451A1.txt,0
9394,"</header>
",1,data/dev/US20200384451A1.txt,0
9395,"<header>
",1,data/dev/US20200384451A1.txt,0
9396,"Entry & Catalyst & Yield (%)b
",1,data/dev/US20200384451A1.txt,0
9397,"</header>
",1,data/dev/US20200384451A1.txt,0
9398,"<header>
",1,data/dev/US20200384451A1.txt,0
9399,"
",1,data/dev/US20200384451A1.txt,0
9400,"</header>
",1,data/dev/US20200384451A1.txt,0
9401,"1 & Cat. 1 & 77
",1,data/dev/US20200384451A1.txt,0
9402,"2 & Cat. 2 & 34
",1,data/dev/US20200384451A1.txt,0
9404,"4 & — & NR
",1,data/dev/US20200384451A1.txt,0
9405,"5 & RuCl2(PPh3)[HN(C2H4SEt)2] & 45
",1,data/dev/US20200384451A1.txt,0
9407,"bYield determined by GC using 1,4-dibromo butane as an internal standard. NR = No reaction.
",1,data/dev/US20200384451A1.txt,0
9408,"</table>
",1,data/dev/US20200384451A1.txt,0
9409,"c) Reaction with Different Basea
",1,data/dev/US20200384451A1.txt,0
9410,"<table>
",1,data/dev/US20200384451A1.txt,0
9411,"<header>
",1,data/dev/US20200384451A1.txt,0
9412,"
",1,data/dev/US20200384451A1.txt,0
9413,"</header>
",1,data/dev/US20200384451A1.txt,0
9414,"<img> id-US20200384451A1_00014.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9415,"<img> id-US20200384451A1_00015.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9416,"<img> id-US20200384451A1_00016.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9417,"Entry & Base & Yield (%)b
",1,data/dev/US20200384451A1.txt,0
9418,"1 & NaOtBu & 63
",1,data/dev/US20200384451A1.txt,0
9420,"3 & KOH & 62
",1,data/dev/US20200384451A1.txt,0
9422,"5 & KHMDS & 67
",1,data/dev/US20200384451A1.txt,0
9423,"6 & KH & 71
",1,data/dev/US20200384451A1.txt,0
9424,"7 & K2CO3 & NR
",1,data/dev/US20200384451A1.txt,0
9425,"8 & KOAc & NR
",1,data/dev/US20200384451A1.txt,0
9426,"9 & — & NR
",1,data/dev/US20200384451A1.txt,0
9427,"aReactions performed using amino alcohol 3c (0.125 mmol), 1-Phenyl ethanol 4a (0.15 mmol), catalyst 1 (2.5 mol %), base (1.1 equiv.) reflux at 150° C. to 180° C.
",1,data/dev/US20200384451A1.txt,0
9428,"bYield determined by GC using 1,4-dibromo butane as an internal standard.
",1,data/dev/US20200384451A1.txt,0
9429,"NR = No reaction.
",1,data/dev/US20200384451A1.txt,0
9430,"</table>
",1,data/dev/US20200384451A1.txt,0
9431,"d) Reaction with Different Base Amounta
",1,data/dev/US20200384451A1.txt,0
9432,"<table>
",1,data/dev/US20200384451A1.txt,0
9433,"<header>
",1,data/dev/US20200384451A1.txt,0
9434,"
",1,data/dev/US20200384451A1.txt,0
9435,"</header>
",1,data/dev/US20200384451A1.txt,0
9436,"<img> id-US20200384451A1_00017.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9437,"<img> id-US20200384451A1_00018.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9438,"<img> id-US20200384451A1_00019.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9439,"Entry & Base (x equiv) & Yield (%)b
",1,data/dev/US20200384451A1.txt,0
9440,"1 & 0.5 eq & 20
",1,data/dev/US20200384451A1.txt,0
9441,"2 & 1.1 eq & 77
",1,data/dev/US20200384451A1.txt,0
9442,"3 & 1.5 eq & 55
",1,data/dev/US20200384451A1.txt,0
9443,"4 & 2 eq & 39
",1,data/dev/US20200384451A1.txt,0
9444,"5 & 2.5 eq & 35
",1,data/dev/US20200384451A1.txt,0
9445,"aReactions performed using amino alcohol 3c (0.125 mmol), 1-Phenyl ethanol 4a (0.15 mmol), catalyst (2.5 mol %), KOtBu (equiv.) reflux at 150° C. to 180° C.
",1,data/dev/US20200384451A1.txt,0
9446,"bYield determined by GC using 1,4-dibromo butane as an internal standard.
",1,data/dev/US20200384451A1.txt,0
9447,"</table>
",1,data/dev/US20200384451A1.txt,0
9448,"e) Reaction with Different Temperaturea
",1,data/dev/US20200384451A1.txt,0
9449,"<table>
",1,data/dev/US20200384451A1.txt,0
9450,"<header>
",1,data/dev/US20200384451A1.txt,0
9451,"
",1,data/dev/US20200384451A1.txt,0
9452,"</header>
",1,data/dev/US20200384451A1.txt,0
9453,"<img> id-US20200384451A1_00020.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9454,"<img> id-US20200384451A1_00021.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9455,"<img> id-US20200384451A1_00022.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9456,"Entry & Temperature & Yield (%)b
",1,data/dev/US20200384451A1.txt,0
9457,"1 & 50° C. & NR
",1,data/dev/US20200384451A1.txt,0
9458,"2 & 80° C. & trace
",1,data/dev/US20200384451A1.txt,0
9459,"3 & 120° C. & 23
",1,data/dev/US20200384451A1.txt,0
9460,"4 & 150° C. & 48
",1,data/dev/US20200384451A1.txt,0
9461,"5 & 180° C. & 77
",1,data/dev/US20200384451A1.txt,0
9462," & (reflux)
",1,data/dev/US20200384451A1.txt,0
9463,"aReactions performed using amino alcohol 3c (0.125 mmol), 1-Phenyl ethanol 4a (0.15 mmol), catalyst (2.5 mol %), KOtBu (equiv.) at different (bath) temperature.
",1,data/dev/US20200384451A1.txt,0
9464,"bYield determined by GC using 1,4-dibromo butane as an internal standard.
",1,data/dev/US20200384451A1.txt,0
9465,"NR = No reaction.
",1,data/dev/US20200384451A1.txt,0
9466,"</table>
",1,data/dev/US20200384451A1.txt,0
9467,"f) Reaction with Different Alcohol and Amino Alcohol Ratioa
",1,data/dev/US20200384451A1.txt,0
9468,"<table>
",1,data/dev/US20200384451A1.txt,0
9469,"<header>
",1,data/dev/US20200384451A1.txt,0
9470,"
",1,data/dev/US20200384451A1.txt,0
9471,"</header>
",1,data/dev/US20200384451A1.txt,0
9472,"<img> id-US20200384451A1_00023.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9473,"<img> id-US20200384451A1_00024.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9474,"<img> id-US20200384451A1_00025.PNG </img>
",1,data/dev/US20200384451A1.txt,0
9475," & Alcohol/amino & 
",1,data/dev/US20200384451A1.txt,0
9476,"Entry & alcohol ratio & Yield (%)b
",1,data/dev/US20200384451A1.txt,0
9479,"3 & 1.5/1 & 71
",1,data/dev/US20200384451A1.txt,0
9481,"5 & 3/1 & 65
",1,data/dev/US20200384451A1.txt,0
9482,"aReactions performed using amino alcohol 3c (0.125 mmol), 1-Phenyl ethanol 4a (0.15 mmol), catalyst (2.5 mol %), KOtBu (equiv.) reflux at 150° C. to 180° C.
",1,data/dev/US20200384451A1.txt,0
9483,"bYield determined by GC using 1,4-dibromo butane as an internal standard.
",1,data/dev/US20200384451A1.txt,0
9484,"NR = No reaction.
",1,data/dev/US20200384451A1.txt,0
9485,"</table>
",1,data/dev/US20200384451A1.txt,0
9518,"xv. 2-isobutyl-5-(naphthalen-2-yl)-1H-pyrrole (5o)
",1,data/dev/US20200384451A1.txt,0
9531,"v. 2-octyl Pyridine (7e)
",1,data/dev/US20200384451A1.txt,0
9532,"Ration of alcohol/amino alcohol=1.5/1 has taken under the identical reaction condition.
",1,data/dev/US20200384451A1.txt,0
9784,"<img> id-US20200181061A1_00016.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9787,"<img> id-US20200181061A1_00017.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9790,"<img> id-US20200181061A1_00018.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9793,"<img> id-US20200181061A1_00019.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9796,"<img> id-US20200181061A1_00020.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9799,"<img> id-US20200181061A1_00021.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9802,"<img> id-US20200181061A1_00022.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9805,"<img> id-US20200181061A1_00023.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9808,"<img> id-US20200181061A1_00024.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9811,"<img> id-US20200181061A1_00025.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9814,"<img> id-US20200181061A1_00026.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9817,"<img> id-US20200181061A1_00027.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9820,"<img> id-US20200181061A1_00028.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9823,"<img> id-US20200181061A1_00029.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9826,"<img> id-US20200181061A1_00030.PNG </img>
",1,data/dev/US20200181061A1.txt,0
9827,"<Synthesis of Compound 1>
",1,data/dev/US20200181061A1.txt,0
9926,"polymerization
",0,data/dev/US20200181061A1.txt,1
10155,"In an embodiment in FIG. 16, Solid phase peptide synthesis of AAPT rhodamine B conjugate 25. The arene rhodamine B conjugate 25 is synthesized using SPPS by introduction of 4-carboxylic acid benzylamine in the peptide spacer to enhance the binding affinity to PSMA protein. 1,2-diaminoethanetrityl resin (0.050 g, 0.0525 mmol) was swelled initially with CH2Cl2 (5 mL) for 30 minutes by bubbling nitrogen and after draining CH2Cl2, the resin is swelled once again with DMF (5 mL) thrice for 15 minutes each. Fmoc-Asp(OtBu)-OH (0.054 g, 0.1312 mmol), PyBOP (0.068 g, 0.1312 mmol) and DIPEA (0.091 mL, 0.525 mmol) in DMF (0.5 mL) was added to the peptide vessel and the coupling reaction was continued for 6 h. The resin was washed with DMF (3.0 mL×3) followed by isopropanol (3.0 mL×3). The completion of reaction was confirmed by performing the Kaiser test. A solution of 20% piperidine in DMF (4 mL) was added to the peptide vessel and the resin beads were bubbled for 10 minutes. The procedure was repeated twice (3 mL×2) to ensure complete deprotection of Fmoc protecting group from the coupled amino acid. The resin beads were washed with DMF (3.0 mL×3) and isopropanol (3.0 mL×3) and the formation of free amine was confirmed by performing the Kaiser test. Consecutively, Fmoc-Lys(Tfa)-OH, Fmoc-8-aminocaprylic acid, Fmoc benzylamine-4-carboxylic acid, Fmoc-Phe-OH, Fmoc-Phe-OH and Fmoc-8-aminocaprylic acid were attached to the growing peptide chain in sequence as mentioned before. After deprotection of Fmoc group from the last amino acid, Fmoc-8-aminocaprylic acid, tris-tert butyl protected AAPT ligand 16a (0.040 g, 0.079 mmol), PyBOP (0.068 g, 0.1312 mmol) and DIPEA (0.091 mL, 0.525 mmol) in DMF (0.5 mL) was added to the resin beads and mixed for 6 h. The completion of coupling reaction was confirmed by performing the Kaiser test. Finally, the trifluoroacetyl (Tfa) protecting group of lysine amino acid was cleaved with 2M aqueous piperidine (10 mL) at room temperature for 6-12 h (depending on completion of the reaction) and the deprotection of Tfa group was confirmed by the Kaiser test. Rhodamine B dye (0.038 g, 0.079 mmol), PyBOP (0.068 g, 0.1312 mmol) and DIPEA (0.091 mL, 0.525 mmol) in DMF (0.5 mL) was added to the peptide vessel and reacted for 6 h at room temperature. The completion of the coupling reaction was confirmed by performing the Kaiser test. A mixture of 9.5 mL trifluoroacetic acid (TFA), 0.25 mL triisopropylsilane (TIPS), and 0.25 mL H2O was prepared in a 15 mL centrifuge tube, and 5 mL of this cocktail solution was added to the resin beads and nitrogen gas was bubbled through the solution for 30 minutes. The cocktail with cleaved rhodamine peptide conjugate in peptide vessel was collected to a round bottom flask (25 mL). The resin beads were treated again with the cocktail solution twice (2.5 mL×2) for 15 minutes each and the mother liquor was collected in the same round bottom flask (25 mL). The pooled cocktail mixture with cleaved peptide arene rhodamine B conjugate 25 was transferred to a 15 mL centrifuge tube, fitted with a septum and concentrated under reduced pressure to obtain a viscous liquid. Ice cold ether (5 mL) was added to the concentrated viscous mixture to precipitate arene rhodamine B conjugate 25 as a bright red solid and the solid was washed thrice with ice cold ether (5 mL×3). The crude product 25 was purified by RP-HPLC using pentafluorophenyl preparative column (5 μm, 10 mm×150 mm) [λ=555 nm; solvent gradient 1% B to 70% B in 25 min, 80% B wash 15 min; A=0.1% TFA, pH=2; B=acetonitrile (ACN)]. Acetonitrile was removed reduced pressure from HPLC fractions, and the pure fractions were freeze-dried to yield peptide arene rhodamine B conjugate 25 as pink solid. The purity of arene rhodamine B conjugate 25 was confirmed by analytical RP-HPLC and the molecular weight is determined by HRMS (+ESI) calcd for [M−Cl]+ (C94H125N14O19)+: 1753.9245 found 1753.9239.
",0,data/dev/US20200164075A1.txt,1
10158,"In an embodiment in FIG. 18, Solid phase synthesis of AAPT ligand conjugated chelating linker 31.H-Cys-2-ClTrt resin (0.100 g, 0.09 mmol) was swelled in CH2Cl2 (5 mL) for 30 minutes by bubbling nitrogen and after draining CH2Cl2, the resin is swelled once again with DMF (5 mL×3) thrice for 15 minutes each. Fmoc-Asp(OtBu)-OH (93 mg, 0.225 mmol), PyBOP (116 mg, 0.225 mmol) and DIPEA (0.16 mL, 0.90 mmol) in DMF (0.5 mL) was added to the peptide vessel and the coupling reaction was continued for 6 h. The resin was washed with DMF (3.0 mL×3) followed by isopropanol (3.0 mL×3). The completion of reaction was confirmed by performing the Kaiser test. A solution of 20% piperidine in DMF (4 mL) was added to the peptide vessel and the resin beads were bubbled for 10 minutes. The procedure was repeated twice (3 mL×2) to ensure complete deprotection of Fmoc protecting group from the coupled amino acid. The resin beads were washed with DMF (3.0 mL×3) and isopropanol (3.0 mL×3) and the formation of free amine was confirmed by performing the Kaiser test. Consecutively, Boc-Dap(Fmoc)-OH, Fmoc-Phe-OH, Fmoc-Phe-OH and Fmoc-8-aminocaprylic acid were attached to the growing peptide chain in sequence as mentioned before. After deprotection of NHFmoc group from the last amino acid, Fmoc-8-aminocaprylic acid, tris-tertbutyl protected compound 16a (68 mg, 0.135 mmol), PyBOP (116 mg, 0.225 mmol) and DIPEA (0.16 mL, 0.90 mmol) in DMF (0.5 mL) were added to the vessel and mixed for 6 h. The completion of reaction was confirmed by the Kaiser test.
",0,data/dev/US20200164075A1.txt,1
10161,"In an embodiment in FIG. 19, Solid phase synthetic procedure for preparation of AAPT ligand conjugated arene chelating linker 34. H-Cys-2-ClTrt resin (0.100 g, 0.09 mmol) was swelled in CH2Cl2 (5 mL) for 30 minutes by bubbling nitrogen and after draining CH2Cl2, the resin is swelled once again with DMF (5 mL×3) thrice for 15 minutes each. Fmoc-Asp(OtBu)-OH (93 mg, 0.225 mmol), PyBOP (116 mg, 0.225 mmol) and DIPEA (0.16 mL, 0.90 mmol) in DMF (0.5 mL) was added to the peptide vessel and the coupling reaction was continued for 6 h. The resin was washed with DMF (3.0 mL×3) followed by isopropanol (3.0 mL×3). The completion of reaction was confirmed by performing the Kaiser test. A solution of 20% piperidine in DMF (4 mL) was added to the peptide vessel and the resin beads were bubbled for 10 minutes. The procedure was repeated twice (3 mL×2) to ensure complete deprotection of Fmoc protecting group from the coupled amino acid. The resin beads were washed with DMF (3.0 mL×3) and isopropanol (3.0 mL×3) and the formation of free amine was confirmed by performing the Kaiser test. Consecutively, Boc-Dap(Fmoc)-OH, Fmoc-8-aminocaprylic acid, 4-(Fmoc-aminomethyl) benzoic acid Fmoc-Phe-OH, Fmoc-Phe-OH and Fmoc-8-aminocaprylic acid were attached to the growing peptide chain in sequence as mentioned before. After deprotection of NHFmoc group from the last amino acid, Fmoc-8-aminocaprylic acid, tris-tertbutyl protected compound 16a (68 mg, 0.135 mmol), PyBOP (116 mg, 0.225 mmol) and DIPEA (0.16 mL, 0.90 mmol) in DMF (0.5 mL) were added to the vessel and mixed for 6 h. The completion of reaction was confirmed by the Kaiser test.
",0,data/dev/US20200164075A1.txt,1
10207,"The purification of ligands 1-3 was performed using Buchi Reveleris Preparative HPLC System. Crude ligand (20 mg) was dissolved in 1:1 ratio of CH3CN:H2O (1 mL) and injected into the sample injector for elution using RP-PFP (Reverse Phase pentafluorophenyl) preparative column (XSelect CSH Prep Fluorophenyl 5 μm OBD, 19 mm×150 mm). A flow rate of 10 mL/min (mobile phase, A=0.1% trifluoro acetic acid/H2O and B=acetonitrile) is maintained throughout the run and the mobile phase gradient was increased from 1% B (v/v) to 50% B (v/v) over a period of 40 min. The mobile phase gradient was further increased to 80% B (v/v) in the next 15 min and the chromatogram was recorded at λ=200-254 nm as well as by ELSD detector. Pure fractions of 1-3 were collected using automatic fraction collector, acetonitrile was evaporated under reduced pressure, lyophilized to afford pure ligands 1-3. The pure ligands were further used for GCPII enzyme inhibition assay.
",0,data/dev/US20200164075A1.txt,1
10208,"Example 20: Procedure for PSMA or GCPII Enzyme Inhibition Assay
",0,data/dev/US20200164075A1.txt,1
10284,"(3) a third step of performing the nucleophilic substitution reaction (2)
",0,data/dev/US20200377536A1.txt,1
10446,"<img> id-US20200377536A1_00026.PNG </img>
",0,data/dev/US20200377536A1.txt,1
10464,"Example 2
",1,data/dev/US20200377536A1.txt,0
10466,"wherein R1 and R2 represent an adamantyl group.
",1,data/dev/US20200377536A1.txt,0
10470,"Example 3
",1,data/dev/US20200377536A1.txt,0
10471,"<img> id-US20200377536A1_00028.PNG </img>
",1,data/dev/US20200377536A1.txt,0
10472,"wherein R1 represents an adamantyl group, and R2 represents a 1,1,3,3-tetramethylbutyl group.
",1,data/dev/US20200377536A1.txt,0
10476,"Example 4
",1,data/dev/US20200377536A1.txt,0
10478,"wherein R1 represents a tert-butyl group, and R2 represents an adamantyl group.
",1,data/dev/US20200377536A1.txt,0
10479,"A phosphine-borane (3d) was used instead of the phosphine-borane (3a) in the first step to obtain a phosphinopyrazine derivative (4d) in the second step.
",1,data/dev/US20200377536A1.txt,0
10483,"Example 5
",1,data/dev/US20200377536A1.txt,0
10484,"<img> id-US20200377536A1_00030.PNG </img>
",1,data/dev/US20200377536A1.txt,0
10485,"wherein R1 represents a tert-butyl group, and R2 represents a 1,1,3,3-tetramethylbutyl group.
",1,data/dev/US20200377536A1.txt,0
10486,"The phosphine-borane (3d) was used instead of the phosphine-borane (3a) in the first step to obtain the phosphinopyrazine derivative (4d).
",1,data/dev/US20200377536A1.txt,0
10490,"Comparative Example 1
",1,data/dev/US20200377536A1.txt,0
10492,"wherein R1 and R2 represent a tert-butyl group.
",1,data/dev/US20200377536A1.txt,0
10493,"The phosphine-borane (3d) was used instead of the phosphine-borane (3a) in the first step to obtain the phosphinopyrazine derivative (4d).
",1,data/dev/US20200377536A1.txt,0
10497,"Example 6
",1,data/dev/US20200377536A1.txt,0
10498,"Enantioselective Markovnikov Hydroboration Reaction
",1,data/dev/US20200377536A1.txt,0
10503,"Organoboron compounds were obtained by the same procedure as in Example 6 with the ligand changed. The results are shown together in Table 1.
",0,data/dev/US20200377536A1.txt,1
10504,"It was confirmed by 1H NMR and 31P NMR that in each of the reaction liquids, the 2,3-bisphosphinopyrazine derivative described in Table 1 and Cu(O-t-Bu) and the 2,3-bisphosphinopyrazine derivative formed a complex in a molar ratio of 1:1. In the following table, “3a” in the “3a:4a” ratio represents the amount of the S form. In the following Table 1, “Optical purity of 3a” is the optical purity of the S form, and is minus when the amount of the R form is larger than that of the S form.
",0,data/dev/US20200377536A1.txt,1
10526,"Comparative & (R) -Quinox-TCF & 39 & 78:22 & −87
",1,data/dev/US20200377536A1.txt,0
10527,"Example 1
",1,data/dev/US20200377536A1.txt,0
10533,"<img> id-US20200377536A1_00033.PNG </img>
",0,data/dev/US20200377536A1.txt,1
10561,"Example 16
",0,data/dev/US20200377536A1.txt,1
10564,"<First Step and Second Step>
",1,data/dev/US20200377536A1.txt,0
10565,"A phosphinopyrazine derivative (4e) was obtained as in Example 1 except that a phosphine-borane (3e) was used instead of the phosphine-borane (3b).
",1,data/dev/US20200377536A1.txt,0
10566,"<Ath Step>
",1,data/dev/US20200377536A1.txt,0
10649,"<img> id-US20180008574A1-20180111-C00014.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10652,"<img> id-US20180008574A1-20180111-C00015.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10655,"<img> id-US20180008574A1-20180111-C00016.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10658,"<img> id-US20180008574A1-20180111-C00017.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10661,"<img> id-US20180008574A1-20180111-C00018.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10665,"Example 2: Synthesis of 2-chloro-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-4-fluorobenzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10666,"<img> id-US20180008574A1-20180111-C00019.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10667,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.22 (d, J=8.4 Hz, 1H), 8.06 (d, J=7.2 Hz, 1H), 7.86 (dd, J=8.8, 5.6 Hz, 1H), 7.82-7.65 (m, 1H), 7.33 (dd, J=8.0, 2.4 Hz, 1H), 7.26 (s, 1H), 7.13 (d, J=7.6 Hz, 1H), 7.00-6.83 (m, 1H), 6.71 (d, J=7.6 Hz, 1H), 3.91 (q, J=7.2 Hz, 2H), 1.32 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10668,"Example 3: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)thiophene-2-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10669,"<img> id-US20180008574A1-20180111-C00020.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10670,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J=7.2 Hz, 1H), 7.92 (d, J=8.4 Hz, 1H), 7.74-7.58 (m, 1H), 7.52 (d, J=5.2 Hz, 1H), 7.41 (d, J=3.6 Hz, 1H), 7.31 (d, J=7.6 Hz, 1H), 7.01-6.93 (m, 1H), 6.91 (s, 1H), 6.82 (d, J=7.6 Hz, 1H), 3.95 (q, J=7.2 Hz, 2H), 1.36 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10671,"Example 4: Synthesis of 5-chloro-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-2-methoxybenzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10672,"<img> id-US20180008574A1-20180111-C00021.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10673,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.18 (d, J=8.4 Hz, 1H), 8.05 (d, J=7.2 Hz, 1H), 7.71 (dd, J=15.2, 5.2 Hz, 2H), 7.45 (dd, J=8.8, 2.4 Hz, 1H), 7.25 (s, 1H), 7.13 (d, J=7.6 Hz, 1H), 7.00 (d, J=8.8 Hz, 1H), 6.72 (d, J=7.6 Hz, 1H), 4.08 (s, 3H), 3.91 (q, J=7.2 Hz, 2H), 1.32 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10674,"Example 5: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)cyclohexanesulfonamide
",1,data/dev/US20180008574A1.txt,0
10675,"<img> id-US20180008574A1-20180111-C00022.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10676,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.23 (d, J=8.4 Hz, 1H), 8.09 (d, J=7.2 Hz, 1H), 7.78 (t, J=7.6 Hz, 1H), 7.55 (d, J=7.6 Hz, 1H), 7.00-6.72 (m, 2H), 3.96 (q, J=7.2 Hz, 2H), 3.21-2.96 (m, 1H), 2.23 (d, J=112.0 Hz, 2H), 1.87 (d, J=7.6 Hz, 2H), 1.65-1.61 (m, 4H), 1.37 (t, J=7.2 Hz, 3H), 1.19 (d, J=9.2 Hz, 2H).
",1,data/dev/US20180008574A1.txt,0
10677,"Example 6: Synthesis of Methyl 2-(N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfamoyl)benzoate
",1,data/dev/US20180008574A1.txt,0
10678,"<img> id-US20180008574A1-20180111-C00023.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10679,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.27 (s, 1H), 8.14 (d, J=8.4 Hz, 1H), 8.01 (d, J=7.2 Hz, 1H), 7.86 (d, J=7.2 Hz, 1H), 7.72-7.49 (m, 3H), 7.41 (t, J=7.6 Hz, 1H), 7.33-7.14 (m, 2H), 6.75 (d, J=7.6 Hz, 1H), 4.12 (s, 3H), 3.92 (q, J=7.2 Hz, 2H), 1.34 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10680,"Example 7: Synthesis of 2-(N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfamoyl)benzoic acid
",1,data/dev/US20180008574A1.txt,0
10681,"<img> id-US20180008574A1-20180111-C00024.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10682,"The synthesis of methyl 2-(N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfamoyl)benzoate can refer Example 6.
",1,data/dev/US20180008574A1.txt,0
10684,"Example 8: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)benzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10685,"<img> id-US20180008574A1-20180111-C00025.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10686,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.00 (d, J=7.2 Hz, 1H), 7.90 (d, J=8.4 Hz, 1H), 7.74 (d, J=7.6 Hz, 2H), 7.60 (t, J=7.6 Hz, 1H), 7.54-7.49 (m, 1H), 7.39 (t, J=7.6 Hz, 2H), 7.21 (d, J=7.6 Hz, 1H), 7.06 (s, 1H), 6.77 (d, J=7.6 Hz, 1H), 3.93 (q, J=7.2 Hz, 2H), 1.34 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10688,"<img> id-US20180008574A1-20180111-C00026.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10689,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.29 (s, 1H), 8.03 (dd, J=16.4, 7.6 Hz, 2H), 7.84-7.63 (m, 3H), 7.33 (t, J=8.8 Hz, 2H), 7.13 (s, 2H), 3.87 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10691,"<img> id-US20180008574A1-20180111-C00027.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10692,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J=7.2 Hz, 1H), 7.91 (d, J=8.4 Hz, 1H), 7.65 (t, J=7.6 Hz, 1H), 7.66-7.45 (m, 2H), 7.38 (dd, J=13.2, 8.0 Hz, 1H), 7.25 (d, J=4.8 Hz, 1H), 7.20 (s, 1H), 6.79 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 1.35 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10694,"<img> id-US20180008574A1-20180111-C00028.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10695,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.22 (d, J=8.4 Hz, 1H), 8.10 (d, J=7.2 Hz, 1H), 7.80 (t, J=7.6 Hz, 1H), 7.54 (d, J=7.6 Hz, 1H), 6.93-6.76 (m, 2H), 3.97 (q, J=7.2 Hz, 2H), 3.16 (q, J=7.2 Hz, 2H), 1.43 (t, J=7.2 Hz, 3H), 1.37 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10696,"Example 12: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-4-methoxybenzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10697,"<img> id-US20180008574A1-20180111-C00029.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10698,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.02 (d, J=7.2 Hz, 1H), 7.95 (d, J=8.4 Hz, 1H), 7.79-7.51 (m, 3H), 7.20 (d, J=7.6 Hz, 1H), 6.89 (s, 1H), 6.84 (d, J=8.8 Hz, 2H), 6.77 (d, J=7.6 Hz, 1H), 3.93 (q, J=7.2 Hz, 2H), 1.35 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10699,"Example 13: Synthesis of 4-cyano-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)benzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10700,"<img> id-US20180008574A1-20180111-C00030.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10701,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.04 (d, J=7.2 Hz, 1H), 7.89 (d, J=8.4 Hz, 1H), 7.85 (d, J=8.4 Hz, 2H), 7.74-7.57 (m, 3H), 7.17 (d, J=7.6 Hz, 1H), 7.11 (s, 1H), 6.79 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 1.35 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10702,"Example 14: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-4-nitrobenzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10703,"<img> id-US20180008574A1-20180111-C00031.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10704,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.25 (d, J=8.8 Hz, 2H), 8.05 (d, J=7.2 Hz, 1H), 7.92 (d, J=9.2 Hz, 3H), 7.67 (t, J=7.6 Hz, 1H), 7.17 (d, J=7.6 Hz, 1H), 6.95 (s, 1H), 6.79 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 1.36 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10705,"Example 15: Synthesis of 4-(tert-butyl)-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)benzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10706,"<img> id-US20180008574A1-20180111-C00032.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10707,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 7.99 (d, J=7.2 Hz, 1H), 7.78 (d, J=8.4 Hz, 1H), 7.63 (d, J=8.4 Hz, 2H), 7.60-7.48 (m, 1H), 7.37 (d, J=8.4 Hz, 2H), 7.28 (s, 1H), 6.80 (d, J=7.6 Hz, 2H), 3.94 (q, J=7.2 Hz, 2H), 1.36 (t, J=7.2 Hz, 3H), 1.27 (s, 9H).
",1,data/dev/US20180008574A1.txt,0
10709,"<img> id-US20180008574A1-20180111-C00033.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10710,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.05 (d, J=7.2 Hz, 1H), 7.86 (d, J=8.4 Hz, 1H), 7.79 (d, J=8.8 Hz, 2H), 7.71-7.53 (m, 1H), 7.23 (d, J=7.6 Hz, 3H), 6.87 (s, 1H), 6.82 (d, J=7.6 Hz, 1H), 3.97 (q, J=7.2 Hz, 2H), 1.38 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10712,"<img> id-US20180008574A1-20180111-C00034.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10713,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.82 (s, 1H), 8.12 (d, J=8.4 Hz, 1H), 8.03 (d, J=6.8 Hz, 1H), 7.82 (dd, J=17.6, 10.0 Hz, 1H), 7.76 (d, J=7.2 Hz, 1H), 7.59 (t, J=7.2 Hz, 1H), 7.28 (t, J=8.0 Hz, 1H), 7.22 (d, J=7.6 Hz, 1H), 7.13 (d, J=7.6 Hz, 1H), 3.87 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10715,"<img> id-US20180008574A1-20180111-C00035.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10716,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.02 (d, J=7.2 Hz, 1H), 7.93 (d, J=8.4 Hz, 1H), 7.63 (t, J=8.4 Hz, 3H), 7.19 (dd, J=7.6, 5.2 Hz, 3H), 6.85 (s, 1H), 6.77 (d, J=7.6 Hz, 1H), 3.93 (q, J=7.2 Hz, 2H), 2.36 (s, 3H), 1.35 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10717,"Example 19: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-2,4-difluorobenzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10718,"<img> id-US20180008574A1-20180111-C00036.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10719,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.14 (d, J=8.4 Hz, 1H), 8.05 (d, J=7.2 Hz, 1H), 7.75-7.70 (m, 2H), 7.23 (d, J=7.6 Hz, 1H), 7.07 (s, 1H), 7.01-6.91 (m, 1H), 6.87 (dd, J=11.6, 5.2 Hz, 1H), 6.75 (d, J=7.6 Hz, 1H), 3.92 (q, J=7.2 Hz, 2H), 1.33 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10720,"Example 20: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)propane-1-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10721,"<img> id-US20180008574A1-20180111-C00037.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10722,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.22 (d, J=8.0 Hz, 1H), 8.09 (d, J=6.8 Hz, 1H), 7.79 (t, J=7.2 Hz, 1H), 7.53 (d, J=7.2 Hz, 1H), 6.99 (s, 1H), 6.88 (d, J=7.2 Hz, 1H), 3.97 (q, J=7.2 Hz, 2H), 3.30-2.79 (m, 2H), 1.91 (dd, J=14.8, 7.2 Hz, 2H), 1.37 (t, J=6.8 Hz, 3H), 1.02 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10724,"<img> id-US20180008574A1-20180111-C00038.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10725,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.25 (d, J=8.0 Hz, 1H), 8.08 (d, J=6.8 Hz, 1H), 7.77 (t, J=7.2 Hz, 1H), 7.58 (d, J=7.2 Hz, 1H), 7.16 (s, 1H), 6.86 (d, J=7.2 Hz, 1H), 3.96 (q, J=7.2 Hz, 2H), 3.51-3.46 (m, 1H), 2.13-2.03 (m, 4H), 1.95-1.78 (m, 4H), 1.36 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10727,"<img> id-US20180008574A1-20180111-C00039.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10728,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.04 (d, J=6.8 Hz, 1H), 7.96-7.73 (m, 3H), 7.68-7.62 (m, 3H), 7.18 (d, J=7.6 Hz, 1H), 6.88 (s, 1H), 6.79 (d, J=7.2 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 1.36 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10729,"Example 23: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-3-(methylsulfonyl)benzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10730,"<img> id-US20180008574A1-20180111-C00040.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10731,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.49 (s, 1H), 8.14 (d, J=9.6 Hz, 2H), 8.00 (d, J=7.2 Hz, 2H), 7.93 (d, J=7.6 Hz, 1H), 7.77 (t, J=7.6 Hz, 1H), 7.69 (t, J=7.6 Hz, 1H), 7.13 (s, 2H), 3.87 (d, J=7.2 Hz, 2H), 3.17 (s, 3H), 1.23 (t, J=6.8 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10732,"Example 24: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)naphthalene-1-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10733,"<img> id-US20180008574A1-20180111-C00041.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10734,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.61 (s, 1H), 8.80 (d, J=8.4 Hz, 1H), 8.15 (d, J=8.0 Hz, 1H), 8.04 (d, J=7.6 Hz, 1H), 7.98 (d, J=7.2 Hz, 1H), 7.92 (t, J=7.6 Hz, 2H), 7.72-7.65 (m, 2H), 7.53-7.49 (m, 2H), 7.09 (d, J=7.6 Hz, 1H), 7.02 (d, J=7.6 Hz, 1H), 3.82 (q, J=7.2 Hz, 2H), 1.18 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10735,"Example 25: Synthesis of Methyl 4-(N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfamoyl)benzoate
",1,data/dev/US20180008574A1.txt,0
10736,"<img> id-US20180008574A1-20180111-C00042.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10737,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.46 (s, 1H), 8.04 (d, J=8.4 Hz, 3H), 8.00 (d, J=7.2 Hz, 1H), 7.80 (d, J=8.4 Hz, 2H), 7.70 (t, J=7.6 Hz, 1H), 7.11 (s, 2H), 3.87 (q, J=7.2 Hz, 5H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10739,"<img> id-US20180008574A1-20180111-C00043.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10740,"The synthesis can refer to Example 7. 1H NMR (400 MHz, d-DMSO) δ 13.41 (s, 1H), 10.44 (s, 1H), 8.17-7.92 (m, 4H), 7.77 (d, J=8.0 Hz, 2H), 7.70 (t, J=7.6 Hz, 1H), 7.11 (s, 2H), 3.86 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10742,"<img> id-US20180008574A1-20180111-C00044.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10743,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.43 (s, 1H), 8.22 (s, 1H), 8.12 (d, J=7.6 Hz, 1H), 8.04-7.98 (m, 2H), 7.86 (d, J=7.6 Hz, 1H), 7.70-7.61 (m, 2H), 7.11 (s, 2H), 3.93-3.77 (m, 5H), 1.22 (t, J=7.1 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10744,"Example 28: Synthesis of 3-(N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfamoyl)benzoic acid
",1,data/dev/US20180008574A1.txt,0
10745,"<img> id-US20180008574A1-20180111-C00045.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10746,"The synthesis can refer to Example 7. 1H NMR (400 MHz, d-DMSO) δ 13.27 (s, 1H), 10.39 (s, 1H), 8.21 (s, 1H), 8.10 (d, J=7.6 Hz, 1H), 8.01-7.98 (m, 2H), 7.84 (d, J=7.6 Hz, 1H), 7.68 (t, J=7.6 Hz, 1H), 7.61 (t, J=7.6 Hz, 1H), 7.11 (s, 2H), 3.86 (q, J=7.2 Hz, 2H), 1.22 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10747,"Example 29: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10748,"<img> id-US20180008574A1-20180111-C00046.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10749,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.14 (s, 1H), 8.10 (d, J=8.4 Hz, 1H), 8.01 (d, J=6.8 Hz, 1H), 7.73 (t, J=7.6 Hz, 1H), 7.26-7.00 (m, 4H), 6.91 (d, J=8.4 Hz, 1H), 4.25 (d, J=9.2 Hz, 4H), 3.87 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10751,"<img> id-US20180008574A1-20180111-C00047.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10752,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.26 (d, J=8.4 Hz, 1H), 8.05 (d, J=7.2 Hz, 1H), 7.87 (d, J=7.6 Hz, 1H), 7.80 (d, J=7.6 Hz, 1H), 7.73 (t, J=7.6 Hz, 1H), 7.40 (t, J=7.6 Hz, 1H), 7.36-7.28 (m, 2H), 7.11 (d, J=7.6 Hz, 1H), 6.69 (d, J=7.6 Hz, 1H), 3.90 (q, J=7.2 Hz, 2H), 1.31 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10753,"Example 31: Synthesis of 5-bromo-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-2-methoxybenzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10754,"<img> id-US20180008574A1-20180111-C00048.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10755,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.29 (s, 1H), 8.24 (d, J=8.4 Hz, 1H), 8.02 (d, J=6.8 Hz, 1H), 7.79 (t, J=7.6 Hz, 1H), 7.71 (d, J=8.8 Hz, 1H), 7.61 (s, 1H), 7.24 (d, J=7.6 Hz, 1H), 7.15 (d, J=8.8 Hz, 1H), 7.10 (d, J=7.6 Hz, 1H), 3.98-3.57 (m, 5H), 1.22 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10756,"Example 32: Synthesis of 2,6-dichloro-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)benzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10757,"<img> id-US20180008574A1-20180111-C00049.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10758,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.17 (d, J=8.0 Hz, 1H), 8.05 (d, J=7.2 Hz, 1H), 7.73 (t, J=7.6 Hz, 1H), 7.50 (s, 1H), 7.45 (d, J=8.0 Hz, 2H), 7.38-7.29 (m, 1H), 7.22 (d, J=7.6 Hz, 1H), 6.74 (d, J=7.6 Hz, 1H), 3.92 (q, J=7.2 Hz, 2H), 1.33 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10759,"Example 33: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-2,5-dimethoxybenzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10760,"<img> id-US20180008574A1-20180111-C00050.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10761,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.23 (d, J=8.4 Hz, 1H), 8.04 (d, J=7.2 Hz, 1H), 7.72 (t, J=7.6 Hz, 1H), 7.27 (d, J=4.4 Hz, 1H), 7.22 (s, 1H), 7.11 (d, J=7.6 Hz, 1H), 7.02 (s, 2H), 6.70 (d, J=7.6 Hz, 1H), 4.07 (s, 3H), 3.90 (q, J=7.2 Hz, 2H), 3.67 (s, 3H), 1.31 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10762,"Example 34: Synthesis of 3,5-dichloro-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)benzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10763,"<img> id-US20180008574A1-20180111-C00051.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10764,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.52 (s, 1H), 8.05 (t, J=8.0 Hz, 2H), 7.93 (s, 1H), 7.76 (t, J=7.6 Hz, 1H), 7.60 (s, 2H), 7.29-6.97 (m, 2H), 3.88 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10765,"Example 35: Synthesis of 2,3-dichloro-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)benzenesulfonamide
",1,data/dev/US20180008574A1.txt,0
10766,"<img> id-US20180008574A1-20180111-C00052.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10767,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.77 (s, 1H), 8.24 (d, J=8.0 Hz, 1H), 8.03 (d, J=6.8 Hz, 1H), 7.89 (d, J=8.0 Hz, 1H), 7.80 (dd, J=7.6, 4.0 Hz, 2H), 7.42 (t, J=8.0 Hz, 1H), 7.18 (d, J=7.6 Hz, 1H), 7.09 (d, J=7.6 Hz, 1H), 3.85 (q, J=7.2 Hz, 2H), 1.21 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10768,"Example 36: Synthesis of methyl4-((N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfamoyl)methyl)benzoate
",1,data/dev/US20180008574A1.txt,0
10769,"<img> id-US20180008574A1-20180111-C00053.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10770,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.10 (d, J=6.8 Hz, 1H), 7.95 (t, J=8.4 Hz, 3H), 7.74 (t, J=7.6 Hz, 1H), 7.52 (d, J=7.6 Hz, 1H), 7.36 (d, J=8.0 Hz, 2H), 6.87 (d, J=7.6 Hz, 1H), 6.82 (s, 1H), 4.43 (s, 2H), 3.97 (q, J=7.2 Hz, 2H), 3.91 (s, 3H), 1.38 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10771,"Example 37: Synthesis of 4-((N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfamoyl)methyl)benzoic acid
",1,data/dev/US20180008574A1.txt,0
10772,"<img> id-US20180008574A1-20180111-C00054.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10773,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 12.92 (s, 1H), 9.96 (s, 1H), 8.31 (d, J=8.4 Hz, 1H), 8.08 (d, J=6.8 Hz, 1H), 7.86-7.80 (m, 3H), 7.48 (d, J=7.6 Hz, 1H), 7.43 (d, J=8.0 Hz, 2H), 7.19 (d, J=7.6 Hz, 1H), 4.59 (s, 2H), 3.92 (q, J=6.8 Hz, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10775,"<img> id-US20180008574A1-20180111-C00055.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10776,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.10 (d, J=7.2 Hz, 1H), 7.96 (d, J=8.4 Hz, 1H), 7.74 (t, J=7.6 Hz, 1H), 7.52 (d, J=7.6 Hz, 1H), 7.32-7.13 (m, 2H), 7.04 (t, J=10.4 Hz, 3H), 6.91-6.66 (m, 2H), 4.37 (s, 2H), 3.98 (q, J=7.2 Hz, 2H), 1.38 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10777,"Example 39: Synthesis of methyl3-((N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfamoyl)methyl)benzoate
",1,data/dev/US20180008574A1.txt,0
10778,"<img> id-US20180008574A1-20180111-C00056.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10779,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 9.94 (s, 1H), 8.27 (d, J=8.4 Hz, 1H), 8.07 (d, J=6.8 Hz, 1H), 7.88 (d, J=7.8 Hz, 1H), 7.86-7.82 (m, 2H), 7.60 (d, J=7.6 Hz, 1H), 7.51-7.35 (m, 2H), 7.17 (d, J=7.6 Hz, 1H), 4.61 (s, 2H), 3.92 (d, J=7.2 Hz, 2H), 3.79 (s, 3H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10780,"Example 40: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-1-(4-(trifluoromethyl)phenyl)methanesulfonamide
",1,data/dev/US20180008574A1.txt,0
10781,"<img> id-US20180008574A1-20180111-C00057.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10782,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.09 (d, J=6.8 Hz, 1H), 7.97 (d, J=8.0 Hz, 1H), 7.73 (t, J=7.6 Hz, 1H), 7.51 (t, J=6.4 Hz, 3H), 7.40 (d, J=7.6 Hz, 2H), 6.94 (s, 1H), 6.86 (d, J=7.6 Hz, 1H), 4.44 (s, 2H), 3.97 (q, J=7.2 Hz, 2H), 1.38 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10783,"Example 41: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-1-(p-tolyl)methanesulfonamide
",1,data/dev/US20180008574A1.txt,0
10784,"<img> id-US20180008574A1-20180111-C00058.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10785,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 9.84 (s, 1H), 8.32 (d, J=8.4 Hz, 1H), 8.07 (d, J=6.8 Hz, 1H), 7.82 (t, J=7.6 Hz, 1H), 7.47 (d, J=7.6 Hz, 1H), 7.20-7.18 (m, 3H), 7.11 (d, J=7.6 Hz, 2H), 4.42 (s, 2H), 3.92 (q, J=7.2 Hz, 2H), 2.28 (s, 3H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10787,"<img> id-US20180008574A1-20180111-C00059.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10788,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 10.03 (s, 1H), 8.34 (d, J=8.4 Hz, 1H), 8.08 (d, J=6.8 Hz, 1H), 7.84 (t, J=7.6 Hz, 1H), 7.50 (d, J=7.6 Hz, 1H), 7.41 (t, J=7.2 Hz, 2H), 7.20-7.16 (m, 3H), 4.53 (s, 2H), 3.93 (q, J=7.2 Hz, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10789,"Example 43: Synthesis of 1-(4-chlorophenyl)-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)methanesulfonamide
",1,data/dev/US20180008574A1.txt,0
10790,"<img> id-US20180008574A1-20180111-C00060.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10791,"The synthesis can refer to Example 1. 1H NMR (400 MHz, d-DMSO) δ 9.92 (s, 1H), 8.31 (d, J=8.4 Hz, 1H), 8.07 (d, J=6.8 Hz, 1H), 7.83 (t, J=7.6 Hz, 1H), 7.48 (d, J=7.6 Hz, 1H), 7.35 (q, J=8.4 Hz, 4H), 7.18 (d, J=7.6 Hz, 1H), 4.51 (s, 2H), 3.92 (q, J=7.2 Hz, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10792,"Example 44: Synthesis of 1-(4-cyanophenyl)-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)methanesulfonamide
",1,data/dev/US20180008574A1.txt,0
10793,"<img> id-US20180008574A1-20180111-C00061.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10794,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 10.01 (s, 1H), 8.29 (d, J=8.0 Hz, 1H), 8.08 (d, J=6.8 Hz, 1H), 7.83 (t, J=7.6 Hz, 1H), 7.78 (d, J=8.0 Hz, 2H), 7.52-7.46 (m, 3H), 7.19 (d, J=7.6 Hz, 1H), 4.64 (s, 2H), 3.92 (q, J=6.8 Hz, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10796,"<img> id-US20180008574A1-20180111-C00062.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10797,"The synthesis can refer to Example 1. 1H NMR (400 MHz, CDCl3) δ 8.10 (d, J=7.2 Hz, 1H), 7.96 (d, J=8.4 Hz, 1H), 7.84-7.68 (m, 1H), 7.51 (d, J=7.6 Hz, 1H), 7.25 (d, J=9.2 Hz, 1H), 6.98 (t, J=8.4 Hz, 2H), 6.87 (d, J=7.6 Hz, 1H), 6.71 (s, 1H), 4.36 (s, 2H), 3.98 (q, J=7.2 Hz, 2H), 1.39 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10800,"<img> id-US20180008574A1-20180111-C00063.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10801,"6-amino-1-ethylbenzo[cd]indol-2(1H)-one can refer to Example 1.
",1,data/dev/US20180008574A1.txt,0
10803,"Example 47: Synthesis of 2-(4-chlorophenyl)-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)acetamide
",1,data/dev/US20180008574A1.txt,0
10804,"<img> id-US20180008574A1-20180111-C00064.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10805,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 10.23 (s, 1H), 8.28 (d, J=8.0 Hz, 1H), 8.06 (d, J=6.8 Hz, 1H), 7.83 (t, J=7.6 Hz, 1H), 7.76 (d, J=7.6 Hz, 1H), 7.61-7.26 (m, 4H), 7.16 (d, J=7.6 Hz, 1H), 3.90 (q, J=7.2 Hz, 2H), 3.82 (s, 2H), 1.25 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10807,"<img> id-US20180008574A1-20180111-C00065.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10808,"The synthesis can refer to Example 46. 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J=6.8 Hz, 1H), 7.87 (d, J=7.6 Hz, 1H), 7.62 (t, J=7.6 Hz, 1H), 7.55 (s, 1H), 7.50 (d, J=8.0 Hz, 1H), 6.98-6.94 (m, 3H), 6.85 (d, J=7.6 Hz, 1H), 3.96-3.92 (m, 8H), 3.82 (s, 2H), 1.34 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10810,"<img> id-US20180008574A1-20180111-C00066.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10811,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 10.29 (s, 1H), 8.33 (d, J=8.0 Hz, 1H), 8.07 (d, J=6.8 Hz, 1H), 7.84 (t, J=7.6 Hz, 1H), 7.74 (d, J=7.6 Hz, 1H), 7.63 (s, 1H), 7.52 (d, J=8.4 Hz, 1H), 7.43 (d, J=8.4 Hz, 1H), 7.17 (d, J=7.6 Hz, 1H), 4.01 (s, 2H), 3.91 (q, J=7.2 Hz, 2H), 1.26 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10812,"Example 50: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-3-phenylpropanamide
",1,data/dev/US20180008574A1.txt,0
10813,"<img> id-US20180008574A1-20180111-C00067.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10814,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 9.95 (s, 1H), 8.11 (d, J=8.4 Hz, 1H), 8.05 (d, J=7.2 Hz, 1H), 7.86-7.73 (m, 1H), 7.71 (d, J=7.6 Hz, 1H), 7.31 (d, J=4.0 Hz, 3H), 7.23 (s, 1H), 7.16 (d, J=7.6 Hz, 1H), 3.91 (q, J=7.2 Hz, 2H), 2.98 (t, J=7.6 Hz, 2H), 2.79 (t, J=7.6 Hz, 2H), 1.26 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10815,"Example 51: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-4,4,4-trifluorobutanamide
",1,data/dev/US20180008574A1.txt,0
10816,"<img> id-US20180008574A1-20180111-C00068.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10817,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 10.14 (s, 1H), 8.32 (d, J=8.4 Hz, 1H), 8.07 (d, J=6.8 Hz, 1H), 7.83 (t, J=7.6 Hz, 1H), 7.77 (d, J=7.6 Hz, 1H), 7.18 (d, J=7.6 Hz, 1H), 3.91 (q, J=7.2 Hz, 2H), 2.88-2.71 (m, 2H), 2.71-2.51 (m, 2H), 1.26 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10818,"Example 52: Synthesis of N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)propionamide
",1,data/dev/US20180008574A1.txt,0
10819,"<img> id-US20180008574A1-20180111-C00069.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10820,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 9.92 (s, 1H), 8.30 (d, J=8.4 Hz, 1H), 8.06 (d, J=6.8 Hz, 1H), 7.89-7.62 (m, 2H), 7.16 (d, J=7.6 Hz, 1H), 3.91 (q, J=7.2 Hz, 2H), 2.46 (q, J=7.6 Hz, 2H), 1.26 (t, J=7.2 Hz, 3H), 1.16 (t, J=7.6 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10821,"Example 53: Synthesis of 4-chloro-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)benzamide
",1,data/dev/US20180008574A1.txt,0
10822,"<img> id-US20180008574A1-20180111-C00070.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10823,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 10.55 (s, 1H), 8.20 (d, J=8.0 Hz, 1H), 8.09 (t, J=8.8 Hz, 3H), 7.81 (t, J=7.6 Hz, 1H), 7.65 (d, J=8.4 Hz, 3H), 7.23 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 1.29 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10825,"<img> id-US20180008574A1-20180111-C00071.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10826,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) d 10.19 (s, 1H), 8.27 (d, J=8.0 Hz, 1H), 8.06 (d, J=6.8 Hz, 1H), 7.82 (t, J=7.6 Hz, 1H), 7.75 (d, J=7.6 Hz, 1H), 7.30 (d, J=7.6 Hz, 2H), 7.16 (d, J=7.6 Hz, 3H), 3.90 (q, J=7.2 Hz, 2H), 3.75 (s, 2H), 2.29 (s, 3H), 1.25 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10827,"Example 55: Synthesis of (E)-N-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)-3-(furan-2-yl)acrylamide
",1,data/dev/US20180008574A1.txt,0
10828,"<img> id-US20180008574A1-20180111-C00072.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10829,"The synthesis can refer to Example 46. 1H NMR (400 MHz, d-DMSO) δ 10.24 (s, 1H), 8.43 (d, J=8.0 Hz, 1H), 8.07 (t, J=7.6 Hz, 2H), 7.84 (d, J=11.2 Hz, 2H), 7.45 (d, J=11.2 Hz, 1H), 7.20 (d, J=7.6 Hz, 1H), 7.04-6.75 (m, 2H), 6.64 (s, 1H), 3.92 (q, J=6.8 Hz, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10831,"Example 56: Synthesis of I-ethyl-6-((3-phenylpropyl)amino)benzo[cd]indol-2(1H)-one
",1,data/dev/US20180008574A1.txt,0
10832,"<img> id-US20180008574A1-20180111-C00073.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10833,"6-amino-1-ethylbenzo[cd]indol-2(1H)-one can refer to Example 1.
",1,data/dev/US20180008574A1.txt,0
10835,"Example 56: Synthesis of 1-ethyl-6-((3-morpholinopropyl)amino)benzo[cd]indol-2(1H)-one
",1,data/dev/US20180008574A1.txt,0
10836,"<img> id-US20180008574A1-20180111-C00074.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10837,"The synthesis can refer to Example 56. 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J=7.6 Hz, 2H), 7.66 (t, J=7.6 Hz, 1H), 6.79 (d, J=7.6 Hz, 1H), 6.35 (d, J=7.6 Hz, 1H), 5.81 (s, 1H), 3.95 (q, J=7.2 Hz, 2H), 3.82 (t, J=4.4 Hz, 4H), 3.35 (t, J=6.0 Hz, 2H), 2.60-2.54 (m, 6H), 2.02-1.87 (m, 2H), 1.36 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10838,"Example 58: Synthesis of 1-ethyl-6-((4-methoxybenzyl)amino)benzo[cd]indol-2(1H)-one
",1,data/dev/US20180008574A1.txt,0
10839,"<img> id-US20180008574A1-20180111-C00075.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10840,"The synthesis can refer to Example 56. 1H NMR (400 MHz, d-DMSO) δ 8.51 (d, J=8.0 Hz, 1H), 7.98 (d, J=7.2 Hz, 1H), 7.71 (t, J=7.6 Hz, 1H), 7.33 (d, J=8.4 Hz, 2H), 7.05 (s, 1H), 6.88 (d, J=8.4 Hz, 3H), 6.21 (d, J=7.6 Hz, 1H), 4.40 (d, J=4.4 Hz, 2H), 3.82 (q, J=7.2 Hz, 2H), 3.70 (d, J=8.8 Hz, 3H), 1.20 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10841,"Example 59: Synthesis of 1-ethyl-6-((4-methylbenzyl)amino)benzo[cd]indol-2(1H)-one
",1,data/dev/US20180008574A1.txt,0
10842,"<img> id-US20180008574A1-20180111-C00076.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10843,"The synthesis can refer to Example 56. 1H NMR (400 MHz, d-DMSO) δ 8.52 (d, J=8.0 Hz, 1H), 7.99 (d, J=6.8 Hz, 1H), 7.71 (t, J=7.6 Hz, 1H), 7.29 (d, J=7.6 Hz, 2H), 7.12 (d, J=7.6 Hz, 3H), 6.87 (d, J=7.6 Hz, 1H), 6.17 (d, J=7.6 Hz, 1H), 4.42 (s, 2H), 3.81 (q, J=7.2 Hz, 2H), 2.26 (s, 3H), 1.20 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10844,"Example 60: Synthesis of 1-ethyl-6-((4-(trifluoromethyl)benzyl)amino)benzo[cd]indol-2(1H)-one
",1,data/dev/US20180008574A1.txt,0
10845,"<img> id-US20180008574A1-20180111-C00077.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10846,"The synthesis can refer to Example 56. 1H NMR (400 MHz, d-DMSO) δ 8.52 (d, J=8.0 Hz, 1H), 8.00 (d, J=6.8 Hz, 1H), 7.74 (t, J=7.6 Hz, 1H), 7.69 (d, J=8.0 Hz, 2H), 7.63 (d, J=8.0 Hz, 2H), 7.26 (s, 1H), 6.87 (d, J=7.6 Hz, 1H), 6.14 (d, J=7.6 Hz, 1H), 4.58 (d, J=5.2 Hz, 2H), 3.81 (q, J=7.2 Hz, 2H), 1.20 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10847,"Example 61: Synthesis of 6-((4-chlorobenzyl)amino)-1-ethylbenzo[cd]indol-2(1H)-one
",1,data/dev/US20180008574A1.txt,0
10848,"<img> id-US20180008574A1-20180111-C00078.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10849,"The synthesis can refer to Example 56. 1H NMR (400 MHz, d-DMSO) δ 8.51 (d, J=8.4 Hz, 1H), 8.00 (d, J=6.8 Hz, 1H), 7.73 (t, J=7.6 Hz, 1H), 7.43 (d, J=8.4 Hz, 2H), 7.37 (d, J=8.4 Hz, 2H), 7.18 (t, J=6.0 Hz, 1H), 6.88 (d, J=7.6 Hz, 1H), 6.15 (d, J=7.6 Hz, 1H), 4.47 (d, J=6.0 Hz, 2H), 3.82 (q, J=7.2 Hz, 2H), 1.20 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10851,"<img> id-US20180008574A1-20180111-C00079.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10852,"The synthesis can refer to Example 56. 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J=7.2 Hz, 1H), 8.00 (d, J=8.2 Hz, 1H), 7.66 (t, J=7.6 Hz, 1H), 7.41 (dd, J=8.4, 5.6 Hz, 2H), 7.06 (t, J=8.4 Hz, 2H), 6.75 (d, J=7.6 Hz, 1H), 6.38 (d, J=7.6 Hz, 1H), 4.66 (s, 1H), 4.45 (s, 2H), 3.94 (q, J=7.2 Hz, 2H), 1.35 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10858,"<img> id-US20180008574A1-20180111-C00081.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10861,"Example 64: Synthesis of N-(1-acetylcyclohexyl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10862,"<img> id-US20180008574A1-20180111-C00082.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10863,"The synthesis can refer to Example 63. 1H-NMR (400 MHz, d-DMSO) d 8.58 (d, J=8.4 Hz, 1H), 8.15 (d, J=7.2 Hz, 1H), 8.09 (d, J=7.6 Hz, 1H), 7.96 (t, J=8.0 Hz, 1H), 7.31 (d, J=7.6 Hz, 1H), 3.92 (q, J=6.8 Hz, 2H), 3.26-3.21 (m, 4H), 1.25 (t, J=7.2 Hz, 3H), 1.01-0.98 (m, 6H). MS (ESI), m/z: M− 400.8.
",1,data/dev/US20180008574A1.txt,0
10864,"Example 65: Synthesis of 1-ethyl-N-((3-isopropyl-4,5-dihydroisoxazol-5-yl)methyl)-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10865,"<img> id-US20180008574A1-20180111-C00083.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10866,"The synthesis can refer to Example 63. 1H-NMR (400 MHz, d-DMSO) δ 8.70 (d, J=8.0 Hz, 1H), 8.14-8.09 (m, 2H), 8.06 (d, J=7.6 Hz, 1H), 7.94 (t, J=7.6 Hz, 1H), 7.29 (d, J=7.2 Hz, 1H), 4.43-4.39 (m, 1H), 3.93 (q, J=6.8 Hz, 2H), 2.84-2.83 (m, 2H), 2.48 (s, 3H), 1.26 (t, J=6.8 Hz, 1H), 0.98 (s, 6H). MS (ESI), m/z: M− 400.0.
",1,data/dev/US20180008574A1.txt,0
10867,"Example 66: Synthesis of N-((3,5-dimethyl-4,5-dihydroisoxazol-5-yl)methyl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10868,"<img> id-US20180008574A1-20180111-C00084.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10869,"The synthesis can refer to Example 63. 1H-NMR (400 MHz, d-DMSO) δ 8.72 (d, J=8.4 Hz, 1H), 8.15-8.10 (m, 2H), 8.07 (d, J=7.6 Hz, 1H), 7.94 (t, J=7.2 Hz, 1H), 7.30 (d, J=7.6 Hz, 1H), 3.93 (q, J=7.2 Hz, 2H), 2.85-2.82 (m, 3H), 2.58 (s, 1H), 1.75 (s, 3H), 1.27-1.22 (m, 4H), 1.17 (s, 2H). MS (ESI), m/z: M− 386.0.
",1,data/dev/US20180008574A1.txt,0
10870,"Example 67: Synthesis of N-(4-acetylphenyl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10871,"<img> id-US20180008574A1-20180111-C00085.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10872,"The synthesis of 1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonyl chloride can refer to Example 63.
",1,data/dev/US20180008574A1.txt,0
10874,"Example 68: Synthesis of N-(2-chlorobenzyl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10875,"<img> id-US20180008574A1-20180111-C00086.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10876,"The synthesis can refer to Example 63. 1H-NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.0 Hz, 1H), 8.13 (d, J=7.2 Hz, 1H), 8.04 (d, J=7.6 Hz, 1H), 7.92 (t, J=7.2 Hz, 1H), 7.27-7.29 (m, 3H), 7.12-7.02 (m, 2H), 4.12 (s, 2H), 3.93 (q, J=7.2 Hz, 1H), 1.27 (t, J=7.2 Hz, 3H). MS (ESI), m/z: M− 399.0.
",1,data/dev/US20180008574A1.txt,0
10878,"<img> id-US20180008574A1-20180111-C00087.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10879,"The synthesis can refer to Example 63. 1H-NMR (400 MHz, d-DMSO) δ 8.64 (d, J=8.4 Hz, 1H), 8.41 (s, 1H), 8.12 (d, J=6.8 Hz, 1H), 8.03 (d, J=8.0 Hz, 1H), 7.91 (t, J=7.2 Hz, 1H), 7.21 (d, J=7.6 Hz, 1H), 7.15 (t, J=8.0 Hz, H), 7.07-7.05 (m, 1H), 7.91-7.83 (m, 2H), 4.06 (s, 2H), 3.92 (q, J=7.2 Hz, 2H), 1.29 (t, J=7.2 Hz, 3H). MS (ESI), m/z: M− 383.0.
",1,data/dev/US20180008574A1.txt,0
10880,"Example 70: Synthesis of N-(1-acetylpiperidin-4-yl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10881,"<img> id-US20180008574A1-20180111-C00088.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10882,"The synthesis can refer to Example 63. 1H-NMR (400 MHz, d-DMSO) δ 8.70 (d, J=8.4 Hz, 1H), 8.16-8.11 (m, 2H), 8.02 (d, J=7.6 Hz, 1H), 7.94 (q, J=7.2 Hz, 1H), 7.30 (d, J=8.0 Hz, 1H), 4.01 (q, J=6.8 Hz, 1H), 3.93 (q, J=7.2 Hz, 2H), 3.58 (d, J=14.0 Hz, 1H), 3.33-3.19 (m, 1H), 2.97-2.90 (m, 1H), 2.62-2.55 (m, 1H), 1.88 (s, 3H), 1.49 (d, J=10.0 Hz, 2H), 1.28 (t, J=7.2 Hz, 3H), 1.27-1.22 (m, 2H). MS (ESI), m/z: M+ 402.1; M− 400.1.
",1,data/dev/US20180008574A1.txt,0
10883,"Example 71: Synthesis of tert-butyl4-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)piperidine-1-carboxylate
",1,data/dev/US20180008574A1.txt,0
10884,"<img> id-US20180008574A1-20180111-C00089.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10885,"The synthesis can refer to Example 63. 1H-NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.4 Hz, 1H), 8.15-8.10 (m, 2H), 7.98-7.92 (m, 2H), 7.29 (d, J=7.6 Hz, 1H), 3.93 (d, J=7.2 Hz, 2H), 3.67-3.64 (m, 2H), 3.18 (s, 1H), 2.69 (s, 2H), 1.47-1.44 (m, 2H), 1.32 (s, 9H), 1.32-1.25 (m, 3H), 1.17-1.51 (m, 2H). MS (ESI), m/z: M 458.0.
",1,data/dev/US20180008574A1.txt,0
10886,"Example 72: Synthesis of N-cyclopentyl-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10887,"<img> id-US20180008574A1-20180111-C00090.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10888,"The synthesis can refer to Example 63. 1H-NMR (400 MHz, d-DMSO) δ 8.72 (d, J=8.4 Hz, 1H), 8.14 (d, J=6.8 Hz, 1H), 8.09 (d, J=7.6 Hz, H), 7.95 (t, J=7.6 Hz, 1H), 7.80 (d, J=7.2 Hz, 1H), 7.26 (d, J=7.6 Hz, 1H), 3.95 (q, J=7.2 Hz, 2H), 3.44 (q, J=6.4 Hz, 1H), 1.51-1.46 (m, 4H), 1.28-1.22 (m, 7H). MS (ESI), m/z: M 343.0.
",1,data/dev/US20180008574A1.txt,0
10889,"Example 73: Synthesis of ethyl 1-((1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)methyl)cyclopentanecarboxylate
",1,data/dev/US20180008574A1.txt,0
10890,"<img> id-US20180008574A1-20180111-C00091.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10891,"The synthesis can refer to Example 63. 1H-NMR (400 MHz, d-DMSO) δ 8.63 (d, J=8.4 Hz, 1H), 8.17 (d, J=7.6 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 7.86 (t, J=8.0 Hz, 1H), 6.93 (d, J=7.6 Hz, 1H), 5.36 (t, J=6.8 Hz, 1H), 4.04-3.96 (m, 4H), 2.92 (d, J=7.2 Hz, 2H), 1.93-1.89 (m, 2H), 1.71 (s, 2H), 1.58-1.54 (m, 6H), 1.39 (t, J=7.2 Hz, 3H), 1.16 (t, J=7.2 Hz, 3H). MS (ESI), m/z: M− 429.0.
",1,data/dev/US20180008574A1.txt,0
10892,"Example 74: Synthesis of 1-((1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)methyl)cyclopentanecarboxylic acid
",1,data/dev/US20180008574A1.txt,0
10893,"<img> id-US20180008574A1-20180111-C00092.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10894,"The synthesis of ethyl 1-((1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)meth yl)cyclopentanecarboxylate can refer to Example 73.
",1,data/dev/US20180008574A1.txt,0
10897,"<img> id-US20180008574A1-20180111-C00093.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10898,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 10.33 (s, 1H), 9.79 (s, 1H), 8.68 (d, J=8.0 Hz, 1H), 8.10 (dd, J=14.4, 6.8 Hz, 2H), 7.92 (t, J=7.2 Hz, 1H), 7.34 (d, J=7.6 Hz, 2H), 7.23 (d, J=7.6 Hz, 1H), 6.94 (d, J=7.6 Hz, 2H), 3.88 (d, J=6.8 Hz, 2H), 1.95 (s, 3H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10899,"Example 76: Synthesis of 2-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)benzoic acid
",1,data/dev/US20180008574A1.txt,0
10900,"<img> id-US20180008574A1-20180111-C00094.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10901,"The synthesis can refer to Example 74. 1H NMR (400 MHz, d-DMSO) δ 11.96 (s, 1H), 8.52 (d, J=8.4 Hz, 1H), 8.26 (d, J=7.6 Hz, 1H), 8.13 (d, J=7.2 Hz, 1H), 8.02-7.84 (m, 1H), 7.80 (d, J=7.2 Hz, 1H), 7.63-7.41 (m, 2H), 7.28 (d, J=7.6 Hz, 1H), 7.02 (t, J=7.6 Hz, 1H), 3.89 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10903,"<img> id-US20180008574A1-20180111-C00095.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10904,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 10.48 (s, 1H), 8.64 (d, J=8.4 Hz, 1H), 8.13-8.07 (m, 2H), 8.00-7.79 (m, 1H), 7.25 (d, J=7.6 Hz, 1H), 7.17-6.83 (m, 4H), 3.89 (q, J=7.2 Hz, 2H), 1.25 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10905,"Example 78: Synthesis of N-butyl-1-ethyl-2-oxo-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10906,"<img> id-US20180008574A1-20180111-C00096.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10907,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.69 (d, J=8.4 Hz, 1H), 8.15 (d, J=7.2 Hz, 1H), 8.08 (d, J=7.6 Hz, 1H), 8.01-7.85 (m, 1H), 7.77 (t, J=6.0 Hz, 1H), 7.31 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 2.75 (dd, J=13.2, 6.8 Hz, 2H), 1.35-1.21 (m, 5H), 1.19-1.12 (m, 2H), 0.70 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10909,"<img> id-US20180008574A1-20180111-C00097.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10910,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.65 (d, J=8.2 Hz, 1H), 8.14 (d, J=6.4 Hz, 1H), 8.06 (d, J=7.2 Hz, 1H), 7.94 (t, J=7.2 Hz, 1H), 7.87 (s, 1H), 7.76 (s, 1H), 7.30 (d, J=7.2 Hz, 1H), 3.93 (d, J=6.8 Hz, 2H), 3.01 (d, J=5.6 Hz, 2H), 2.77 (s, 2H), 1.65 (s, 3H), 1.26 (t, J=6.4 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10911,"Example 80: Synthesis of 1-ethyl-N-(2-(methyl sulfonyl)ethyl)-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10912,"<img> id-US20180008574A1-20180111-C00098.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10913,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.64 (d, J=8.4 Hz, 1H), 8.16-8.10 (m, 3H), 7.96 (t, J=7.6 Hz, 1H), 7.33 (d, J=7.6 Hz, 1H), 3.94 (q, J=6.8 Hz, 2H), 3.23 (t, J=6.8 Hz, 2H), 3.14 (t, J=6.8 Hz, 2H), 2.97 (s, 3H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10914,"Example 81: Synthesis of 1-ethyl-2-oxo-N-(2-(2-oxoimidazolidin-1-yl)ethyl)-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10915,"<img> id-US20180008574A1-20180111-C00099.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10916,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.66 (d, J=8.0 Hz, 1H), 8.14 (d, J=6.4 Hz, 1H), 8.08 (d, J=7.2 Hz, 1H), 7.92 (d, J=6.4 Hz, 2H), 7.29 (d, J=7.2 Hz, 1H), 6.23 (s, 1H), 3.93 (d, J=6.4 Hz, 2H), 3.18 (d, J=7.2 Hz, 2H), 3.09-3.02 (m, 4H), 2.86-2.84 (m, 2H), 1.26 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10917,"Example 82: Synthesis of tert-butyl(4-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)butyl)carbamate
",1,data/dev/US20180008574A1.txt,0
10918,"<img> id-US20180008574A1-20180111-C00100.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10919,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.67 (d, J=8.4 Hz, 1H), 8.13 (d, J=6.8 Hz, 1H), 8.06 (d, J=7.6 Hz, 1H), 7.93 (t, J=7.6 Hz, 1H), 7.76 (s, 1H), 7.29 (d, J=7.6 Hz, 1H), 6.67 (s, 1H), 3.92 (d, J=7.2 Hz, 2H), 2.91-2.64 (m, 4H), 1.26 (s, 9H), 1.25-1.24 (m, 4H), 1.24 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10921,"<img> id-US20180008574A1-20180111-C00101.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10922,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 10.48 (s, 1H), 10.34 (s, 1H), 8.62 (d, J=8.4 Hz, 1H), 8.12 (d, J=7.6 Hz, 1H), 8.06 (d, J=7.6 Hz, 1H), 7.99-7.70 (m, 3H), 7.41 (d, J=8.8 Hz, 1H), 7.23 (d, J=7.6 Hz, 1H), 3.88 (q, J=6.8 Hz, 2H), 1.98 (d, J=8.4 Hz, 3H), 1.22 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10923,"Example 84: Synthesis of tert-butyl3-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)pyrrolidine-1-carboxylate
",1,data/dev/US20180008574A1.txt,0
10924,"<img> id-US20180008574A1-20180111-C00102.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10925,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.62 (d, J=8.4 Hz, 1H), 8.23 (d, J=7.6 Hz, 1H), 8.13 (d, J=7.2 Hz, 1H), 7.85 (t, J=7.6 Hz, 1H), 6.95 (d, J=7.6 Hz, 1H), 5.10 (d, J=7.2 Hz, 1H), 4.00 (q, J=7.2 Hz, 2H), 3.86 (d, J=4.8 Hz, 1H), 3.48-3.30 (m, 2H), 3.29-3.26 (m, 1H), 3.07-3.03 (m, 1H), 1.94-1.87 (m, 2H), 1.48-1.29 (m, 12H).
",1,data/dev/US20180008574A1.txt,0
10926,"Example 85: Synthesis of tert-butyl3-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)azetidine-1-carboxylate
",1,data/dev/US20180008574A1.txt,0
10928,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.60 (d, J=8.4 Hz, 1H), 8.14 (d, J=7.6 Hz, 1H), 8.12 (d, J=6.8 Hz, 1H) 7.85 (t, J=7.6 Hz, 1H), 6.92 (d, J=7.6 Hz, 1H), 5.31 (d, J=8.8 Hz, 1H), 4.11 (d, J=8.0 Hz, 1H), 4.01-3.95 (m, 4H), 3.56 (s, 2H), 1.44-1.30 (m, 12H).
",1,data/dev/US20180008574A1.txt,0
10929,"Example 86: Synthesis of N-(2-cyclohexylethyl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10931,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J=8.4 Hz, 1H), 8.19 (d, J=7.6 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 7.84 (t, J=7.2 Hz, 1H), 6.93 (d, J=7.5 Hz, 1H), 4.41 (t, J=6.0 Hz, 1H), 3.99 (q, J=7.2 Hz, 2H), 2.97 (dd, J=13.2, 6.8 Hz, 2H), 1.39-1.37 (m, 4H), 1.28-1.25 (m, 6H), 1.13-1.08 (m, 2H), 1.02-0.97 (m, 2H), 0.96-0.89 (m, 2H).
",1,data/dev/US20180008574A1.txt,0
10932,"Example 87: Synthesis of I-ethyl-2-oxo-N-(pyrrolidin-3-yl)-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10934,"The synthesis of tert-butyl3-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido) pyrrolidine-1-carboxylate can refer to 84.
",1,data/dev/US20180008574A1.txt,0
10936,"Example 88: Synthesis of N-(azetidin-3-yl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10938,"The synthesis can refer to Example 87. 1H NMR (400 MHz, d-DMSO) δ 8.78 (d, J=7.6 Hz, 1H), 8.61 (d, J=8.4 Hz, 2H), 8.18 (d, J=7.2 Hz, 1H), 8.10 (d, J=7.6 Hz, 1H), 7.99 (t, 7.2 Hz, 1H), 7.33 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 3.86 (t, J=9.2 Hz, 2H), 3.66 (s, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10939,"Example 89: Synthesis of 1-ethyl-N-hexyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10941,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.4 Hz, 1H), 8.14 (d, J=7.2 Hz, 1H), 8.07 (d, J=7.6 Hz, 1H), 8.00-7.83 (m, 1H), 7.76 (t, J=6.0 Hz, 1H), 7.29 (d, J=7.6 Hz, 1H), 3.93 (q, J=7.2 Hz, 2H), 2.75 (dd, J=12.8, 6.4 Hz, 2H), 1.35-1.12 (m, 6H), 1.09-0.88 (m, 6H), 0.67 (t, J=6.8 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10942,"Example 90: Synthesis of I-ethyl-2-oxo-N-(2-(pyrrolidin-1-yl)ethyl)-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10944,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.2 Hz, 1H), 8.17 (d, J=6.8 Hz, 1H), 8.12 (d, J=7.6 Hz, 1H), 7.96 (t, J=7.6 Hz, 1H), 7.33 (d, J=7.6 Hz, 1H), 4.00-3.88 (m, 2H), 3.18-3.02 (m, 3H), 2.85 (s, 4H), 1.73 (s, 3H), 1.28 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10945,"Example 91: Synthesis of 1-ethyl-2-oxo-N-(2-(tetrahydro-2H-pyran-4-yl)ethyl)-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10947,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.69 (d, J=8.4 Hz, 1H), 8.16 (d, J=7.2 Hz, 1H), 8.08 (d, J=7.6 Hz, 1H), 7.96 (t, J=7.6 Hz, 1H), 7.78 (s, 1H), 7.30 (d, J=7.6 Hz, 1H), 3.93 (t, J=7.2 Hz, 2H), 3.63 (dd, J=11.2, 3.6 Hz, 2H), 2.89 (t, J=11.2 Hz, 2H), 2.80 (d, J=4.8 Hz, 2H), 1.35-1.10 (m, 8H), 0.90-0.86 (m, 2H).
",1,data/dev/US20180008574A1.txt,0
10948,"Example 92: Synthesis of 1-ethyl-2-oxo-N-(tetrahydrofuran-3-yl)-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10949,"<img> id-US20180008574A1-20180111-C00110.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10950,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.69 (d, J=8.4 Hz, 1H), 8.16 (d, J=6.0 Hz, 2H), 8.11 (d, J=7.6 Hz, 1H), 7.95 (t, J=7.6 Hz, 1H), 7.32 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 3.72 (s, 1H), 3.64 (dd, J=14.4, 7.2 Hz, 1H), 3.59-3.44 (m, 2H), 1.81-1.76 (m, 1H), 1.53 (dd, J=12.4, 6.0 Hz, 1H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10951,"Example 93: Synthesis of N-(2-(4-chlorophenoxy)ethyl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10952,"<img> id-US20180008574A1-20180111-C00111.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10953,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.61 (d, J=8.4 Hz, 1H), 8.19 (d, J=7.6 Hz, 1H), 8.09 (d, J=7.2 Hz, 1H), 7.82 (t, J=7.6 Hz, 1H), 7.10 (d, J=8.8 Hz, 2H), 6.88 (d, J=7.6 Hz, 1H), 6.51 (d, J=8.8 Hz, 2H), 5.08 (t, J=6.0 Hz, 1H), 3.97 (q, J=7.2 Hz, 2H), 3.88 (t, J=5.2 Hz, 2H), 3.37 (dd, J=10.8, 5.2 Hz, 2H), 1.38 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10954,"Example 94: Synthesis of N,1-diethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10955,"<img> id-US20180008574A1-20180111-C00112.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10956,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.65 (d, J=8.4 Hz, 1H), 8.20 (d, J=7.6 Hz, 1H), 8.12 (d, J=6.8 Hz, 1H), 7.84 (t, J=7.6 Hz, 1H), 6.93 (d, J=7.6 Hz, 1H), 4.52 (s, 1H), 3.99 (q, J=7.2 Hz, 2H), 3.02 (t, J=7.2 Hz, 2H), 1.39 (t, J=7.2 Hz, 3H), 1.08 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10957,"Example 95: Synthesis of 1-ethyl-2-oxo-N-pentyl-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10958,"<img> id-US20180008574A1-20180111-C00113.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10959,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.6 Hz, 1H), 8.11 (d, J=6.8 Hz, 1H), 7.84 (t, J=7.6 Hz, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.54 (d, J=6.0 Hz, 1H), 3.99 (q, J=7.2 Hz, 2H), 2.94 (q, J=6.8 Hz, 2H), 1.40 (q, J=7.2 Hz, 5H), 1.16 (d, J=6.4 Hz, 4H), 0.75 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10960,"Example 96: Synthesis of 1-ethyl-N-methyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10961,"<img> id-US20180008574A1-20180111-C00114.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10962,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J=8.4 Hz, 1H), 8.19 (d, J=7.6 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 7.83 (t, J=7.6 Hz, 1H), 6.94 (d, J=7.6 Hz, 1H), 4.49 (d, J=5.2 Hz, 1H), 3.99 (q, J=7.2 Hz, 2H), 2.65 (d, J=5.2 Hz, 3H), 1.39 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10963,"Example 97: Synthesis of N-cyclohexyl-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10964,"<img> id-US20180008574A1-20180111-C00115.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10965,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.61 (d, J=8.4 Hz, 1H), 8.20 (d, J=7.6 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 7.84 (t, J=7.2 Hz, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.52 (d, J=7.6 Hz, 1H), 3.99 (q, J=7.2 Hz, 2H), 3.29-2.92 (m, 1H), 1.75-1.63 (m, 2H), 1.58-1.50 (m, 1H), 1.49-1.46 (m, 1H), 1.40 (t, J=7.2 Hz, 3H), 1.25-1.05 (m, 6H).
",1,data/dev/US20180008574A1.txt,0
10966,"Example 98: Synthesis of tert-butyl3-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)piperidine-1-carboxylate
",1,data/dev/US20180008574A1.txt,0
10967,"<img> id-US20180008574A1-20180111-C00116.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10968,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.60 (d, J=8.4 Hz, 1H), 8.21 (d, J=7.6 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 7.84 (t, J=7.6 Hz, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.87 (s, 1H), 3.98 (q, J=7.2 Hz, 2H), 3.47-3.16 (m, 4H), 3.02 (dd, J=13.2, 7.2 Hz, 1H), 1.67-1.53 (m, 2H), 1.47-1.25 (m, 14H).
",1,data/dev/US20180008574A1.txt,0
10969,"Example 99: Synthesis of 1-ethyl-N-isobutyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfon amide
",1,data/dev/US20180008574A1.txt,0
10970,"<img> id-US20180008574A1-20180111-C00117.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10971,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.6 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 7.84 (t, J=7.6 Hz, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.61 (t, J=6.4 Hz, 1H), 3.99 (q, J=7.2 Hz, 2H), 2.75 (t, J=6.4 Hz, 2H), 1.67 (dt, J=13.2, 6.8 Hz, 1H), 1.39 (t, J=7.2 Hz, 3H), 0.81 (d, J=6.8 Hz, 6H).
",1,data/dev/US20180008574A1.txt,0
10972,"Example 10: Synthesis of 1-ethyl-2-oxo-N-propyl-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10973,"<img> id-US20180008574A1-20180111-C00118.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10974,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.65 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.6 Hz, 1H), 8.10 (d, J=7.2 Hz, 1H), 7.92-7.68 (m, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.66 (t, J=6.0 Hz, 1H), 3.98 (q, J=7.2 Hz, 2H), 2.91 (dd, J=13.2, 6.8 Hz, 2H), 1.46 (dt, J=14.4, 7.2 Hz, 2H), 1.39 (t, J=7.2 Hz, 3H), 0.80 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10975,"Example 101: Synthesis of 1-ethyl-N-(3-(4-methylpiperazin-1-yl)propyl)-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10976,"<img> id-US20180008574A1-20180111-C00119.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10977,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.4 Hz, 1H), 8.16 (d, J=6.8 Hz, 1H), 8.08 (d, J=7.2 Hz, 1H), 7.95 (t, J=7.6 Hz, 1H), 7.78 (s, 1H), 7.31 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 2.79 (d, J=5.6 Hz, 2H), 2.23-1.86 (m, 11H), 1.48-1.33 (m, 2H), 1.28 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10978,"Example 102: Synthesis of 1-ethyl-2-oxo-N-(2-(piperidin-1-yl)ethyl)-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10979,"<img> id-US20180008574A1-20180111-C00120.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10980,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.4 Hz, 1H), 8.15 (d, J=6.8 Hz, 1H), 8.10 (d, J=7.6 Hz, 1H), 7.94 (t, J=7.6 Hz, 1H), 7.67 (s, 1H), 7.30 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 2.88 (t, J=6.4 Hz, 2H), 2.23-2.11 (m, 2H), 2.10-2.01 (m, 3H), 1.30-1.22 (m, 7H), 0.94-0.65 (m, 2H).
",1,data/dev/US20180008574A1.txt,0
10981,"Example 103: Synthesis of N-(4,4-diethoxybutyl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10982,"<img> id-US20180008574A1-20180111-C00121.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10983,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.67 (d, J=8.4 Hz, 1H), 8.14 (d, J=6.8 Hz, 1H), 8.06 (d, J=7.6 Hz, 1H), 7.93 (t, J=7.6 Hz, 1H), 7.79 (t, J=5.2 Hz, 1H), 7.29 (d, J=7.6 Hz, 1H), 4.18 (s, 1H), 3.92 (q, J=6.8 Hz, 2H), 3.42-3.31 (m, 2H), 3.23-3.17 (m, 2H), 2.78 (d, J=5.2 Hz, 2H), 1.35-1.21 (m, 7H), 0.95 (t, J=6.8 Hz, 6H).
",1,data/dev/US20180008574A1.txt,0
10985,"<img> id-US20180008574A1-20180111-C00122.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10986,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.61 (d, J=8.4 Hz, 1H), 8.19 (d, J=7.6 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 7.96-7.69 (m, 1H), 6.93 (d, J=7.6 Hz, 1H), 5.35 (t, J=6.4 Hz, 1H), 4.01-3.96 (m, 4H), 3.19 (dd, J=12.4, 6.4 Hz, 2H), 2.48 (t, J=6.0 Hz, 2H), 1.39 (t, J=7.2 Hz, 3H), 1.18 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10987,"Example 105: Synthesis of 1-ethyl-N-((1-ethylpyrrolidin-2-yl)methyl)-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10988,"<img> id-US20180008574A1-20180111-C00123.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10989,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.68 (d, J=8.4 Hz, 1H), 8.12 (dd, J=10.4, 7.2 Hz, 2H), 7.96-7.78 (m, 1H), 6.90 (d, J=7.6 Hz, 1H), 3.98 (q, J=7.2 Hz, 2H), 3.67 (d, J=5.6 Hz, 1H), 3.46 (s, 1H), 3.37 (dd, J=14.4, 7.6 Hz, 2H), 3.19 (dd, J=14.4, 3.2 Hz, 1H), 2.87 (s, 1H), 2.76 (s, 1H), 2.15-1.80 (m, 5H), 1.38 (t, J=7.2 Hz, 6H).
",1,data/dev/US20180008574A1.txt,0
10990,"Example 106: Synthesis of 1-ethyl-N-(1-methylpiperidin-4-yl)-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10991,"<img> id-US20180008574A1-20180111-C00124.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10992,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.4 Hz, 1H), 8.14 (d, J=7.2 Hz, 1H), 8.09 (d, J=7.6 Hz, 1H), 7.93 (dd, J=12.4, 5.6 Hz, 2H), 7.29 (d, J=7.6 Hz, 1H), 3.93 (q, J=7.2 Hz, 2H), 2.93 (s, 1H), 2.58 (d, J=11.2 Hz, 2H), 2.06 (s, 3H), 1.82 (s, 2H), 1.44 (d, J=10.4 Hz, 2H), 1.38-1.35 (m, 2H), 1.27 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
10993,"Example 107: Synthesis of N-cycloheptyl-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10994,"<img> id-US20180008574A1-20180111-C00125.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10995,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.63 (d, J=8.4 Hz, 1H), 8.21 (d, J=7.6 Hz, 1H), 8.13 (d, J=7.2 Hz, 1H), 7.93-7.60 (m, 1H), 6.94 (d, J=7.6 Hz, 1H), 4.55 (d, J=8.0 Hz, 1H), 4.01 (q, J=7.2 Hz, 2H), 3.50-3.20 (m, 1H), 1.73-1.69 (m, 2H), 1.55-0.99 (m, 15H).
",1,data/dev/US20180008574A1.txt,0
10996,"Example 108: Synthesis of 1-ethyl-2-oxo-N-(tetrahydro-2H-pyran-4-yl)-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
10997,"<img> id-US20180008574A1-20180111-C00126.TIF </img>
",1,data/dev/US20180008574A1.txt,0
10998,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.61 (d, J=8.4 Hz, 1H), 8.21 (d, J=7.6 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 7.93-7.77 (m, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.65 (d, J=8.0 Hz, 1H), 3.99 (q, J=7.2 Hz, 2H), 3.82 (d, J=12.0 Hz, 2H), 3.44-3.34 (m, 1H), 3.30 (t, J=10.8 Hz, 2H), 1.69 (d, J=13.2 Hz, 2H), 1.51-1.35 (m, 5H).
",1,data/dev/US20180008574A1.txt,0
10999,"Example 64: Synthesis of tert-butyl4-(2-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)ethyl)piperazine-1-carboxylate
",1,data/dev/US20180008574A1.txt,0
11000,"<img> id-US20180008574A1-20180111-C00127.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11001,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.63 (d, J=8.4 Hz, 1H), 8.19 (d, J=7.6 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 7.93-7.75 (m, 1H), 6.93 (d, J=7.6 Hz, 1H), 5.35 (s, 1H), 3.99 (q, J=7.2 Hz, 2H), 3.28-3.10 (m, 4H), 2.98 (s, 2H), 2.41-2.23 (m, 2H), 2.16-2.04 (m, 4H), 1.47-1.30 (m, 12H).
",1,data/dev/US20180008574A1.txt,0
11002,"Example 110: Synthesis of N-cyclohexyl-1-methyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11003,"<img> id-US20180008574A1-20180111-C00128.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11004,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.70 (d, J=8.4 Hz, 1H), 8.14 (d, J=7.6 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 8.02-7.89 (m, 1H), 7.85 (d, J=7.6 Hz, 1H), 7.23 (d, J=7.6 Hz, 1H), 3.38 (s, 3H), 2.94 (s, 1H), 1.57-1.33 (m, 5H), 1.04-0.88 (m, 5H).
",1,data/dev/US20180008574A1.txt,0
11005,"Example 64: Synthesis of N-butyl-1-methyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11006,"<img> id-US20180008574A1-20180111-C00129.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11007,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.68 (d, J=8.4 Hz, 1H), 8.15 (d, J=7.2 Hz, 1H), 8.08 (d, J=7.6 Hz, 1H), 7.99-7.83 (m, 1H), 7.77 (s, 1H), 7.25 (d, J=7.6 Hz, 1H), 3.39 (s, 3H), 2.74 (d, J=3.2 Hz, 2H), 1.27 (dd, J=14.8, 7.2 Hz, 2H), 1.15 (dd, J=14.8, 7.2 Hz, 2H), 0.70 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11008,"Example 112: Synthesis of N-cyclohexyl-2-oxo-1-propyl-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11009,"<img> id-US20180008574A1-20180111-C00130.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11010,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.62 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.2 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 7.83 (t, 7.2 Hz, 1H), 6.91 (d, J=7.6 Hz, 1H), 4.57 (d, J=7.6 Hz, 1H), 3.89 (t, J=7.2 Hz, 2H), 3.31-3.03 (m, 1H), 1.82 (dt, J=14.8, 7.2 Hz, 2H), 1.74-1.64 (m, 2H), 1.57-1.56 (m, 2H), 1.48 (d, J=12.4 Hz, 1H), 1.17-1.08 (m, 4H), 1.02 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11011,"Example 113: Synthesis of 2-oxo-N,1-dipropyl-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11012,"<img> id-US20180008574A1-20180111-C00131.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11013,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.6 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 7.94-7.66 (m, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.60 (t, J=6.0 Hz, 1H), 3.89 (t, J=7.2 Hz, 2H), 2.92 (d d, J=13.6, 6.8 Hz, 2H), 1.78 (dt, J=14.4, 7.2 Hz, 2H), 1.44 (dt, J=14.4, 7.2 Hz, 2H), 1.01 (t, J=7.2 Hz, 3H), 0.81 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11014,"Example 114: Synthesis of N-butyl-2-oxo-1-propyl-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11015,"<img> id-US20180008574A1-20180111-C00132.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11016,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.64 (d, J=8.4 Hz, 1H), 8.18 (d, J=7.6 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 7.84 (dd, J=8.2, 7.2 Hz, 1H), 6.92 (d, J=7.6 Hz, 1H), 4.51 (t, J=6.0 Hz, 1H), 3.90 (t, J=7.2 Hz, 2H), 2.94 (dd, J=13.2, 6.8 Hz, 2H), 1.88-1.70 (m, 2H), 1.50-1.33 (m, 2H), 1.23 (dt, J=14.4, 7.2 Hz, 3H), 1.01 (t, J=7.2 Hz, 3H), 0.78 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11017,"Example 115: Synthesis of N-butyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11018,"<img> id-US20180008574A1-20180111-C00133.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11019,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 11.13 (s, 1H), 8.68 (d, J=8.4 Hz, 1H), 8.11 (d, J=7.2 Hz, 1H), 8.03 (d, J=7.6 Hz, 1H), 7.98-7.87 (m, 1H), 7.74 (t, J=5.6 Hz, 1H), 7.06 (d, J=7.6 Hz, 1H), 2.74 (dd, J=13.2, 6.8 Hz, 2H), 1.35-1.19 (m, 2H), 1.19-0.98 (m, 2H), 0.69 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11020,"Example 116: Synthesis of N-butyl-1-isobutyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11021,"<img> id-US20180008574A1-20180111-C00134.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11022,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 8.69 (d, J=8.4 Hz, 1H), 8.16 (d, J=7.2 Hz, 1H), 8.06 (d, J=7.6 Hz, 1H), 8.03-7.83 (m, 1H), 7.77 (t, J=6.0 Hz, 1H), 7.30 (d, J=7.6 Hz, 1H), 3.72 (d, J=7.2 Hz, 2H), 2.76 (dd, J=12.8, 6.8 Hz, 2H), 2.15 (dt, J=13.2, 6.8 Hz, 1H), 1.37-1.21 (m, 2H), 1.18-1.10 (m, 2H), 0.93 (s, 3H), 0.91 (s, 3H), 0.68 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11023,"Example 117: Synthesis of N-cyclohexyl-1-isobutyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11024,"<img> id-US20180008574A1-20180111-C00135.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11025,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) 8.70 (d, J=8.4 Hz, 1H), 8.12 (d, J=7.2 Hz, 1H), 8.08 (d, J=7.6 Hz, 1H), 8.08-7.93 (m, 1H), 7.85 (t, J=6.0 Hz, 1H), 7.30 (d, J=7.6 Hz, 1H), 3.71 (d, J=7.2 Hz, 2H), 2.94 (s, 1H), 2.08-1.96 (m, 1H), 1.47-1.36 (m, 5H), 1.05-0.90 (m, 5H).
",1,data/dev/US20180008574A1.txt,0
11026,"Example 118: Synthesis of N-cyclohexyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11027,"<img> id-US20180008574A1-20180111-C00136.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11028,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 11.10 (s, 1H), 8.69 (d, J=8.4 Hz, 1H), 8.09 (d, J=6.8 Hz, 1H), 8.04 (d, J=7.6 Hz, 1H), 7.96-7.87 (m, 1H), 7.81 (d, J=7.6 Hz, 1H), 7.04 (d, J=7.6 Hz, 1H), 2.93 (s, 1H), 1.58-1.30 (m, 5H), 1.06-0.98 (m, 5H).
",1,data/dev/US20180008574A1.txt,0
11029,"Example 119: Synthesis of N-(3-acetylphenyl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11030,"<img> id-US20180008574A1-20180111-C00137.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11031,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 10.82 (s, 1H), 8.70 (d, J=8.4 Hz, 1H), 8.19 (d, J=7.6 Hz, 1H), 8.13 (d, J=6.8 Hz, 1H), 7.95 (t, J=7.6 Hz, 1H), 7.65-7.46 (m, 2H), 7.39-7.24 (m, 3H), 3.88 (q, J=6.8 Hz, 2H), 2.45 (s, 3H), 1.22 (t, J=7.2 Hz, 3H). 13C NMR (500 MHz, d-DMSO) δ 197.1, 166.6, 143.4, 138.0, 137.5, 133.5, 130.7, 129.6, 128.9, 127.4, 126.0, 125.2, 124.8, 123.9, 123.8, 123.2, 117.7, 103.9, 34.6, 26.5, 13.5.
",1,data/dev/US20180008574A1.txt,0
11032,"Example 120: Synthesis of N-(4-chlorophenyl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11033,"<img> id-US20180008574A1-20180111-C00138.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11034,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.54 (d, J=8.4 Hz, 1H), 8.09 (d, J=7.6 Hz, 2H), 7.79 (t, J=7.6 Hz, 1H), 7.13 (d, J=8.4 Hz, 2H), 6.94 (d, J=8.4 Hz, 2H), 6.90 (s, 1H), 6.85 (d, J=7.6 Hz, 1H), 3.95 (q, J=7.2 Hz, 2H), 1.36 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11035,"Example 121: Synthesis of 1-ethyl-2-oxo-N-phenyl-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11036,"<img> id-US20180008574A1-20180111-C00139.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11037,"The synthesis can refer to Example 67. 1H NMR (400 MHz, d-DMSO) δ 10.56 (s, 1H), 8.69 (d, J=8.4 Hz, 1H), 8.16-8.11 (m, 2H), 7.93 (t, J=7.6 Hz, 1H), 7.26 (d, J=7.6 Hz, 1H), 7.16 (t, J=7.6 Hz, 2H), 7.04 (d, J=7.6 Hz, 2H), 6.94 (t, J=7.2 Hz, 1H), 3.89 (q, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11038,"Example 122: Synthesis of N-(2-chlorophenyl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11039,"<img> id-US20180008574A1-20180111-C00140.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11040,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.51 (d, J=8.4 Hz, 1H), 8.14 (d, J=7.6 Hz, 1H), 8.07 (d, J=7.2 Hz, 1H), 7.77 (t, J=7.6 Hz, 1H), 7.66 (d, J=8.4 Hz, 1H), 7.22 (t, J=7.6 Hz, 1H), 7.13 (d, J=7.6 Hz, 2H), 6.99 (t, J=7.6 Hz, 1H), 6.84 (d, J=7.6 Hz, 1H), 3.94 (q, J=7.2 Hz, 2H), 1.35 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11041,"Example 123: Synthesis of N-(3-chlorophenyl)-1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
",1,data/dev/US20180008574A1.txt,0
11042,"<img> id-US20180008574A1-20180111-C00141.TIF </img>
",1,data/dev/US20180008574A1.txt,0
11043,"The synthesis can refer to Example 67. 1H NMR (400 MHz, CDCl3) δ 8.55 (d, J=8.4 Hz, 1H), 8.16 (d, J=7.6 Hz, 1H), 8.10 (d, J=7.2 Hz, 1H), 7.80 (t, J=7.6 Hz, 1H), 7.16-7.01 (m, 3H), 6.93-6.82 (m, 2H), 3.96 (d, J=7.2 Hz, 2H), 1.37 (t, J=7.2 Hz, 3H).
",1,data/dev/US20180008574A1.txt,0
11380,"<img> id-US20180016269A1-20180118-C00016.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11382,"<img> id-US20180016269A1-20180118-C00017.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11384,"<img> id-US20180016269A1-20180118-C00018.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11386,"<img> id-US20180016269A1-20180118-C00019.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11390,"<img> id-US20180016269A1-20180118-C00021.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11392,"<img> id-US20180016269A1-20180118-C00022.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11394,"<img> id-US20180016269A1-20180118-C00023.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11396,"<img> id-US20180016269A1-20180118-C00024.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11398,"<img> id-US20180016269A1-20180118-C00025.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11400,"<img> id-US20180016269A1-20180118-C00026.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11402,"<img> id-US20180016269A1-20180118-C00027.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11404,"<img> id-US20180016269A1-20180118-C00028.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11406,"<img> id-US20180016269A1-20180118-C00029.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11408,"<img> id-US20180016269A1-20180118-C00030.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11410,"<img> id-US20180016269A1-20180118-C00031.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11412,"<img> id-US20180016269A1-20180118-C00032.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11414,"<img> id-US20180016269A1-20180118-C00033.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11416,"<img> id-US20180016269A1-20180118-C00034.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11418,"<img> id-US20180016269A1-20180118-C00035.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11420,"<img> id-US20180016269A1-20180118-C00036.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11422,"<img> id-US20180016269A1-20180118-C00037.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11424,"<img> id-US20180016269A1-20180118-C00038.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11426,"<img> id-US20180016269A1-20180118-C00039.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11428,"<img> id-US20180016269A1-20180118-C00040.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11430,"<img> id-US20180016269A1-20180118-C00041.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11432,"<img> id-US20180016269A1-20180118-C00042.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11434,"<img> id-US20180016269A1-20180118-C00043.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11436,"<img> id-US20180016269A1-20180118-C00044.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11438,"<img> id-US20180016269A1-20180118-C00045.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11440,"<img> id-US20180016269A1-20180118-C00046.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11442,"<img> id-US20180016269A1-20180118-C00047.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11444,"<img> id-US20180016269A1-20180118-C00048.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11446,"<img> id-US20180016269A1-20180118-C00049.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11448,"<img> id-US20180016269A1-20180118-C00050.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11450,"<img> id-US20180016269A1-20180118-C00051.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11452,"<img> id-US20180016269A1-20180118-C00052.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11454,"<img> id-US20180016269A1-20180118-C00053.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11456,"<img> id-US20180016269A1-20180118-C00054.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11458,"<img> id-US20180016269A1-20180118-C00055.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11460,"<img> id-US20180016269A1-20180118-C00056.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11462,"<img> id-US20180016269A1-20180118-C00057.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11464,"<img> id-US20180016269A1-20180118-C00058.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11466,"<img> id-US20180016269A1-20180118-C00059.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11468,"<img> id-US20180016269A1-20180118-C00060.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11470,"<img> id-US20180016269A1-20180118-C00061.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11472,"<img> id-US20180016269A1-20180118-C00062.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11474,"<img> id-US20180016269A1-20180118-C00063.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11476,"<img> id-US20180016269A1-20180118-C00064.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11478,"<img> id-US20180016269A1-20180118-C00065.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11480,"<img> id-US20180016269A1-20180118-C00066.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11482,"<img> id-US20180016269A1-20180118-C00067.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11484,"<img> id-US20180016269A1-20180118-C00068.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11486,"<img> id-US20180016269A1-20180118-C00069.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11488,"<img> id-US20180016269A1-20180118-C00070.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11490,"<img> id-US20180016269A1-20180118-C00071.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11492,"<img> id-US20180016269A1-20180118-C00072.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11494,"<img> id-US20180016269A1-20180118-C00073.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11496,"<img> id-US20180016269A1-20180118-C00074.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11498,"<img> id-US20180016269A1-20180118-C00075.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11500,"<img> id-US20180016269A1-20180118-C00076.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11502,"<img> id-US20180016269A1-20180118-C00077.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11504,"<img> id-US20180016269A1-20180118-C00078.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11506,"<img> id-US20180016269A1-20180118-C00079.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11508,"<img> id-US20180016269A1-20180118-C00080.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11517,"<img> id-US20180016269A1-20180118-C00081.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11530,"<img> id-US20180016269A1-20180118-C00082.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11532,"<img> id-US20180016269A1-20180118-C00083.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11534,"<img> id-US20180016269A1-20180118-C00084.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11536,"<img> id-US20180016269A1-20180118-C00085.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11538,"<img> id-US20180016269A1-20180118-C00086.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11540,"<img> id-US20180016269A1-20180118-C00087.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11542,"<img> id-US20180016269A1-20180118-C00088.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11544,"<img> id-US20180016269A1-20180118-C00089.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11546,"<img> id-US20180016269A1-20180118-C00090.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11548,"<img> id-US20180016269A1-20180118-C00091.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11550,"<img> id-US20180016269A1-20180118-C00092.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11552,"<img> id-US20180016269A1-20180118-C00093.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11554,"<img> id-US20180016269A1-20180118-C00094.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11556,"<img> id-US20180016269A1-20180118-C00095.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11558,"<img> id-US20180016269A1-20180118-C00096.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11560,"<img> id-US20180016269A1-20180118-C00097.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11562,"<img> id-US20180016269A1-20180118-C00098.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11564,"<img> id-US20180016269A1-20180118-C00099.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11566,"<img> id-US20180016269A1-20180118-C00100.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11568,"<img> id-US20180016269A1-20180118-C00101.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11570,"<img> id-US20180016269A1-20180118-C00102.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11572,"<img> id-US20180016269A1-20180118-C00103.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11574,"<img> id-US20180016269A1-20180118-C00104.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11576,"<img> id-US20180016269A1-20180118-C00105.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11578,"<img> id-US20180016269A1-20180118-C00106.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11580,"<img> id-US20180016269A1-20180118-C00107.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11582,"<img> id-US20180016269A1-20180118-C00108.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11584,"<img> id-US20180016269A1-20180118-C00109.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11586,"<img> id-US20180016269A1-20180118-C00110.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11588,"<img> id-US20180016269A1-20180118-C00111.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11590,"<img> id-US20180016269A1-20180118-C00112.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11592,"<img> id-US20180016269A1-20180118-C00113.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11594,"<img> id-US20180016269A1-20180118-C00114.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11596,"<img> id-US20180016269A1-20180118-C00115.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11598,"<img> id-US20180016269A1-20180118-C00116.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11600,"<img> id-US20180016269A1-20180118-C00117.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11602,"<img> id-US20180016269A1-20180118-C00118.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11604,"<img> id-US20180016269A1-20180118-C00119.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11606,"<img> id-US20180016269A1-20180118-C00120.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11608,"<img> id-US20180016269A1-20180118-C00121.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11610,"<img> id-US20180016269A1-20180118-C00122.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11612,"<img> id-US20180016269A1-20180118-C00123.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11614,"<img> id-US20180016269A1-20180118-C00124.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11616,"<img> id-US20180016269A1-20180118-C00125.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11618,"<img> id-US20180016269A1-20180118-C00126.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11620,"<img> id-US20180016269A1-20180118-C00127.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11622,"<img> id-US20180016269A1-20180118-C00128.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11624,"<img> id-US20180016269A1-20180118-C00129.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11626,"<img> id-US20180016269A1-20180118-C00130.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11628,"<img> id-US20180016269A1-20180118-C00131.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11630,"<img> id-US20180016269A1-20180118-C00132.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11632,"<img> id-US20180016269A1-20180118-C00133.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11634,"<img> id-US20180016269A1-20180118-C00134.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11636,"<img> id-US20180016269A1-20180118-C00135.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11665,"From: & (20 g) & (150 g) & (3.5 kg) & (8 kg) & (60 kg)
",0,data/dev/US20180016269A1.txt,1
11698,"6. EDCI: 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
",0,data/dev/US20180016269A1.txt,1
11703,"11. HOAt: 1-hydroxy-7-azabenzotriazole
",0,data/dev/US20180016269A1.txt,1
11704,"12. HPLC: high pressure liquid chromatography
",0,data/dev/US20180016269A1.txt,1
11707,"15. MeOH: methanol
",0,data/dev/US20180016269A1.txt,1
11714,"22. THF: tetrahydrofuran
",0,data/dev/US20180016269A1.txt,1
11716,"Intermediate 1
",1,data/dev/US20180016269A1.txt,0
11721,"Intermediate 2
",1,data/dev/US20180016269A1.txt,0
11725,"Example 1
",1,data/dev/US20180016269A1.txt,0
11730,"Intermediate 1
",1,data/dev/US20180016269A1.txt,0
11734,"Example 2
",1,data/dev/US20180016269A1.txt,0
11738,"Example 3. Synthesis of Exemplary Compounds
",1,data/dev/US20180016269A1.txt,0
11847,"Example 4. N1-(2-(4-((Z)-1,2-Diphenylbut-1-en-1-yl)phenoxy)ethyl)-N11-((S)-1-((2S,4R)-4-hydroxy-2-((4-(quinazolin-6-yl)benzyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)-N1-methylundecanediamide
",0,data/dev/US20180016269A1.txt,1
11848,"<img> id-US20180016269A1-20180118-C00177.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11867,"<img> id-US20180016269A1-20180118-C00182.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11869,"<img> id-US20180016269A1-20180118-C00183.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11889,"<img> id-US20180016269A1-20180118-C00184.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11891,"<img> id-US20180016269A1-20180118-C00185.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11923,"<img> id-US20180016269A1-20180118-C00193.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11927,"<img> id-US20180016269A1-20180118-C00194.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11934,"<img> id-US20180016269A1-20180118-C00195.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11973,"<img> id-US20180016269A1-20180118-C00196.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11978,"<img> id-US20180016269A1-20180118-C00197.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11983,"<img> id-US20180016269A1-20180118-C00198.TIF </img>
",0,data/dev/US20180016269A1.txt,1
11991,"<img> id-US20180016269A1-20180118-C00199.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12004,"<img> id-US20180016269A1-20180118-C00200.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12007,"<img> id-US20180016269A1-20180118-C00201.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12016,"<img> id-US20180016269A1-20180118-C00202.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12027,"<img> id-US20180016269A1-20180118-C00203.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12038,"<img> id-US20180016269A1-20180118-C00204.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12041,"<img> id-US20180016269A1-20180118-C00205.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12052,"<img> id-US20180016269A1-20180118-C00206.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12099,"<img> id-US20180016269A1-20180118-C00207.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12138,"<img> id-US20180016269A1-20180118-C00208.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12141,"<img> id-US20180016269A1-20180118-C00209.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12144,"<img> id-US20180016269A1-20180118-C00210.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12147,"<img> id-US20180016269A1-20180118-C00211.TIF </img>
",0,data/dev/US20180016269A1.txt,1
12233,"EXAMPLE 1. Procedure for obtaining compounds of formula XIV.
",0,data/dev/EP3305797A1.txt,1
12235,"Phenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopyranoside, 12
",1,data/dev/EP3305797A1.txt,0
12238,"Phenyl 2,3,4-tri-O-acetyl-1-thio-α-L-arabinopyranoside, 13.
",1,data/dev/EP3305797A1.txt,0
12242,"Phenyl 1-thio-β-D-galactopyranoside, 14
",1,data/dev/EP3305797A1.txt,0
12245,"Phenyl 1-thio-α-L-arabinopyranoside, 15.
",1,data/dev/EP3305797A1.txt,0
12248,"1.3. Preparation of 3,4-O-isopropylidene acetals.
",0,data/dev/EP3305797A1.txt,1
12249,"Phenil 3,4-O-isopropylidene-1-thio-β-D-galactopyranoside, 16.
",1,data/dev/EP3305797A1.txt,0
12252,"Phenyl 3,4-O-isopropylidene-1-thio-α-L-arabinopyranoside, 17.
",1,data/dev/EP3305797A1.txt,0
12255,"1.4. Selective protection of the primary hydroxyl.
",1,data/dev/EP3305797A1.txt,0
12256,"Phenyl 3,4-O-isopropylidene-6-O-tert-butyldiphenylsilyl-1-thio-β-D-galactopyranoside, 18
",1,data/dev/EP3305797A1.txt,0
12259,"1.5. Reaction of the hydroxyl in position 2 with p-fluorobenzyl derivatives.
",0,data/dev/EP3305797A1.txt,1
12263,"Phenyl 2-O-(p-fluorobenzyl)-3,4-O-isopropylidene-1-thio-α-L-arabinopyranoside, 20.
",1,data/dev/EP3305797A1.txt,0
12271,"2-O-(p-fluorobenzyl)-3,4-O-isopropylidene-α,β-L-arabinopyranoside, 22.
",1,data/dev/EP3305797A1.txt,0
12281,"2.2. Glycosidation of trichloroacetimidate.
",1,data/dev/EP3305797A1.txt,0
12282,"Derived from galactose 25 and 26:
",1,data/dev/EP3305797A1.txt,0
12284,"α: anomer of (R)-{1-[3,5-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-3,4-O-isopropylidene-6-O-tert-butyldiphenylsilyl-α-D-galactopyranoside, 25
",0,data/dev/EP3305797A1.txt,1
12285,"<img> id-imgb0036.tif </img>
",0,data/dev/EP3305797A1.txt,1
12288,"<img> id-imgb0037.tif </img>
",0,data/dev/EP3305797A1.txt,1
12290,"Derivatives of L-arabinose 8 and 7:
",1,data/dev/EP3305797A1.txt,0
12292,"(R)-{1-3,5-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-3,4-O-isopropylidene-β-L-arabinopyranoside, 8.
",0,data/dev/EP3305797A1.txt,1
12293,"<img> id-imgb0038.tif </img>
",0,data/dev/EP3305797A1.txt,1
12295,"(R)-{1-3,5-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-3,4-O-isopropylidene-α-L-arabinopyranoside, 7.
",0,data/dev/EP3305797A1.txt,1
12296,"<img> id-imgb0039.tif </img>
",0,data/dev/EP3305797A1.txt,1
12298,"EXAMPLE 3. Selective deprotection of position 6.
",1,data/dev/EP3305797A1.txt,0
12299,"General procedure
",1,data/dev/EP3305797A1.txt,0
12301,"Alpha anomer: (R)-{1-[3,5-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-3,4-O-isopropylidene-α-D-galactopyranose, 27.
",1,data/dev/EP3305797A1.txt,0
12307,"EXAMPLE 4. Deprotection of positions 3 and 4.
",1,data/dev/EP3305797A1.txt,0
12308,"General procedure
",1,data/dev/EP3305797A1.txt,0
12324,"EXAMPLE 5.
",1,data/dev/EP3305797A1.txt,0
12329,"Beta anomer: (R)-{1-[3,5-bis-(trifluoromethyl)phenyl]ethyl} 2-O-p-fluorobenzyl-(R)-[4,5-O-benzylidene]-β-D-D-galactopyranoside, 1
",1,data/dev/EP3305797A1.txt,0
12771,"II. Synthesis Procedures
",0,data/dev/US20180057448A1.txt,1
12816,"II.B. Synthesis Procedures for (R)-1f and (S)-1f
",0,data/dev/US20180057448A1.txt,1
12821,"Synthesis of (R)-4-benzyl-3-(3-phenylpropanoyl)oxazolidin-2-one ((R)-12)
",1,data/dev/US20180057448A1.txt,0
